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Abstract 
This thesis examines Escherichia coli pyruvate kinase type 1 (PK1), a regulatory enzyme 
core to energy metabolism. Specifically, this thesis characterises a series of mutations in 
PK1 that were found when populations of E. coli were evolved in a glucose-limited 
environment for 20,000 generations. The gene pykF, which codes for the PK1 enzyme, 
was found to have developed nonsynonymous mutations in all replicate populations. 
Although the mutations at the nucleotide level were not the same (i.e. not parallel), it is not 
clear whether parallel adaptation exists at the protein structure/function level. This study 
aimed to address this question by investigating the kinetic and biophysical properties of the 
wild-type and seven mutant enzymes. 
The recombinant wild-type PK1 enzyme used in this study was found to have steady state 
kinetics consistent with those previously reported. Unlike the rabbit kidney PK enzyme, 
E. coli PK1 was shown to have a very tight tetrameric structure (picomolar range), which 
was not affected by the enzyme’s substrates (PEP and ADP), or the allosteric effector 
(FBP), as judged by analytical ultracentrifugation with fluorescence detection. 
The mutated residues were highly conserved, and found to fall loosely into three groups: 
those at the active site (P70T, P70Q and D127N); those at the subunit interface (I264F, 
A301T and A301S); and at the allosteric binding site (G381A). The seven mutated PK1 
enzymes were obtained by mutagenesis followed by protein purification. Steady state 
kinetic analysis showed that the mutated enzymes displayed a variety of functional changes, 
suggesting that the populations had not evolved in a parallel manner at the enzyme 
structure/function level. 
Mutations within the active site (P70T, P70Q and D127N) all showed a decrease in 
catalytic potency. P70 is located at the hinge connecting the A and B domains, which 
forms the active site. PK1-P70Q showed strong cooperative binding to PEP, similar to 
the wild-type enzyme, in the absence of FBP, whereas PK1-P70T had little cooperativity, 
suggesting changes in the active site. PK1-D127N showed severely attenuated activity, 
suggesting, for the first time, that this residue is essential for catalysis. Mutations at the 
subunit interface (I264F, A301T and A301S) all showed altered allosteric regulation, 
suggesting that this interface is important in the FBP allosteric response. PK1-I264F, 
which had lower activity, but greater affinity for PEP, displayed a decreased α-helix 
content (as judged by CD), indicating that a subunit interface helix that includes this 
residue had altered. Despite still having a similar response to FBP, PK1-G381A showed 
an increased affinity for PEP, which, together with an increased α-helix content, suggests 
that this mutation had changed the structure of the FBP binding domain. None of the 
mutated enzymes showed altered quaternary structure. 
Although the populations evolved parallel changes with respect to cell physiology, fitness, 
and gene expression, this study suggests, for the first time, that the populations have not 
evolved in a parallel way with respect to protein structure and function. 
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Chapter 1 
Introduction 
 
The work presented in this thesis examines the role of the seven mutations in pyruvate 
kinase identified from an adaptive evolutionary experiment.  The aim is to describe how 
the mutations have altered the catalytic and/or regulatory mechanisms of pyruvate kinase 
and relate these back to the adaptive evolution experiment. In this chapter, the 
background to both the evolution experiment and the structure and function of pyruvate 
kinase will be discussed. Firstly, the evolutionary background of this study is introduced, 
followed by an overview of pyruvate kinase from Escherichia coli. More detailed 
information on the structure and function of this enzyme, together with the regulatory 
pattern, which was core to this research, is then presented. Finally, the sequence and 
structural positions of the mutants studied in this research are illustrated. 
1.1 Lenski’s evolutionary experiment 
Parallel and convergent changes across lineages are two main themes of evolution (Cooper 
et al. 2003). These different concepts are distinguished on the basis that parallelism 
describes the changes of homologous features among closely related organisms, whereas 
convergence occurs in antecedent features among less related organisms (Simpson 1953). 
Under these situations, derived similarity results from adaptation by natural selection, 
provided the base pool of all possible changes is so large that the similarity is unlikely to 
have evolved by a random process (Woods et al. 2006). The degree of parallelism is very 
hard to quantify in a natural system, as it involves the quantification of parallelism in 
nature (Pelosi et al. 2006; Woods et al. 2006). Bias in the estimated degree of the 
parallelism may exist, when the outcomes caused by parallelism are miscounted 
(downward bias), or the subtle changes in the environment are not included (upward bias) 
(Woods et al. 2006). On the other hand, well designed evolutionary experiments using 
fast evolving populations (usually viruses or bacteria) provide an excellent tool to study 
parallelism (Elena & Lenski 2003; Lenski et al. 1991; Wichman et al. 1999).  The 
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advantage of these systems is that the environment is well controlled and is usually 
constant and identical for each evolving population (usually derived from a single ancestor 
to avoid initial genetic difference) and thus all the systematic differences are controlled 
(Lenski 1991; Lenski et al. 1991; Lenski & Travisano 1994). 
 
Two decades ago, Lenski and colleagues began an ongoing evolution study using a 
bacterial strain of Escherichia coli B (Lenski et al. 1991). In the founder study, twelve 
populations of E. coli were evolved in a constant glucose-limited environment.  The 
experimental system was designed such that no initial genetic variance existed among the 
populations, since all the strains arose from a single E. coli cell. The experimental 
environment was kept as uniform and identical as possible. Later studies examined this 
system for morphological, physiological and genetic changes and found altered 
morphology (i.e. cell size) and improved mean fitness (determined by competition assays 
with the ancestor) in all the evolved populations (Cooper & Lenski 2000; Lenski & 
Travisano 1994) (Figure 1.1). 
 
 
Figure 1.1      Trajectory of mean fitness of E. coli during 20,000 generations in a glucose- 
limited environment. Figure was regenerated from (Cooper & Lenski 2000). 
 
The pattern in which the populations evolved also suggested that the independently derived 
genotypes adapted to the glucose-limited environment by similar changes in physiological 
mechanisms for glucose utilisation (Travisano & Lenski 1996). Thus, the populations 
appeared to be evolving in a parallel way. 
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DNA transcriptional profiles in two populations were examined by DNA expression arrays 
on all 4,290 genes from the E. coli genome (Cooper et al. 2003). This expression profile 
of the E. coli genome is a composite phenotype from which parallelism can be assessed 
(Cooper et al. 2003). Remarkably, this research found that the 59 genes with significantly 
changed expression profile were changed in the same direction relative to the ancestor, 
again implying parallelism. 
 
A more recent genetic study compared the pattern of mutational substitutions in candidate 
genes and found that the pykF and nadR genes had substitutions in all twelve populations 
(Woods et al. 2006) (Figure 1.2). The pykF gene codes for the enzyme pyruvate kinase 
type 1 (PK1), which is a core regulatory enzyme in the glycolytic pathway. Glycolysis is 
an important pathway for bacterial survival, especially in the glucose-limited environment 
used in the evolutionary experimental system (Lenski et al. 1991). Thus, it would seem 
that at a genetic level the populations have developed changes in parallel (i.e. the same 
genes carry persistent mutations in all populations). 
 
 
Figure 1.2      Positions of the substituted amino acids mutated during 20,000 generations 
in candidate genes pykF and nadR in 12 experimental populations of E. coli. Lighter regions 
indicate the protein-coding sequences for pykF (panel A) and nadR (panel B). Long bars below 
show the sequence range, short bars show the scale (200 bp). Each arrow marks a mutation, the 
number shows the population identity (+ means the population contained a mutual genetic marker, 
and – means the population did not have the marker): *, An IS150 insertion; Δ, A 1-bp deletion; and 
§, A synonymous mutation. Figure was taken directly from (Woods et al. 2006). 
 
Although the same genes sustained mutations, at the nucleotide level the mutations were 
different, changing residues throughout the enzyme. It could be concluded therefore that 
mutations were not parallel at the nucleotide level, but the affect of the mutations on 
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enzyme function is not known. Many studies have documented how the twelve 
populations adapted to the glucose limiting environment (i.e. with altered morphology, 
gene expression and improved fitness); however, it is not known how the genotypic 
changes affected phenotype. Here, this question is asked for the first time from a 
biochemical perspective by studying the affects of the mutations found in PK1. 
1.2 Glycolysis 
Glycolysis is the metabolic pathway that breaks down glucose to pyruvate and generates 
energy in the form of ATP and NADH. During the process, the six-carbon glucose is split 
into two three-carbon sugars which are then oxidised to form pyruvate by several 
enzyme-catalysed reactions. 
 
There are three major regulatory enzymes in glycolysis: hexokinase, phophofructokinase 
and pyruvate kinase [ATP:pyruvate 2-O-phosphotransferase (E.C. 2.7.1.40), PK], which 
together control the metabolic flux in this pathway in virtually every cell type (Allert et al. 
1991; Fothergill & Michels 1992) (Figure 1.3). 
 
Figure 1.3       An overview of the glycolysis. Pyruvate kinase controls the second part of 
the pathway, and is activated by FBP and PEP. The figure was adapted from (Mattevi et al. 1996).  
 
Pyruvate is the first non-phosphorylated sugar generated in this process and can feed into a 
number of metabolic processes (Campbell et al. 1999). This reaction is essentially 
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irreversible under physiological conditions, and PK is allosterically regulated by 
fructose-1,6-bisphosphate (FBP) in order to control metabolic flux. PK is thus at a 
primary metabolic regulation point (Mattevi et al. 1995). 
1.3 Pyruvate kinase 
1.3.1 Reaction 
Pyruvate kinase is an ancient protein that existed before the split of eukaryotes and 
prokaryotes, as indicated by a similar glycolytic pathway in both eukaryotes and 
prokaryotes (Hattori et al. 1995). PK catalyses the transfer of a phosphoryl group from 
phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP), generating ATP and 
pyruvate (Figure 1.4). It requires monovalent (K+) and divalent cations (Mg2+or Mn2+) to 
assist its function.  
O O-
OPO3
2-
O O-
O
ADP + H+                         ATP
Mg2+, K+
Pyruvate Kinase
PEP                                                            Pyruvate 
Figure 1.4       Reaction catalysed by pyruvate kinase 
 
PK1 is regulated by its substrate PEP homotropically (i.e. the binding of one PEP molecule 
favours the binding of a second PEP) and kinetically characterised by sigmoidal activity in 
response to increased PEP concentrations. Most of the PK isozymes are also 
heterotropically regulated (i.e. binding of a ligand affects the binding of a different ligand, 
often at a distant position to the active site) by sugars with one or two phosphoryl groups 
(Fenton 2008). The nature of the heterotropic effector varies among isozymes from 
different sources (Mattevi et al. 1996; Munoz & Ponce 2003). 
1.3.2 Kinetics 
Kinetic studies of PK from different sources found that the substrate PEP binds 
cooperatively, with mammalian muscle PKM1 the only exception (Muirhead et al. 1986; 
Munoz & Ponce 2003). However, when an allosteric effector is present, the kinetic 
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pattern for PEP changes to Michaelis-Menten type behaviour, and the enzyme has a much 
greater affinity for PEP (Fenton & Blair 2002; Valentini et al. 2000; Valentini et al. 2002). 
Despite that, the maximal capacity of the enzyme does not change, as shown by the 
enzyme turnover number (kcat) (Valentini et al. 2000; Valentini et al. 2002) or the maximal 
velocity (Vmax) (Fenton & Blair 2002). ADP binding, on the other hand, was barely 
affected by the allosteric effector (Fenton & Blair 2002; Lovell et al. 1998; Valentini et al. 
2000; Valentini et al. 2002). 
 
PK requires monovalent (K+, H+) and divalent cations (Mg2+ or Mn2+) for function 
(Mesecar & Nowak 1997a). It has been suggested that the divalent cation orients the 
phospho-groups of PEP and ADP in the active site, before the phosphotransfer takes place 
(Munoz & Ponce 2003). K+ has a critical role to the random substrate binding pattern of 
PK. It has been reported that without K+ present, ADP binding is dependent on the 
binding of PEP (Oria-Hernandez et al. 2005). 
 
The E. coli PK1 investigated in this study is allosterically regulated by FBP (Mattevi et al. 
1996; Mattevi et al. 1995; Valentini et al. 2000). In a previous study, it was found that 
FBP changed the enzyme affinity for PEP dramatically (PEP concentration at half of 
maximal velocity from 3.6 mM (FBP free) to 0.08 mM (FBP present)) (Valentini et al. 
2000). Cooperative binding of PEP was abolished in the presence of FBP, with Hill 
constant changing from 3.2 (strong positive cooperativity) to 1.0 (no cooperativity) 
(Valentini et al. 2000). 
1.3.3 Sequence alignment 
Generally, PK consists of four identical (or very similar) subunits, each composed of 
approximately 500 residues (Muirhead et al. 1986). E. coli PK1 has three domains: A 
(residues 1-70, residues 171-345), B (residues 71-170) and C (residues 352-470) (Mattevi 
et al. 1995). In addition to these principal domains, an N-terminal domain is found in 
mammalian PK (residues 1-42 of cat muscle PK) (Muirhead et al. 1986), and a C-terminal 
domain is observed in some organisms (residues 476-587 of Bacillus Stearothermophilus 
PK) (Sakai & Ohta 1993); both are absent in E. coli PK1. Many pyk genes have been 
sequenced and some are cloned because of their important role in glycolysis regulation and 
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interesting properties (Munoz & Ponce 2003). The sequence alignment of some of the 
genes with known protein structures is shown in Figure 1.5, using the online multiple 
sequence alignment tool CLUSTALW (http://align.genome.jp/). The sequence 
differences are not randomly distributed, with the highest diversity observed in domain B, 
when domain A is highly conserved and domain C sequences are variable.  
 
Figure 1.5      Alignment of the PK sequences from different sources with structures 
solved. The origins of these sequences are: Escherichia coli type 1 (bacterium); Saccharomyces 
cerevisiae (yeast); Leishmania maxicana (Leishmania); Felis silvestris catus (cat); Oryctolagus 
cuniculus M (rabbit); Rattus norvegicus M (rat); and Homo sapiens R/L (M15465). The residues 
thought to be involved in binding PEP and ADP/ATP are indicated with P and A, respectively. D 
and M indicate the ligands for divalent and monovalent cations. The vertical bars identify the 
domain boundaries and domains were labelled. Point mutations found in the evolutionary study 
(Woods et al. 2006) are identified are coloured. h and e indicate the residues belonged to α-helix 
and β-sheet. Conserved residues are marked with (*), conservative substitutions are marked with 
(:), and semi-conservative substitutions are marked with (.). The absolutely conserved Aα6’ helix is 
highlighted with a border. The alignment used the online program CLUSTAL W. The mutated 
residues investigated in this study are coloured. 
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1.3.4 Structure 
The monomeric molecular mass of PK is generally around 55 kDa (Aust & Suelter 1978; 
Malcovati & Valentini 1982). Although the majority of PK isozymes appear to be 
tetrameric (Mattevi et al. 1995; Rigden et al. 1999), many other forms, including a 
monomer, dimer and hexamer are also known (Munoz & Ponce 2003). 
 
The crystal structure of pyruvate kinase has been obtained from various sources including 
rabbit muscle (Larsen et al. 1998), yeast Saccharomyces cerevisiae (Jurica et al. 1998), 
protozoan parasite Leshmania mexicana (Rigden et al. 1999), bacterial E. coli type 1 
(Mattevi et al. 1995), human erythrocyte isozyme (Pendergrass et al. 2006; Valentini et al. 
2002), and human tumor pyruvate kinase M2 (Dombrauckas et al. 2005). The overall 
structure of these pyruvate kinase isozymes is similar (Munoz & Ponce 2003).  
 
E. coli PK1 is a homotetramer (Figure 1.6a). Each subunit can be divided into three 
domains: domain A forms a large (β/α)8-barrel structure, a fold common in enzymes 
(Mattevi et al. 1996); domain B, which is characterised by a small irregular β barrel; and 
domain C, which has an (α+β) open sheet topology (Figure 1.6b). The allosteric FBP 
binding site is located in domain C near the C/C’ interface, and the active site lies within a 
cleft between domains A and B (Figure 1.6b) (Mattevi et al. 1995).  Upon binding the 
effector FBP, the enzyme conformation changes from a low-affinity T-state to a 
high-affinity R-state for the substrates (Mattevi et al. 1995) (Section 1.3.6). 
 
E. coli PK1 crystallises in the low affinity T-state and the addition of FBP has been shown 
to crack PK1 crystals (Mattevi et al. 1995), whereas yeast (S. cerevisiae) pyruvate kinase 
crystallises with FBP at the high-affinity R-state conformation (Jurica et al. 1998). 
Mammalian muscle PK (PKM1), an enzyme that lacks sigmoidal kinetics, is likely to 
adopt an active R-state conformation (Muirhead 1990; Walker et al. 1992). Data obtained 
from these X-ray crystallographic studies have been used to interpret the allosteric 
regulation of the enzyme, which is still not fully understood. 
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Figure 1.6       Structure of E. coli PK1.  (a) the quaternary structure, and (b) the monomeric 
structure. The structure is generated by PDB file 1pky (Mattevi et al. 1995) using Pymol (DeLano 
2002). 
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The FBP binding site is in domain C, near the A/C domain interface (Figure 1.8). The 
site is clearly shown in the structure of yeast PK co-crystallised with FBP (Jurica et al. 
1998). The 6’-phosphate fits in a pocket with residues with positive side chains (residues 
402-407 in yeast PK), which are not completely conserved. In E. coli PK1, a similar 
pocket is observed (Figure 1.8); however, it is not clear whether FBP binds at the same 
position, due to the absence of crystal structures with FBP bound.
1.3.4.2 The FBP binding site 
 
The active site lies in the pocket between domains A and B. A high degree of sequence 
identity among PK isozymes has been observed (Munoz & Ponce 2003) (Figure 1.5). 
The residues involved in constructing the active site have been identified in rabbit muscle 
PKM1 (Larsen et al. 1998; Larsen et al. 1994) and the corresponding residues in E. coli 
PK1 are shown in Figure 1.7. 
1.3.4.1 The active site 
 
 
Figure 1.7       Schematic drawing of the proposed residues at the active site and involved in cation binding in E. coli PK1. Drawing was based on 
residues at the corresponding positions of the rabbit muscle PKM1 (Larsen et al. 1994). (a) A side view of the active site. The residues that bind to divalent 
cations (D246 and E222) are shown in purple sticks; the residues involved in pyruvate binding (K220 and T278) are shown in yellow sticks; the residues that 
directly bind to the monovalent cation (N34, S36, D66 and T67) are shown in blue sticks. P70 and D127N, which were mutated in this study, are shown in red 
and orange sticks respectively. The helices to which the residues belong are marked in italics. (b) A top view of the active site with all residues labelled as in 
(a), and all α-helices labelled in italics. Loop 6 is shaded in dark green and labelled. This picture was generated using PDB file 1pky (Mattevi et al. 1995) by 
Pymol (DeLano 2002).
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Figure 1.8       FBP binding site of yeast PK with FBP bound and structural alignment with 
E. coli PK1. (a) The structural alignment between yeast PK and E. coli PK1; (b) An expanded view 
at the FBP binding site; (c) Surface image of the FBP binding pocket in yeast PK, with FBP bound; 
(d) proposed FBP binding pocket in E. coli PK1, with FBP placed at the same orientation as in yeast 
PK. The E. coli PK1 structure is shown in green and yeast PK in blue. FBP is represented in 
yellow and orange sticks. The r.m.s.d. value for the Cα overlay is 1.7 Å. Figure was generated 
using PDB files 1pky (E. coli PK1) (Mattevi et al. 1995) and 1a3w (yeast PK) (Jurica et al. 1998) by 
Pymol (DeLano 2002). 
1.3.5 Structural changes upon catalysis 
Comparison between the tertiary structures of E. coli PK1 and rabbit PKM1 obtained from 
crystallographic studies revealed large variations in the domain orientations, while the 
structure within each domain is highly conserved (Larsen et al. 1994; Mattevi et al. 1995).  
When taking domain A as a reference, a rotation of 17° in domain B was observed, which 
caused a narrowing of the active-site cleft in the rabbit PKM1 model. This movement is 
achieved through a hinge-bending action. P70, which is located on this flexible hinge as 
a domain linker, may play a crucial role in this conformation change (Mattevi et al. 1996). 
Structural studies have demonstrated this for the rabbit PKM1 enzyme (Larsen et al. 1997) 
(Figure 1.9), where causes the opening or closing of the active site. The residue is 
mutated in this study. 
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Figure 1.9       Schematic drawing of the hinge-bending action between domains A and B 
in rabbit PKM1. (a) Overlay of the α-carbons of subunit 1 (red, closed active site cleft) and 2 (blue, 
open active site cleft). The spheres represent the linkers. (b) A ball-and-stick model of the K+ 
binding site for the open (green) and closed (yellow) cleft. K+ is shown as a green sphere. Figure 
was directly copied from Larsen et al. (1997). 
 
Residue D127 is located on a loop at domain B in E. coli PK1 (Figure 1.5). D177 in the 
rabbit muscle PK, which corresponds to D127 in E. coli PK1, pokes into the active site in 
the rabbit muscle PK enzyme upon the hinge-bending motion (Mattevi et al. 1995). 
D127N is also mutated in this study. 
1.3.6 Regulation 
The kinetic properties of pyruvate kinase have been extensively studied, together with 
site-directed mutagenesis and crystallographic data, to elucidate the regulation mechanism 
of the enzyme (Bond et al. 2000; Fenton & Blair 2002; Friesen et al. 1998b; Jurica et al. 
1998; Lovell et al. 1998; Mattevi et al. 1996; Valentini et al. 2000; Wooll et al. 2001). 
Thus far, a definitive mechanism has been elusive, although a number of allosteric 
regulation models have been proposed. 
 
1.3.6.1 The Domain Rotation model 
As an allosterically regulated enzyme, PK undergoes a transition from a low-affinity 
T-(tensed) state to a high-affinity R-(relaxed) state. The R-state subunits bind to substrate 
more readily than those in the T-state (Monod et al. 1965). 
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Figure 1.10       Schematic comparisons of the T-state (a, E. coli PK1 (Mattevi et al. 1995)) 
and R-state (b, rabbit M1 PK (Larsen et al. 1994)) tetramers. The set of motions that affect 
domain and subunit orientations are outlined. Figure was taken from (Mattevi et al. 1995). 
 
In E. coli PK1, the FBP binding site is distal to the active site and the allosteric signal 
needs to be transmitted across the domain interface to reach the active site (Jurica et al. 
1998; Valentini et al. 2002). In the “domain rotation model”, Mattevi and colleagues 
(studying E. coli PK1) argued that the transition between T- and R-states requires little 
motion within domains, but rather involves rigid body motion between domains and within 
the subunits (Mattevi et al. 1996; Mattevi et al. 1995; Valentini et al. 2000). By 
comparing the crystal structures of E. coli PK1 in the T-state with the rabbit muscle M1 
isozyme (which resembles the R-state conformation (Mattevi et al. 1995)) (Figure 1.10), 
large orientation differences were found between domains. These were functionally 
relevant since they affected the shape and space of the domain interfaces in which the 
active site and the allosteric site lie (Mattevi et al. 1995). Structural elements must exist 
for the coupling of domain movements to the conformational change at the active site 
(Mattevi et al. 1996; Mattevi et al. 1995). It was found that loop 6 of the (β/α)8-barrel 
(shaded green in Figure 1.5 and Figure 1.7b), which takes part in PEP binding, appears to 
be in a conformation that distorts the active site, as observed in the T-state crystal (Mattevi 
et al. 1995). This implies that the domain rotation upon FBP binding may restore the 
active site and therefore assist PEP binding. Structural information regarding the R-state 
of PK1 in complex with the activator FBP, and with substrates PEP and ADP, is still not 
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available for the E. coli enzyme to support this regulation mechanism. These structural 
studies need to be complemented with mutagenesis studies of PK1 enzymes with altered 
allosteric regulation, such as reported in this work. 
 
1.3.6.2 “Network mechanism” model 
An alternative model, the so called network mechanism, was proposed by Friesen and 
colleagues, in their studies of recombinant rabbit muscle (rRMPK) and kidney (rRKPK) 
pyruvate kinases (Friesen et al. 1998a; Friesen et al. 1998b). rRMPK shows 
non-allosteric kinetic behaviour whereas rRKPK shows allostery with respect to 
phenylalanine and FBP, even though they differ by only 22 residues (Friesen et al. 1998a). 
Friesen et al. (1998b) show that for the rRKPK enzyme, the tetramer dissociates to a 
(presumably less active) dimer at the C/C’ subunit interface and that this process is 
modulated by FBP (which promotes tetramer formation) and phenylalanine and the 
substrate ADP (which promote dimer formation). However, this work did not consider 
how the signal was transferred from the allosteric binding site to the active site. 
 
Using both molecular modelling and site-directed mutagenesis, coupled with enzyme 
kinetics, it was hypothesised that all the substrates and effectors of pyruvate kinase 
communicated through the C/C’ subunit interface (Friesen et al. 1998b), and the allosteric 
signal is transmitted from the C/C’ subunit interface to the active site through a hydrogen 
bonding network (Friesen et al. 1998a). This mechanism proposed that only a few 
residues serve pivotal roles in coupling a conformational change in the C/C’ subunit 
interfacial region to the active site (Friesen et al. 1998a). K421 (K368 in E. coli) forms a 
salt bridge with Y443 (Y390), which in turn interacts with A319 (A301) at the C-terminal 
of Aα6. This helix spans the length of the subunit and the loop at the N-terminal end of 
this helix makes up part of the PEP binding site (Friesen et al. 1998a). A further 
structural study suggested that in the mammalian enzymes the R- and T-states are 
somewhat modulated by an intersubunit salt bridge between D127 and R289 (E. coli 
numbering), a connection which is not evident in the E. coli structures. The mechanism 
involved in this model is still under investigation.  
 
Despite the two models, no conclusion about the allosteric signal transfer mechanism of E. 
coli PK1 has yet been drawn. 
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1.3.6.3 Phosphotyrosine peptide binding 
Recently, Christofk and colleagues proposed a third mechanism of regulation, by which the 
mammalian tumour isozyme (PKM2) binds phosphotyrosine peptides, which results in loss 
of FBP binding, thus releasing the enzyme from activation (Christofk et al. 2008a; 
Christofk et al. 2008b). The phosphotyrosine peptide binds near the FBP-binding site 
(unique in PKM2) and lysine 433 was found to be important for the interaction. A similar 
mechanism was not found in other mammalian PK isozyme (Christofk et al. 2008b).  No 
study has reported whether E. coli PK1 is regulated in this fashion in vitro or in vivo. 
1.4 The PK1 mutants 
The seven PK1 mutants investigated in this study were identified by Woods and colleagues 
(Woods et al. 2006). They identified two genes (nadR and pykF) that had mutations in all 
twelve evolved populations (Section 1.2), another that had mutations in six populations 
(pbpA-radA) and the fourth mutated gene (hokB/socB) was found in three populations 
(Woods et al. 2006). The position of each PK1 mutation in the populations is shown in 
Figure 1.2. Interestingly, four separately evolved populations showed mutations at the 
same residue of PK1: A301. In theory, after just 10,000 generations, each base pair in the 
genome was, on average, mutated over a 100 times, although genetic drift eliminates most 
changes immediately (Elena & Lenski 2003; Lenski et al. 1991). It is therefore likely that 
the mutations found in pykF were selected for. 
 
The positions of the seven mutations were mapped onto the known E. coli PK1 structure 
(Figure 1.11). They fall loosely into three groups: those in or near the active site (P70T, 
P70Q and D127N); those in or near to the subunit interface between the A domains (A/A’ 
interface, I264F, A301T and A301S); and that within the FBP binding site (G381A). 
While the mutations at the active site were predicted to affect catalysis, several studies 
have found that PK1 enzymes with mutations at both the FBP binding site and the subunit 
interfaces lead to changes of kinetic behaviour or allosteric regulation pattern (Christofk et 
al. 2008b; Collins et al. 1995; Friesen et al. 1998a; Mattevi et al. 1996; Valentini et al. 
2000). Therefore, mutations in the FBP and subunit interfaces (as predicted by the 
domain rotation model of allostery) were predicted to alter regulation. 
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1.4.1 Active site mutations 
Residue P70 is highly conserved across species (Munoz & Ponce 2003) (Figure 1.5).  
Interestingly, the adjacent residue E71 (in domain B) belongs to a group of residues highly 
conserved across species and involved in the construction of the active site (Figure 1.5) 
(Munoz & Ponce 2003). Structural studies suggest that E71 has an critical role in binding 
the monovalent cation (K+) and, interestingly, is replaced by lysine in PK enzymes that 
lack a dependence on monovalent cation (Munoz & Ponce 2003). 
 
 
Figure 1.11       View of the PK1 mutations with respect to their spatial positions. The 
monomeric structure embedding the seven mutations is shown. The mutated residues are 
illustrated as coloured spheres. P70 was mutated to threonine and glutamine. D127 was 
mutated to asparagine, I264 was mutated to phenylalanine, A301 was mutated to threonine and 
serine, and G381 was mutated to alanine. Image was created using PDB:1pky (Mattevi et al. 
1995). 
 
Cation binding is essential for function for the majority of PK isozymes investigated to 
date (Munoz & Ponce 2003). Enzymatic activity is stimulated upon binding to the 
monovalent cation K+ (Boyer et al. 1942; Oria-Hernandez et al. 2005). In yeast PK, 
regulation of FBP to PEP requires the presence of a divalent cation in the active site 
(Mesecar & Nowak 1997a; b). All these studies have implied the significant role of 
residue P70, suggesting that the mutation at this position will affect catalysis and allosteric 
regulation. 
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The residue D127 is situated on a loop that folds into the active site cleft upon ADP 
binding and is strictly conserved among PK sequences (Mattevi et al. 1995). When 
comparing the E. coli PK1 T-state with the rabbit PKM1 model (R-state) it was found that 
in the T-state, the side chain of D297 forms a salt-bridge with R292 from the adjacent 
subunit; however, in the R-state, R292 makes a salt bridge with D127 of the adjacent 
subunit and changes conformation (Figure 1.12). It is proposed that this transition 
represents the real transition process of PK1 from the T-state to R-state during catalysis 
(Mattevi et al. 1995). This transition is crucial for PEP binding at helix α6 in domain A, 
as it reconstructs the subunit interface and forces helix Aα6’ on loop 6 to move towards the 
inner part of the active site for PEP binding (Mattevi et al. 1995) and locks the cleft 
between domain A and B in a closed conformation. A mutagenesis study found that 
R292D caused PK1 to be inactive, though it was able to retain the T-state quaternary 
structure (Valentini et al. 2000). It is possible that the R292D mutant is unable to bind to 
D127 to “lock the cleft”. Therefore, the transition for the enzyme from T-state to R-state 
could not occur. 
 
 
Figure 1.12      Close-up view of the cleft between domain A and B with relevant 
interactions. (a) in the E. coli T-state PK1 and (b) in the rabbit PKM1.  Secondary structure 
elements and the residues belonging to the adjacent subunit (subunit 2) are labeled (r).  Residues 
involved in the E. coli PK1 A/A’ interface connections are illustrated with red sticks and labeled 
(D297 and R292(r)) in (a).  The residues at the corresponding positions in rabbit PKM1 are 
illustrated with red sticks and labeled (D346 and R341(r)).  D127 on the loop of domain B is 
labelled in orange stick in both figures.  Each monomer across the A/A’ interface in both structures 
is pale green, and purple for the E. coli structure (a) and pale purple for the rabbit muscle structure 
(b).  The secondary structure is labeled in italics.  Figure was adapted from (Mattevi et al. 1995), 
PDB 1pky (E. coli PK1) and 1a49 (rabbit PKM1). 
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Given the putative role of D127, altered catalytic function (via interactions with the active 
site upon ADP binding as seen in the rabbit muscle PK1, PDB: 1a49) and altered 
regulation (via interactions with the adjacent subunit as discussed above) were thus 
predicted for PK1-D127N in this study. 
1.4.2 A/A’ interface mutations 
The residues I264 and A301 are situated at the A/A’ interface and are close together in 
space (Figure 1.13). Sequence analysis among PK1 enzymes from a variety of organisms 
showed that I264 and A301 were well conserved across species (Figure 1.5). Mutations 
at these positions were of particular interest, since allosteric binding is thought to promote 
domain movements, interface rearrangements, or changes in oligomeric states (Fenton & 
Blair 2002) and thus the PK mutants in this category may inform a new allosteric 
mechanism. 
 
 
Figure 1.13      Position of A301, I264 and D127 relative to the catalytic helices (Aα6 – Aα8).  
A301 is illustrated in blue sticks, I264 in yellow sticks and D127 in orange sticks. Subunit 1 loops 
are illustrated in pale green; the r-related subunit loops are in purple. Aα6’ and loop 6 are 
illustrated in dark green.  The loops are labelled in italics. 
 
The mutations A301T and A301S were found in 4 of the 12 evolved populations in the 
microevolutionary study (1 population showed the mutation A301T and 3 populations 
showed the mutation A301S) (Cooper et al. 2003; Lenski et al. 1998; Lenski & Travisano 
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1994).  Why is this residue in PK1, over all others, a locus for mutation in a low glucose 
environment?  Residues involved in the A/A’ interface contacts are highly conserved 
among PK sequences, with a strikingly high sequence identity (76%) between E. coli PK1 
and rabbit PKM1 in segments Aβ6 to Aα8 (Mattevi et al. 1995).  Residue A301 belongs 
to helix Aα7 (Figure 1.13).  Among the twelve residues that constitute this helix, nine are 
strictly conserved (Figure 1.5, highlighted in red).  Moreover, A301 showed close 
proximity to D297 and R292 in helix Aα7 of the adjacent subunit (Figure 1.14), which are 
critical for the function of PK1 (Mattevi et al. 1996; Mattevi et al. 1995; Valentini et al. 
2000). 
 
Inter-subunit communications were shown to be critical for the allosteric regulation of PK 
(Fenton & Blair 2002); therefore, these two mutations were thus predicted to affect the 
allosteric regulation pattern of E. coli PK1. 
 
 
Figure 1.14      Schematic drawing of the spatial position of A301.  (a) in quaternary 
structure and b) at the A/A’ interface along the r axis away from the centre of the molecule.  A301 is 
illustrated in red spheres, R292 is illustrated in yellow sticks and D297 is in blue sticks. 
1.4.3 FBP binding site mutations 
The residue G381 was the only position in the FBP binding domain to be investigated in 
this study.  G381 belongs to a stretch of conserved residues involved in the formation of 
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the putative FBP binding site (Munoz & Ponce 2003). 
 
Only a subtle change is achieved by changing the glycine residue to an alanine residue, 
leaving the polarity of the residue unaltered.  G381 belongs to the loop connecting strand 
Cβ1 and helix Cα3 (residues 377-383) in PK1, both of which are thought to be involved in 
the binding of FBP at the 6’-phosphate position (Valentini et al. 2000) (Figure 1.15). 
 
 
Figure 1.15     Structure alignments between E. coli PK1 and yeast PK at the FBP binding 
site (domain C). E. coli PK1 is shown in green, and yeast PK in blue. FBP is shown in red and 
orange sticks. The corresponding loop in E. coli PK1 in contact with the 6’-phosphate of FBP is 
shown in red, and the corresponding loop in contact with the 1’-phosphate of FBP is shown in 
orange.  Figure was generated using PDB files 1pky (Mattevi et al. 1995) and 1a3w (Jurica et al. 
1998). 
 
G381 is in close proximity to K382 (Figure 1.16), which was found to be in close 
proximity to R271 across the A/C domain interface that may be involved in the allosteric 
signal transition, and was shown to be involved in the binding of FBP in chemical 
modification studies (Mattevi et al. 1995). This was further supported by the fact that 
T406 in the yeast PK, which is structurally analogous to K382 (E. coli numbering), is 
directly in contact with the 1’-phosphate of FBP (Jurica et al. 1998). A previous study of 
the E. coli PK1-K382Q mutant enzyme resulted in a drastic alteration of enzyme functional 
properties with a 70-fold increase in S0.5 (substrate concentration at 1/2 Vmax in Hill 
cooperative model (Hill 1910)) for FBP and decreases in the kcat/S0.5 for PEP in the absence 
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and presence of FBP (Valentini et al. 2000). They concluded that K382 is crucial for both 
FBP binding and the allosteric equilibrium (Valentini et al. 2000). Another residue, Q379, 
which is in close proximity to G381, was proposed to be crucial for FBP binding in 
allosterically regulated PK. A study of rat PKM1, which exhibited a hyperbolic kinetic 
profile with respect to PEP had glutamate at the corresponding position (E432) to Q379 in 
E. coli PK1 (Ikeda et al. 2000). This suggested the role of E432 in preventing FBP 
binding by repulsive electrostatic interaction (Ikeda et al. 2000). Thus it is possible that a 
subtle change at G381 alters the kinetic properties of PK1, via changes in the FBP binding 
site. 
 
 
Figure 1.16      Schematic drawing shows the position of G381 in the E. coli PK1 dimer. (a) 
the positions of G381, K382 and R271 relative to the tetramer; (b) An expanded view of G381 , K382 
and R271 at domain C. G381 is illustrated in red; K382 in blue and R271 across the cleft on 
domain A in yellow. 
1.5 Aim of this project 
The aim of this study was to define the changes found in the enzyme pyruvate kinase in 
Lenski’s evolution experiment at a molecular level. Although Lenski’s evolved 
populations have been studied from a genetic, physiological and evolutionary perspective, 
no study has looked into the molecular basis of the parallelism observed in the system. 
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This work, therefore, is fundamentally important in understanding how organisms adapt to 
a stable environment at the protein structural-functional level, and is a pivotal step in 
Lenski’s long-term evolution experiment (Lenski et al. 1991).  In addition, the current 
view of the mechanisms of allosteric regulation operating in pyruvate kinase is reviewed. 
The molecular details of the allosteric activation in PK1 have also been studied. 
Specifically, it is hypothesised that the adaptive mutations are altering the regulation of 
PK1. 
 
This work seeks to address the following questions: 
 
(a) Although the replicate populations show parallel evolution at a physiological and 
genetic level, do they also show parallel evolution at a biochemical level? 
(b) Have the mutations affected PK1 regulation or catalytic function? Can these 
mutations allow us to further understand the mechanisms of allosteric regulation in PK1? 
 
The aims of this study are, therefore, to: 
 
1. Obtain the wild-type PK1 enzyme by transforming the plasmid encoding the enzyme 
into E. coli BL21, over-express and purify the protein (Chapter 2). 
2. Characterise the wild-type enzyme using kinetics and structural analysis (secondary and 
quaternary) (Chapter 2) to determine whether E. coli PK1 is in a dimer-tetramer 
equilibrium and whether the substrates and FBP affect this equilibrium. 
3. Obtain PK1 bearing each of the 7 mutations by mutagenesis, transformation, 
over-expression and purification (Chapter 3). 
4. Characterise the seven mutant enzymes using enzyme kinetics (Chapter 3) and structural 
analysis (secondary, quaternary) (Chapter 4).  
5. Relate any experimentally determined altered function back to the evolutionary 
observations of Lenski and others (Chapter 5). 
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Chapter 2 
Functional and structural characterisation of 
the E. coli PK1: wild-type 
 
2.1 Introduction 
Pyruvate kinase type 1 (PK1) from E. coli has been well studied with respect to its role in 
glycolysis and in terms of its structure and function (Mattevi et al. 1996; Mattevi et al. 
1995; Munoz & Ponce 2003; Ponce et al. 1995). In this chapter, the biochemical 
characterisations of the wild-type PK1 were presented, to ensure the clone used in this 
study is consistent with published results and to allow the direct comparison of these data 
with those observed for the later introduced mutants. The kinetic properties of the 
enzyme were examined using the LDH-coupled assay (Section 6.4.1). Circular dichroism 
was used to examine the secondary structure of PK1. In addition, analytical 
ultracentrifugation (AUC) and fluorescence detection coupled with AUC (AUC-FDS) were 
utilised to assess the quaternary structure of this enzyme. A previous paper reported that 
FBP assisted tetramer assembly in rabbit kidney PKRK, whereas ADP prompted the 
tetramer to disassemble into dimers (Friesen et al. 1998b). Therefore, the protein 
association in the presence of substrates PEP and ADP and the effector FBP were also 
tested in this chapter. 
2.2 Expression and purification of the wild-type PK1 
The rigorous biochemical and biophysical characterisation of the wild-type enzyme 
required production and purification of the enzyme in milligram scales. A high 
copy-number plasmid carrying the gene for E. coli PK1 (pykF) was utilised in this study, 
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which facilitated purification of the enzyme from E. coli BL21 cultures, a common 
bacterial expression system. 
2.2.1 Enzyme expression  
The plasmid pGV5A (Valentini et al. 1997), which is a modified pBlueScriptII KS+ 
vector carrying the wild-type PK1 gene (pykF) was kindly donated by Professor Andrea 
Mattevi (University of Pavia, Italy). This plasmid was transformed into E. coli BL21 
(DE3) competent cells by the calcium chloride method (Section 6.2.15). The plasmid 
conferred ampicillin resistance to transformed cells. Transformed cells were cultured 
on a LB plate with ampicillin and incubated overnight. Colonies were subcultured and 
stored in LB-glycerol media at -80 °C. 
 
E. coli BL21 (DE3) cells transformed with pGV5A were cultured in 10 ml of 
LB-ampicillin medium, which was used to inoculate 1 litre of LB-ampicillin medium 
overnight. Over-expression of the enzyme was induced by the addition of 
isopropyl-1-thio-β-D-galactopyranoside (IPTG). A cell-free lysate was produced by 
ultrasonication followed with centrifugation (Section 6.3.3.3). 
2.2.2 Enzyme purification 
The protocol for purification of the wild-type PK1 was adapted from the procedure used 
by Mattevi and colleagues (Mattevi et al. 1996). In each step, the activity of the 
fractions containing the PK1 enzyme was examined using a lactate dehydrogenase (LDH) 
coupled assay (Malcovati & Valentini 1982) (Section 6.4.1). In this assay, pyruvate, 
one of the products of the pyruvate kinase catalysed reaction, was utilised as a substrate 
for LDH. This reaction leads to loss of NADH. Therefore, activity of a fraction is 
correlated to the decrease in absorbance of NADH in the spectrometer at 340 nm. 
 
The purification procedure contained three steps (Section 6.3.3). Initially, the cell free 
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crude extract was subjected to anion exchange chromatography with an increasing salt 
gradient of KCl. The active fractions were then analysed by SDS-PAGE (section 6.3.2) 
(Figure 2.1, lane 3). The pooled fractions contained PK1 (~55 kDa), as judged by 
SDS-PAGE, with highly improved purity as compared to the cell lysate (Figure 2.1, lane 
2). The pooled fractions containing PK1 were then applied to a phenyl-Sepharose 
column for hydrophobic interaction chromatography and eluted with a decreasing 
ammonium sulphate gradient (Section 6.3.3). This step further improved the purity of 
the PK1 enzyme (Figure 2.1, lane 4). Finally, the pooled active fractions from the 
hydrophobic interaction chromatographic step were concentrated by centrifugation and 
purified and desalted by size-exclusion chromatography (Section 6.3.3). The enzyme 
was stored in the desalt buffer containing 10 mM Tris, pH 7.5, with ethylene diamine 
tetra-acetic acid (EDTA, 1 mM) and β-mercaptoethanol (2 mM). The eluent was 
analysed by both the LDH coupled assay and the SDS-PAGE for purity (Figure 2.1, lanes 
5 & 6). 
 
Figure 2.1      SDS-PAGE of the wild-type PK1 purification. Lane 1 shows the molecular 
weight markers with relevant bands indicated. Lane 2 shows the crude extract, lane 3 shows 
pooled fractions after ion exchange chromatography, lane 4 shows pooled fractions after 
phenyl-Sepharose chromatography, lane 5 and 6 show the protein after size exclusion 
chromatography (with 5 µl and 2 µl loaded, respectively). 
 
The protein concentration after each purification step was determined by the Bio-Rad 
protein assay (Section 6.3.1), a modification of the method developed by Bradford, using 
bovine serum albumin (BSA) as a standard (Bradford 1976). Coupled with the 
activities of the eluents determined by the LDH coupled assay, the specific PK1 activities 
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were calculated. The purification table (Table 2.1) showed that the specific activity 
increased throughout the purification. A high yield of enzyme was recovered following 
purification (40%), consistent with the yield achieved in an early study (Valentini et al. 
2000). 
Table 2.1      Purification of the wild-type PK1 from E. coli BL21 (DE3)-pGV5A 
 Proteina Total 
Activityb
Specific 
Activity 
Yield Degree of 
purification 
 (mg) (Uc) (U/mg) (%) (fold) 
Crude extract 236 231 1.0 - - 
Ion exchange 59 197 3.3 85 3.3 
Phenyl-Sepharose 32 142 4.4 61 4.4 
Size exclusion 21 95 4.5 41 4.5 
a Protein obtained per litre culture 
b Activity was determined using the LDH coupled assay. 
c 1 U is defined as the oxidation of 1 µmole of NADH per second. 
 
The pure PK1 enzyme was stored in Tris buffer (10 mM Tris, pH 7.5, with 1 mM EDTA 
and 2 mM β-mercaptoethanol) at -20 °C at equal or less than10 mg/ml without loss of 
activity for up to 9 months (Malcovati & Valentini 1982). 
2.3 Residual PK1 activity in E. coli BL21 (DE3) cells 
The residual PK1 activity of E. coli BL21 (DE3) strain was examined. This was 
important since some of the mutated enzymes examined in Chapter 3 may have low 
activity, in which case contamination by wild-type PK1 may be a confounding factor. 
Therefore, it was necessary to measure the residual PK1 activity as a control for the 
kinetic study. 
 
BL21 (DE3) bacteria (without pGV5A) were cultured in similar conditions to those used 
to grow BL21 (DE3)-pGV5A in a medium without antibiotics, but including IPTG 
(Sections 6.2.7 & 6.3.3). After ultrasonication and the removal of all cell debris, the 
whole cell lysate was subjected to the LDH coupled assay for the PK1 activity test 
(Section 6.4.1). Protein concentration was determined by the Bio-Rad protein assay. 
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The E. coli BL21 (DE3) cells had a residual PK1 activity of 0.5 U/l (unit activity per litre 
of culture harvested in the same conditions as the cultures transformed with the plasmid 
pGV5A), which is about 0.2% of the activity of the wild-type PK1 (with FBP added). 
This is equal to less than 0.1 mg of endogenous PK1 activity in every litre of BL21 (DE3) 
cell culture. At this low level of activity, the residual PK1 activity should not be a 
concern when studying the kinetics of the mutants that are reasonably active. Moreover, 
the small portion of PK1 activity observed in crude extract (Table 2.1) may be due to the 
function of other pyruvate, PEP and NADH utilising enzymes in the cell lysate. 
2.4 Kinetic study of the wild-type PK1 
2.4.1 pH optimisation and buffer strength 
The pH tolerance of E. coli PK1 was tested. The enzyme was active over a broad pH 
range (pH 5.4-8.2) with the highest activity achieved between pH 6.0 and pH 7.5 (Figure 
2.2). All subsequent assays for characterisation of the PK1 wild-type and the mutants 
were performed at pH 7.5. 
 
Figure 2.2       The activity of E. coli PK1 (wild-type) at different pH. One unit (U) is equal 
to the oxidation of 1 µmole NADH/sec under the assay conditions in Section 6.4.1. MES buffer 
(■, 10 mM) was used for assays between pH 5.4 and pH 7.0, HEPES buffer (□, 10 mM) was used 
for assays between pH 6.5 and pH 8.2. Error bars represent the standard error of the mean 
between two replicates. 
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HEPES buffer (10 mM) was used in the kinetic assay, following Valentini (2000).  
However, this buffer strength was too weak to keep the reaction mixture at a constant pH 
when a high substrate concentration (i.e. > 2 mM) of phosphoenolpyruvate (PEP) 
monosodium salt was added into the reaction solution.  Enzyme activity changed 
steeply about pH 7.5 (Figure 2.2), affecting trial experiments.  To solve this problem, 
higher HEPES concentrations were used and the activity of the wild-type PK1 with 
respect to buffer concentration was tested. 
 
 
Figure 2.3     The activity of wild-type PK1 with respect to HEPES buffer concentration. 
The activity of the wild-type PK1 was tested under the standard assay conditions (Section 6.4.1), 
with various buffer concentrations. Error bars represent the standard error of the mean specific 
activity of two replicates. 
 
Figure 2.3 shows that at high concentrations of HEPES buffer, the enzyme was 
moderately inhibited. About 80% of the activity of the enzyme was retained when a 
concentration of 100 mM HEPES was used. The activity further decreased to ~60% 
when a 200 mM HEPES buffer was used in the assay. Given the decrease in activity 
with increasing HEPES concentrations, the buffer concentration was kept standard. As 
an alternative strategy of solving the pH problem, the PEP monosodium stock solution at 
200 mM was pre-adjusted to a neutral pH (as judged by universal pH testing strips) using 
concentrated potassium hydroxide, so that the pH of the reaction mixture was not altered 
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on addition of PEP. 
2.4.2 Coupling efficiency of LDH 
When utilising coupled reactions to monitor enzyme activity, a necessary control is to 
show that the coupling enzyme (in this case LDH) is in excess and does not limit the rate 
of the enzyme catalysed reaction being measured (see Figure 2.4 for the chemistry of the 
LDH catalysed reaction). 
 
 
Figure 2.5       LDH titration curve with respect to PK1 activity as measured by the 
coupled assay. The activity of the wild-type PK1 was tested under the standard assay 
conditions (Section 6.4.1) and various amounts of lactate dehydrogenase (LDH) in a total volume 
of 1 ml.  The reaction was performed at 30 °C and was initiated by adding pure wild-type PK1 
into the reaction mixture.  Error bars represent the standard error of the mean of the specific 
activity between two replicates. 
 
Figure 2.5 shows the coupling efficiency of LDH at increasing concentrations. The 
amount of LDH in the coupled reaction should be in excess, so that the overall reaction 
rate is only limited by the rate of the PK1 catalysed reaction. In this way, the decrease 
in NADH will accurately reflect the initial rate of the PK1 enzyme (Bücher & Pfeiderer 
1955). 
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The assay result suggested that approximately 2.5 units of LDH per assay were sufficient 
to ensure that the coupling enzyme was in excess and that the measured rate represented 
the PK1 catalysed reaction (Figure 2.5). In this study, 23 units of LDH (~10 times 
excess) were used in each kinetic assay to ensure that the LDH was in excess under all 
conditions tested. 
2.4.3 Steady-state kinetic analysis of the PK1 wild-type 
Steady state kinetic analysis of the wild-type PK1 was performed by measuring the initial 
velocity at various PEP and ADP concentrations (Section 6.4.2). Two approaches have 
been successfully used in assaying PK1 kinetics. The most widely used is the 
“coupled” assay, in which the oxidation of NADH is monitored in an UV-vis 
spectrophotomer at 340 nm (Bücher & Pfeiderer 1955). Alternatively, the analysis can 
be performed “directly” by monitoring the spectrophotometric recording of the decrease 
in absorbance at 230 nm due to PEP loss (Malcovati & Valentini 1982). In this thesis, 
the LDH coupled assay (Section 6.4.1) was used, as it required a minimal amount of 
enzyme and the loss of NADH absorbance signal was directly related to PK1 activity. 
Therefore, the enzyme activity was expressed as the spectral reading of the loss of the 
NADH, where one unit equals to the consumption of 1 µmole NADH per second per 
milligram of protein in a 1 ml assay (Valentini et al. 2000), and the turnover number kcat 
(s-1) was used to interpret the kinetic data. Data were processed with the program 
Origin (OriginLab, version 8E) to determine the mode of catalysis and various 
parameters, such as kcat, S0.5 and the Hill coefficient (nH). 
 
PK1 is an allosterically regulated protein. It is homotropically regulated (ligand binding 
affects the binding of an identical ligand) by the substrate PEP and heterotropically 
regulated (binding of ligand affects the binding of a different ligand) by FBP (Lovell et al. 
1998). Previous studies found that in the presence of FBP and with respect to varying 
PEP concentrations, the enzyme showed a typical Michaelis-Menten type kinetic pattern; 
whereas when FBP is absent, the Hill cooperative model (Hill 1910) applied (Mattevi et 
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al. 1996; Valentini et al. 2000). A typical Michaelis-Menten model is achieved when 
the Hill coefficient is 1 (Equation 2.1b, when n = 1), in which case no cooperativity is 
observed. Equations for the Michaelis-Menten and Hill cooperative model are shown 
below: 
 
Michaelis-Menten model: υ = (kcat [S]) / (KM + [S]) (Equation 2.1a), 
Hill cooperativity model: υ = (kcat [S]n / ((S0.5n) + ([S]n)) (Equation 2.1b), 
 
where kcat is the turnover number; [S] is the substrate concentration; KM is the 
Michaelis–Menten coefficient for substrate [S]; S0.5 is the substrate concentration when 
half of the Vmax is reached under Hill cooperativity model; nH is Hill coefficient; and υ is 
the initial velocity. In this study, the kinetic data were fitted to the best of the above two 
models by comparing the R2 value of the non-linear regression and standard error 
associated with the kinetic parameters. S0.5 was further defined at S0.5PEP and S0.5ADP in 
this study. 
 
The steady state kinetic parameters for purified wild-type PK1 were measured by 
following the signal loss of NADH at pH 7.5 at 30 °C (Section 6.4.2). Parameters for 
the substrates PEP and ADP were determined, as well as the allosteric effector FBP. For 
PEP and ADP, the initial velocity values were determined at varying concentrations of 
one substrate at a fixed concentration of the other, and in the presence and absence of 
FBP. For FBP, the initial values were determined as a function of the effect at fixed 
concentrations of the two substrates.  
 
By fitting the data to the Hill cooperative model, the turnover number (kcat), the S0.5 value 
(defined as the substrate concentration at 1/2 Vmax in Hill model) and the Hill coefficient 
nH were determined (Table 2.2). 
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Table 2.2      Kinetic parameters determined for E. coli wild-type PK1. Results are 
means ± standard errors. 
PEP 
FBP(-) 2 mM FBP 
kcat
s-1 
S0.5PEP 
mM 
nH kcat/S0.5
s-1/mM
kcat
s-1 
S0.5PEP 
mM 
nH kcat/S0.5
s-1/mM
243 ± 2 1.5 ± 0.1 3.1 ± 0.6 162 268 ± 4 0.06 ± 0.002 1.0 ± 0.04 4467 
ADP 
FBP(-) 2 mM FBP 
kcat
s-1 
S0.5ADP 
mM 
nH kcat/S0.5
s-1/mM
kcat
s-1 
S0.5ADP 
mM 
nH kcat/S0.5
s-1/mM
241 ± 12 0.54 ± 0.22 0.8 ± 0.07 446 309 ± 19 0.34 ± 0.07 1.0 ± 0.08 909 
 
When FBP was absent from the assay solution, strong positive cooperativity was evident 
with respect to PEP (nH = 3.1 ± 0.6) (Figure 2.6), consistent with PEP being a homotropic 
effector for PK1. This value agreed well with data obtained in a previous study to 
investigate the regulation of E. coli PK1 (nH = 3.2 ± 0.06) (Valentini et al. 2000). The 
S0.5PEP increased dramatically (1.5 ± 0.1 mM), as compared to the titration done in the 
presence of FBP. 
 
Figure 2.6      Kinetic properties of wild-type PK1.  The activity of wild-type PK1 was 
measured at varying concentrations of substrates (PEP and ADP) and allosteric activator (FBP) 
(Section 6.4.2). Varying concentrations of PEP and ADP are in the absence (○) or presence (■) 
of 2 mM FBP. To obtain PEP response plots PEP was varied at constant 2 mM ADP, and to 
obtain ADP response plots ADP was varied at constant 2 mM PEP. Plots represent the best fit by 
non-linear regression to the Hill equation. 
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In the presence of 2 mM FBP, the KM values for PEP and ADP were 0.06 ± 0.001 mM 
and 0.3 ± 0.03 mM, respectively. The kcat values were 268 ± 4 s-1 (kcatPEP) and 309 ± 19 
s-1 (kcatADP), which were similar. 
 
Although no study has found FBP to have any regulatory interaction with ADP on the 
wild-type PK1, an ADP titration assay in the presence and absence of FBP was 
performed (Figure 2.6). An nHADP value of 0.8 ± 0.07 was obtained, which represented 
a slightly negative cooperativity. However, the data also fitted the Michaelis-Menten 
model well, with similar kcatADP and S0.5ADP values (R2 = 0.98, by Origin fitting). This is 
again in agreement with previous studies (Valentini et al. 2000), and implied that FBP 
binding influenced PEP binding, as discussed in several earlier studies (Fenton & Blair 
2002; Friesen et al. 1998a; Mattevi et al. 1996; Mattevi et al. 1995). ADP binding was 
not affected, as indicated by similar S0.5ADPvalues of 1.0 and 0.8, with and without FBP 
(Table 2.2). 
 
These data support the previous findings that FBP does not affect the kcat, but does affect 
the mode of PEP binding. 
2.5 Biophysical Characterisation of wild-type PK1 
2.5.1 Circular dichroism spectroscopy 
Circular dichroism spectroscopy (CD) gives information about the secondary structure of 
a protein (Johnson 1999; Kelly et al. 2005). In addition, information relevant to protein 
folding and binding properties can be rapidly established by this method (Greenfield 
2006). This technology utilises the handedness of circular polarized light. 
Asymmetric molecules interact with light and may absorb the right- and left-handed 
circularly polarized light to different extents. Data are usually recorded as the 
difference in the absorbance of the right- and left-handed lights and further processed as 
degrees of ellipticity. Ellipticity describes the shape the rotated light traces on the plane 
 40
of light (Greenfield 2006). In terms of protein, where amide chromophores of the 
polypeptide backbone are aligned, their optical transitions are changed (Greenfield 1996). 
Each alignment has its characteristic shape and degree of ellipticity, which is used to 
define the secondary structure. For instance, the CD spectra of α-helical proteins is 
characterised by the two negative peaks at 222 nm and 208 nm. CD spectra are 
processed by comparing the data with existing protein reference libraries, so that content 
of α-helix, β-sheet and random coils in the protein of interest can be determined. 
Conformational changes of the protein due to temperature, mutations, denaturants and 
bindings can be monitored by CD (Greenfield 2006). The secondary structures of the 
protein derived from the CD spectra are largely dependent on the spectral magnitude 
effect (Miles et al. 2005). Calibration of the instrument, the spectral cell length and the 
protein concentration needs to be accurately determined to obtain meaningful results 
(Greenfield 2006). 
 
The secondary structure of wild-type PK1 was evaluated by circular dichroism (CD) 
spectroscopy using a Jasco-815 CD spectropolarimeter (Section 6.5.2). CD spectra 
were processed with 3 algorithms (SELCON3, CONTIN-LL and CDSSTR) on the 
DICHROWEB website and the results were compared (Compton & Johnson 1986; 
Sreerama et al. 1999; van Stokkum et al. 1990) (Table 2.3). These algorithms can be 
used in conjunction with any of the seven reference datasets on the DICHROWEB 
website (Sreerama et al. 2000). The quality of the fit was judged by the normalised root 
mean square deviation (n.r.m.s.d.) value, which is a goodness-of-fit parameter used to 
measure the correspondence between the calculated and the experimental spectra 
(Wallace et al. 2003). Among all the algorithms applied in DICHROWEB, CDSSTR is 
the least sensitive to the magnitude effect, with an overall low n.r.m.s.d. in all 
measurements (Miles et al. 2005). Dataset 7 was chosen because the data collected by 
the spectropolarimeter fell into the dataset range of 190 to 240 nm. 
 
The CDSSTR algorithm requires a minimum number of reference proteins in a good 
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analysis, and follows four criteria: (1) the sum of the secondary structures are between 
0.95 and 1.05, (2) fractions of the secondary structures should be above -0.03, (3) the 
re-constructed CD spectrum fits the original CD spectra well, with a low n.r.m.s.d. value, 
(4) the fraction of α-helices should be similar to that obtained using all reference proteins 
(Johnson 1999). 
 
The n.r.m.s.d. showed that the CDSSTR algorithm best fitted the data using dataset 7 
(Figure 2.7), as judged by the n.r.m.s.d. (0.017). Therefore, CDSSTR was chosen for 
data interpretation and comparison. 
 
Figure 2.7     Circular dichroism spectroscopy of wild-type PK1. Mean residue ellipticity 
([θ]) is plotted as a function of wavelength from 190 nm to 250 nm. The symbols show the raw 
data (?=0.47 mg/ml, ?=0.23 mg/ml, and ?=0.16 mg/ml) and the line shows fitting with CDSSTR 
algorithm (reference set 7) from DICHROWEB using 0.16 mg/ml enzyme. 
 
In the experiment, the measurement of wavelengths ranged from 190 nm to 250 nm, 
using only data where the HT voltage was below 600 V. When the HT voltage exceeds 
600 V, the signal-to-noise ratio greatly diminishes, making the data noisy and unreliable 
(Greenfield 2006). 
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The spectrum obtained for wild-type PK1 was comprised of two absorbance minima at 
approximately 208 nm and 222 nm, characteristic of α-helices (Figure 2.7). This result 
is consistent with the crystal structures obtained from several sources of pyruvate kinase, 
that the protein has a high content of α-helices (Larsen et al. 1998; Mattevi et al. 1995; 
Rigden et al. 1999). Although it does not give the residue-specific information that can 
be obtained by X-ray crystallography or NMR (Greenfield 2006), it suggests that the 
enzyme is well structured, with primarily α-helix and β-sheet secondary content. 
 
Table 2.3       Comparison of the wild-type CD fitting parameters using three different 
algorithms 
Parameters SELCON3 CONTIN-LL CDSSTR 
n.r.m.s.d. 0.161 0.072 0.017 
α-helix(1) 0.132 0.11 0.14 
α-helix(2) 0.121 0.116 0.10 
β-strand(1) 0.16 0.24 0.16 
β-strand(2) 0.089 0.096 0.1 
Turn 0.204 0.2 0.2 
uncoiled 0.287 0.238 0.30 
Total 0.993 1 1 
Helix segments per 100 residues: 3.0 2.9 2.6 
Ave helix length per segment: 8.4 7.8 9.3 
Strand segments per 100 residues: 4.5 4.8 4.7 
Ave strand length per segment:  5.6 7.0 5.2 
 
Six secondary structures have been estimated, which are the regular α-helix (1), distorted 
α-helix (2), regular β-strand (1), distorted β-strand (2), turns and uncoiled structure. 
The number of α-helical and β-strand segments in the protein gives valuable information 
regarding distortion of the protein, that on average four residues per α-helix and two 
residues per β-strand may be considered to distort in protein (Sreerama et al. 1999). In 
the situation of wild-type PK1, the protein appeared to be well folded, as the lengths 
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(residues) per segment of the α-helix and the β-strand were 9.3 and 5.2, respectively. 
2.5.2 Mass spectrometry 
Electrospray ionisation (ESI) mass spectrometry (MS) accurately determines the mass of 
a molecule by generating a mass spectrum that is represented as ion intensity versus the 
mass-to-charge ratio (m/z) of sample components. Biological samples with large 
molecular weights are often multiply charged in positive or negative ionisation states. 
In addition, salt adducts may be present in the protein sample, resulting in different peaks 
of m/z on the histogram. A Gaussian-type distribution with multiple charged states in 
the ES/MS spectra is usually observed (Domon & Aebersold 2006).  
 
The m/z distribution is used to estimate the molecular weight of the sample, by applying 
the equation:  
m/z = (MW + nH+)/n 
where m/z is the mass-to-charge ratio of the sample, MW is the molecular mass, n is the 
integer number of charges on the ions and H is the mass of a proton  Domon & 
Aebersold 2006).  In the situation where n is not known, an assumption is made that any 
two adjacent members in the series of multiply charged ions differ by one charge, so that 
molecular weight may be estimated. 
 
For carrying out the mass spectrometric analysis, purified wild-type PK1 was directly 
injected into the mass spectrometer at various time points with the solution of acetonitrile 
in water combined with formic acid, at 0.25 ml/min (Section 6.5.1). Data were 
collected using the mass spectrometer with an electrospray ionising (ESI) source coupled 
to an Agilent 1100 LC system (Agilent, Palo Alto, CA). 
 
The deconvoluted mass of the wild-type PK1 monomer was estimated to be 50729.34 Da 
(Figure 2.8), which is consistent with the isotopically averaged molecular weight of 
50729.28 Da by amino acid (Valentini et al. 1979). There were two other adducts (+17 
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and +37 Da) associated with the main peak. A search of the ABRF DeltaMass database 
(a database of protein post-translational modifications, at http://www.abrf.org/), 
suggested the two adducts were most likely to be a sodium derivative (+22 Da) and a 
potassium salt adduct (+37 Da). 
 
There was another peak (50805.18 Da) and two sub-peaks further away from the main 
peak, with a repeated pattern to the main peak. This peak was +76 Da heavier than the 
main peak and is consistent with a β-mercaptoethanol adduct. During protein 
purification, β-mercaptoethanol was added into buffer solution at every purification step. 
Therefore, it is likely that β-mercaptoethanol binds to the protein post purification. 
 
 
Figure 2.8       Counts versus deconvoluted mass (amu) graph of wild-type PK1.  The 
peak with amu equal to 50729.34 represented a wild-type PK1 monomer, the following two peaks 
(50746.47 Da (+17) and 50766.04 Da (+37)) represented a PK1 monomer with different adducts. 
The peak with mass 50805.18 Da is consistent with the PK1 monomer plus β-mercaptoethanol. 
2.5.3 Analytical ultracentrifugation 
Generally, XL-I (or the older XL-A) ultracentrifuge instruments are used for carrying out 
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AUC experiments. These are equipped with optical systems that scan the solute 
concentration during the ultracentrifugation process. The technique of AUC has been 
improved largely by the development of new instruments and computational data 
analysis tools (Lebowitz et al. 2002). AUC sedimentation velocity experiments have 
been performed in this study to characterise the biophysical properties of wild-type PK1 
and the variants. 
 
At a large centrifugal force, protein leaves the meniscus and forms a boundary that 
moves towards the bottom of the cell as a function of time. The speed of movement 
through the solution is determined primarily by the size, but also the shape of the protein. 
Other factors that affect the sedimentation rate include protein concentration, solvent 
ionic strength (i.e. density) and solvent viscosity (Cole et al. 2008). In addition, there is 
a sample concentration distribution around the boundary, which is caused by diffusion.  
 
Data obtained from a sedimentation velocity experiment can be analysed by various 
methods (Cole et al. 2008). The c(s) distribution method implemented in the SEDFIT 
software interface and based on the assumption of a non-interacting molecules (Schuck 
2000) was used in this study. 
 
The hydrodynamic properties of wild-type PK1 were examined by sedimentation 
velocity studies in the analytical ultracentrifuge. The wild-type PK1 was initially 
examined at 1.0 mg/ml (19.7 μM based on the monomeric mass of 50,729 Da) at 35,000 
rpm and 20 °C. The data were collected at 236 nm with a step size 0.001 cm and fitted 
to a continuous sedimentation coefficient distribution (c(s)) model and to a continuous 
mass distribution (c(M)) model using the program SEDFIT (Schuck 2000). Continuous 
sedimentation distribution (c(s)) was plotted as a function of sedimentation coefficient 
(Svedberg, S) (Figure 2.9). 
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 Figure 2.9      Sedimentation velocity analysis of wild type PK1 at 1.0 mg/ml (19.7 μM) 
protein. (a) Absorbance at 236 nm as a function of radius (cm) from the axis of rotation is 
plotted. The raw data are presented as open circles and are overlaid with the nonlinear least 
squares best-fit to a continuous-size distribution model (Lamm equation) by SEDFIT. Residuals 
for the nonlinear least squares best-fit are also shown. (b) The continuous sedimentation 
coefficient [c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). The fit had 
a resolution of 150 species between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ 
= 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.31.  The r.m.s.d. and runs test-Z score for the fit 
were 0.0068 and 6.5, respectively. 
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Data were fitted at a high resolution of 150 with an s value ranging between 0.1 S and 14 
S. SEDNTERP was used to calculate the partial-specific volume of wild-type PK1 
(0.7413 ml/g, based on the amino acid sequence), solvent density (1.00117 g/ml) and 
viscosity (0.010066 poise). The frictional ratio (ƒ/ƒ0) of wild-type PK1, which indicates 
the maximum shape asymmetry of the enzyme (Lebowitz et al. 2002), was allowed to 
float during the fit, resulting in a ƒ/ƒ0 of 1.31. The fit resulted an r.m.s.d. of 0.0068 and 
a runs test-Z score of 6.5, both of which indicated a good fit (Lebowitz et al. 2002). A 
continuous mass distribution fit of the same data was performed (data not shown here), 
and the results indicated that wild-type PK1 is a single species with molar mass 
approximately 200 kDa, which agreed well with the theoretical mass of the tetrameric 
mass of wild-type PK1 (203 kDa). 
 
AUC of the wild-type PK1 was further performed at 1/10 concentration of previous 
analysis (i.e. at 0.1 mg/ml (1.97 μM)). At lower concentrations, the macromolecule 
may dissociate into smaller species (such as dimers) as the solute sediments to the 
bottom of the cell (Lebowitz et al. 2002). The dissociation constant (kD) can be 
calculated using this information and further sedimentation equilibrium experiments 
(Cole et al. 2008).  
 
However, in this experiment, the dissociation did not occur, as indicated on the c(s) 
distribution plot, where a single peak at ~8.5 S was observed (Figure 2.10). This 
experiment was performed under the same conditions as for that at 1.0 mg/ml (19.7 μM), 
and resulted in an r.m.s.d. and runs-Z test score for the fit of 0.0048 and 4.7, respectively, 
indicating a good fit. 
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 Figure 2.10      Sedimentation velocity analysis of wild type PK1 at 0.1 mg/ml (1.97 μM) 
protein. (a) Absorbance at 228 nm as a function of radius (cm) from the axis of rotation plotted. 
The raw data are presented as open circles and are overlaid with the nonlinear least squares 
best-fit to a continuous-size distribution model (Lamm equation) by SEDFIT. Residuals for the 
nonlinear least squares best-fit are also shown. (b) The continuous sedimentation coefficient 
[c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). The fit had a 
resolution of 150 species between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ = 
1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.34.  The r.m.s.d. and runs test-Z score for the fit were 
0.0048 and 4.7, respectively. 
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2.5.4 Fluorescence detection system coupled with analytical 
ultracentrifugation: a new tool for analysing proteins at low 
concentrations 
Protein and nucleic acid concentrations ranging from 10 µg/ml to 5 mg/ml are suitable 
for traditional AUC analyses (Cole & Hansen 1999). The addition of a fluorescence 
detection system is a new technology developed that extends the detectable concentration 
of macromolecules into the picomolar range (MacGregor et al. 2004). A trace quantity 
of the molecule of interest can be detected in solution, even in the presence of a high 
level of background molecules, which makes this technology very powerful for 
characterising low concentrations of molecules in solution, and for observing the 
metabolites in a similar-to-matrix background (Laue 2005). 
 
The distribution of the radial concentration is a critical measurement in sedimentation 
velocity analysis. The absorbance optical system in a normal AUC will measure the 
absorbance of the samples at each radial position at a given wavelength from 190 nm to 
800 nm. The intensity of the signal (A) is a direct reflection of (in this case) the protein 
concentration, as represented by the Beer-Lambert law:  
A = ε·c·l, 
where ε is the solute’s weight extinction coefficient, c is the solute weight concentration 
and l is the sample pathlength (Cole et al. 2008). Fluorescence detection systems 
require a laser light source to achieve sufficient radial resolution (20-50 µm). The 
AUC-FDS measures a single wavelength at 488 nm; therefore, the protein must be 
labelled with a fluorescent label, so that an extrinsically acquired fluorescence signal can 
be measured (Cole et al. 2008). The intensity of AUC-FDS (F) is can be expressed as: 
F = Io·Q·ε·c, 
where ε is the extinction coefficient, c is the concentration of the solute, Io is the intensity 
of the beam light and Q is the quantum field. The quantum field is largely affected by 
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degree of labelling and presence of quenchers, therefore, it is difficult to relate the 
intensity of the signal to concentration of the solute (Cole et al. 2008). 
 
Although it is more difficult to run AUC-FDS in terms of sample preparation, 
experimental operation and data interpretation, as compared to the traditional absorbance 
analysis (Laue 2005), this novel technique has its advantages. First of all, the 
concentration detectable in the experiment is much lower; therefore a very dilute solute 
can be studied and allows one to study molecules with a very tight association. 
Secondly, the molecule can be examined in a very complex environment, as the 
fluorescence signal can be easily distinguished from the non-fluorescent absorbance 
signal. This makes it possible to examine the molecule in an environment that mimics 
the cell matrix, which is useful to characterise a molecule in near physiological 
conditions. Thirdly, the broad range of analysis from picomolar to micromolar range 
allows the concentration range where molecular association becomes significant. 
 
Although AUC-FDS is an excellent technology for studying the structural and 
hydrodynamic properties of a protein at extremely low concentration, analysis of the E. 
coli PK1 by AUC-FDS (or AUC for that matter) has never been applied in previous 
studies. This analysis is novel, and is critical for this study, as it gives information 
about how this enzyme behaves in a highly diluted environment, with a concentration 
approaching the physiological level, and with the effectors. 
 
Recent studies with dihydrodipicolinate synthase have shown that the substrate pyruvate 
may regulate enzyme activity by promoting an active dimer from an inactive monomer 
(Burgress et al. 2008). In an early paper it was found that FBP helped the association of 
a cytosolic thyroid hormone-binding protein (monomer) which shared 97% similarity 
with human PKM2 at amino acid level to tetrameric form (Fanjul & Farias 1993).  
 
More strikingly, a study demonstrated the propensity of rabbit kidney PKRK to undergo 
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reversible subunit assembly and disassembly (KDdimer-tetramer = 0.6 μM) using analytical 
gel filtration combined with stimulated sedimentation velocity experiment (Friesen et al. 
1998b). It was proposed, according to the analytical gel filtration data, that the 
assembly of the tetramer was favoured by binding of PEP and FBP, whereas ADP and 
phenylalanine shifted the equilibrium towards disassembly to a dimer (Friesen et al. 
1998b).  
 
Since AUC with absorbance optics was not able to show dissociation of the wild-type E. 
coli PK1 enzyme, AUC-FDS was employed. The experimental aim was to estimate 
how tightly associated the tetramer of PK1 was, and to examine the effect of substrates 
(PEP and ADP) and the effector FBP on the oligomeric state. 
 
In order to utilise AUC-FDS, the enzyme was labelled with a fluorescent tag. Wild-type 
PK1 was labelled with Alexa Fluor® 488 succinimidyl ester dye at 2.4 mg/ml (i.e. 1.2 x 
10-5 M) (Section 6.5.4). The labelled protein was separated from the dye by passage 
through a Sephadex G-25 Column. A pale green band separated from the bright green 
dye could be visualised. Fractions containing the labelled protein were collected at 1.5 
ml portions and pooled. The protein concentration and degree of labelling were 
determined spectrophotomically (Section 6.5.4). 
 
AUC-FDS sedimentation velocity experiments with wild-type PK1 at 0.01 mg/ml (197 
nM) were performed (Figure 2.11). Additional experiments followed the sedimentation 
of wild-type PK1 at 0.001 mg/ml (19.7 nM) (Figure 2.12), with and without 1.8 mM of 
substrates (PEP (Figure 2.13) and ADP (Figure 2.14)) and effector (FBP) (Figure 2.15) 
(Section 6.5.4). Subsequently, wild-type PK1 at a much diluted 0.0005 mg/ml (9.9 nM) 
(Figure 2.16) were analysed by AUC-FDS, which required the presence of 0.1 mg/ml 
ovalbumin as a loading protein (Cole et al. 2008; MacGregor et al. 2004). Different 
laser intensities and PMT voltages were set, adjusted for the protein concentration and 
the intensity of the fluorescence signal at the initial run (MacGregor et al. 2004). 
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 Figure 2.11      AUC-FDS analysis of wild-type PK1 at 0.01 mg/ml (197 nM) protein with 
gains set at 2 × 84%. (a) Fluorescence counts at 488 nm as a function of radius (cm) from the 
axis of rotation plotted. The raw data are presented as open circles and overlaid with the 
nonlinear least squares best-fit to a continuous-size distribution model (Lamm equation) by 
SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The continuous 
sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient (S). The fit 
had a resolution of 150 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 
0.7436, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.45. The r.m.s.d. and runs test-Z score for 
the fit were 19 and 24, respectively. 
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 Figure 2.12      AUC-FDS analysis of wild-type PK1 at 0.001 mg/ml (19.7 nM) protein with 
gains set at 8 × 95%. (a) Fluorescence counts at 488 nm as a function of radius (cm) from the 
axis of rotation plotted. The raw data are presented as open circles and are overlaid with the 
nonlinear least squares best-fit to a continuous-size distribution model (Lamm equation) by 
SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The continuous 
sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient (S). The fit 
had a resolution of 150 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 
0.7436, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.63. The r.m.s.d. and runs test-Z score for 
the fit were 26 and 22, respectively. 
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 Figure 2.13      AUC-FDS analysis of wild- type PK1 at 0.001 mg/ml (19.7 nM) protein with 
1.8 mM PEP added, with gains set at 2 × 84%. (a) Fluorescence counts at 488 nm as a 
function of radius (cm) from the axis of rotation plotted. The raw data are presented as open 
circles and are overlaid with the nonlinear least squares best-fit to a continuous-size distribution 
model (Lamm equation) by SEDFIT. Residuals for the nonlinear least squares best-fit are also 
shown. (b) The continuous sedimentation coefficient [c(s)] distribution as a function of 
sedimentation coefficient (S). The fit had a resolution of 150 species between smin of 0.1 S and 
smax of 15 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.71. 
The r.m.s.d. and runs test-Z score for the fit were 21 and 18, respectively. 
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 Figure 2.14      AUC-FDS analysis of wild- type PK1 at 0.001 mg/ml (19.7 nM) protein with 
1.8 mM ADP added, with gains set at 1 × 63%. (a) Fluorescence counts at 488 nm as a 
function of radius (cm) from the axis of rotation plotted. The raw data are presented as open 
circles and are overlaid with the nonlinear least squares best-fit to a continuous-size distribution 
model (Lamm equation) by SEDFIT. Residuals for the nonlinear least squares best-fit are also 
shown. (b) The continuous sedimentation coefficient [c(s)] distribution as a function of 
sedimentation coefficient (S). The fit had a resolution of 150 species between smin of 0.1 S and 
smax of 15 S with P = 0.95, v-bar = 0.7436, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.60. 
The r.m.s.d. and runs test-Z score for the fit were 23 and 19, respectively. 
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 Figure 2.15      AUC-FDS analysis of wild-type PK1 at 0.001 mg/ml (19.7 nM) protein with 
1.8 mM FBP added, with gains set at 8 × 95%. (a) Fluorescence counts at 488 nm as a 
function of radius (cm) from the axis of rotation plotted. The raw data are presented as open 
circles and are overlaid with the nonlinear least squares best-fit to a continuous-size distribution 
model (Lamm equation) by SEDFIT. Residuals for the nonlinear least squares best-fit are also 
shown. (b) The continuous sedimentation coefficient [c(s)] distribution as a function of 
sedimentation coefficient (S). The fit had a resolution of 150 species between smin of 0.1 S and 
smax of 15 S with P = 0.95, v-bar = 0.7436, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.59. 
The r.m.s.d. and runs test-Z score for the fit were 29 and 23, respectively. 
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 Figure 2.16      AUC-FDS analysis of wild- type PK1 at 0.0005 mg/ml (9.9 nM) protein with 
0.1 mg/ml OVA added, with gains set at 8 × 95%. (a) Fluorescence counts at 488 nm as a 
function of radius (cm) from the axis of rotation plotted.  The raw data are presented as open 
circles and are overlaid with the nonlinear least squares best-fit to a continuous-size distribution 
model (Lamm equation) by SEDFIT. Residuals for the nonlinear least squares best-fit are also 
shown. (b) The continuous sedimentation coefficient [c(s)] distribution as a function of 
sedimentation coefficient (S). The fit had a resolution of 150 species between smin of 0.1 S and 
smax of 15 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.77. 
The r.m.s.d. and runs test-Z score for the fit were 23 and 19, respectively. 
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Figure 2.17    AU-FDS c(s) distributions of the wild-type PK1. This graph was 
re-generated from the individual c(s) distribution plots. 
 
The S value for the labelled protein at various concentrations was unchanged compared 
to the AUC with absorbance optics, suggesting that the enzyme is unaffected by the 
presence of the label. An LDH assay revealed that 118% of the activity of the labelled 
enzyme was retained compared to the unlabelled protein, which confirmed this view. 
Figure 2.17 showed that the c(s) distribution overlaid well at different concentrations, 
with and without substrates and effector binding. This indicated that a single species 
was present in every solution, at the S value corresponding to a tetramer. 
 
AUC-FDS data of wild-type PK1 were processed using SEDFIT. At 0.01 mg/ml (197 
nM), the c(s) distribution showed a clear peak at around 8.5 S corresponded to a single 
species (Figure 2.11). This indicated that the enzyme remained tetrameric when 
labelled with Alexa Fluor® 488. Further analyses of wild-type PK1 at an even lower 
concentration at 0.001 mg/ml (19.7 nM), with and without the substrates (PEP and ADP) 
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and the allosteric effector (FBP) showed a similar single species corresponding to the 
tetramer (Figures 2.12-2.15). Although the signal-to-noise ratio decreased dramatically 
with the decrease of protein concentration, the data still showed a good fit, as indicated 
by the r.m.s.d. values. In addition, a slight broadening of the peak on the c(s) 
distribution curve at low concentrations was observed, which suggested some 
dissociation of the tetramer was occurring. To further test the strength of association of 
the PK1 tetramer, sedimentation velocity run of AUC-FDS was performed again, at a 
very low concentration of 0.0005 mg/ml (9.9 nM) protein. Pure ovalbumin at 0.1 
mg/ml was added at this point as a loading protein to stabilise the labelled wild-type PK1 
protein and to prevent the stickiness of protein to the centrepiece wall (MacGregor et al. 
2004). When the sedimentation coefficient distribution was examined (Figure 2.16), a 
much broadened peak at 8.5 S was observed, with an increased friction ratio 1.77 
(compare to ƒ/ƒ0 = 1.31, observed in PK1 at 0.1 mg/ml), indicated that the tetramer may 
have changed shape in the solution, or may reflect an average ƒ/ƒ0 of two species, one of 
which is highly asymmetric. A smaller species may be evident; however, no conclusion 
can be drawn at this point, due to the high noise level. What is clear is that the 
dissociation constant (KD) for the tetramer is very low (picomolar range). 
 
The AUC-FDS experiments detailed here confirmed the results obtained by AUC with 
absorbance optics and suggest that wild-type PK1 has a very low dissociation constant 
(KD) in the picomolar range.  The addition of the substrates PEP and ADP and allosteric 
effector FBP did not affect enzyme dissociation at the concentrations tested. 
2.6 Summary 
The E. coli PK1 wild-type enzyme has been structurally and functionally characterised. 
Kinetic studies revealed that this enzyme showed cooperative binding with the substrate 
PEP, and was allosterically activated by the effector FBP. This finding was consistent 
with earlier studies (Mattevi et al. 1996; Valentini et al. 2000). Structural properties of 
the PK1 wild-type were characterised by different techniques. The secondary structure 
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was investigated by circular dichroism, suggesting that the structure was highly ordered, 
with mainly α-helices and β-sheets present and consistent with the crystal structure (PDB 
accession number 1pky). The solution structure and subunit association/dissociation 
were probed by AUC and further by the new technology AUC-FDS at much lower 
concentration. From the results it can be concluded that wild-type PK1 forms a very 
tight tetramer, which does not dissociate even when concentration decreases to 
nanomolar range. Some early studies indicated that binding effector and substrates may 
affect protein subunit assembly or disassembly (Burgress et al. 2008; Fanjul & Farias 
1993; Friesen et al. 1998b). In the AUC-FDS experiment, the effects of the enzyme 
substrates (PEP and ADP) and effector FBP on quaternary structure were examined. It 
was concluded that at the enzyme concentrations used, these molecules do not alter the 
quaternary structure of the enzyme. 
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Chapter 3 
Mutagenesis, over-expression, purification and 
kinetic studies of the PK1 mutants 
 
3.1 Introduction 
The seven PK1 mutants investigated in this study originated from a long-term evolutionary 
system aimed to address the nature of adaptation in biological systems (Lenski et al. 1991) 
(Section 1.1). It was found that the populations of E. coli carrying these mutations, which 
were evolved in a stable glucose-limited environment, showed generally improved fitness 
and changed morphology (Lenski et al. 1998; Lenski & Travisano 1994). Further studies 
investigated the parallel changes in the gene expression profiles (Cooper et al. 2003) and 
found these unique mutations in the pykF gene, which codes for PK1 in E. coli (Woods et 
al. 2006). 
 
The aim of the work in this chapter was to: (1) obtain pure mutated PK1 enzymes; (2) 
collect data on the kinetic properties of the seven mutants and compare these to the 
wild-type PK1 (Chapter 2); and (3) address the question of whether the replicate 
populations evolved in the same way at the function level; that is, by parallel evolution at 
the enzyme function level. To the author’s knowledge, no previous study has 
characterised the molecular basis for adaptation in an in vivo context.  
 
This study is pivotal to Lenski’s long-term evolution study, since it begins to extend the 
previous population description of the evolved bacteria (e.g. Cooper et al. 2003; Woods et 
al. 2006) to examine how evolved populations adapt at a molecular level. In addition, 
this work attempts to enhance and/or challenge the understanding of how allostery operates 
in pyruvate kinase. 
 
It is hypothesised here that the evolved populations have adapted to the low glucose 
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environment by altering the way in which PK1 is regulated. The mutations that will be 
described are implicated in the allosteric models in Section 1.3.6 (Christofk et al. 2008; 
Fenton & Blair 2002; Friesen et al. 1998a; Friesen et al. 1998b; Jurica et al. 1998; Lovell 
et al. 1998; Mattevi et al. 1996; Valentini et al. 2000). Understanding the mechanisms of 
allosteric regulation of enzyme function has been an ongoing challenge. Surprisingly, a 
firm account of the allosteric activation of PK1 (by FBP and the substrate PEP) has been 
elusive, despite over 50 years of biochemical and structural study on this enzyme.  
3.2 Mutagenesis, over-expression and purification of the 
mutated PK1 enzymes 
3.2.1 Site-directed mutagenesis of pykF gene 
Synthetic oligonucleotide primers containing the desired mutations were designed to be 
used in the site-directed mutagenesis experiments (Section 6.2.9).  The primer design 
process is illustrated using the P70T mutation as an example.  The pykF sequence around 
P70 (which is underlined) is shown below: 
 
              5’CTGCTTGATACCAAAGGTACGGAAATCCGCACC 3’ 
181     GCCGCTATCCTGCTTGATACCAAAGGTCCGGAAATCCGCACCATGAAACTGGAAGGCGGT 
                 3’GACGAACTATGGTTTCCATGCCTTTAGGCGTGG 5’  
 
The designed primer for P70T (in both directions) was 33 base pairs in length (shown in 
red), with the melting temperature at 82 °C (Section 6.2.9.1). GC content of the primer 
was 51%. 
 
The plasmid pGV5A (containing the pykF gene coding for the wild-type PK1) served as 
the template for PCR-based site-directed mutagenesis (Section 6.2.9). The resulting PCR 
products were confirmed on agarose gels (Figure 3.1). 
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Figure 3.1     PCR products with pGV5A derivatives embedding PK1 mutations obtained 
from site-directed mutagenesis. (a) Lane 1: DNA ladder; lane 2: pGV5A-D127N; lane 3: 
pGV5A-A301S; lane 4: pGV5A-A301T; lane 5: pGV5A-G381A. (b) Lane 1: DNA ladder; lane 2: 
pGV5A-P70T; lane 3: pGV5A-P70Q. 
 
The modified pGV5A plasmids with the desired mutations were used to transform 
competent E. coli XL1-Blue cells (Section 6.2.9.4). The process was found to be 
successful by DNA sequencing of the plasmid prepared from these cells (Section 6.2.14). 
Plasmids with the mutated PK1 were then used to transform E. coli BL21 (DE3) cells 
(Section 6.2.15) for over-expression and purification. 
3.2.2 Over-expression and purification of PK1 mutants 
E. coli BL21 (DE3) cells transformed with pGV5A derived plasmids were cultured and the 
PK1 enzymes over-expressed using IPTG induction (Section 6.3.3). The cell lysate was 
loaded onto a SDS-PAGE gel (Figure 3.2, lane 2 shows the cell lysate of PK1-P70T). A 
clear band at approximately 50 kDa was seen on the gel, among other impurities. This 
band is consistent with the molecular mass of an E. coli PK1 monomer (Mattevi et al. 1996) 
and confirmed the over-expression of the protein.  Activity of the whole cell lysate was 
tested by the LDH coupled assay (Section 6.5.1), which further confirmed the expression. 
Over-expression of all the mutant proteins was comparable to the wild-type. 
 
Purification of the PK1 mutants was performed according to the method developed by 
Valentini and colleagues (2000) for the wild-type PK1. E. coli BL21 (DE3) cells, 
transformed with pGV5A mutated plasmids, were cultured and the cells were harvested 
after induction by IPTG (Section 6.3.3). Cells were lysed by ultrasonication followed by 
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centrifugation. A three-step purification procedure, including ion-exchange (step 1), 
phenyl-Sepharose hydrophobic interaction (step 2) and size-exclusion chromatography 
(step 3) was performed to obtain pure protein.  SDS-PAGE analysis was performed to 
check the purity of the proteins (Figure 3.2 shows a typical SDS-PAGE for PK1-P70T).  
All protein purification yields were calculated by using the Bio-Rad protein assay based on 
the Bradford method (Bradford 1976) (Section 6.3.1) to determine the protein 
concentration and the LDH coupled activity assay for determining PK1 activity (Table 
3.1). 
 
 
 
Figure 3.2      SDS-PAGE gel of PK1-P70T mutant protein expression.  Lane 1: Protein 
marker; lane 2: the cell free crude extract of the BL21 (DE3) with PK1-P70T over-expressed; lane 3: 
the pooled fractions after ion exchange chromatography; lane 4: the pooled fractions after 
phenyl-Sepharose chromatography; lane 5: the pooled fractions after size-exclusion 
chromatography.  
 
This procedure appeared to be an effective method for purifying both the wild-type PK1 
enzyme and its derivatives. All the proteins eluted at a similar position, with a similar salt 
content and conductivity in the column. This indicated that the structure (or at least the 
pIs) of the mutants were similar. A major protein band at ~50 kDa was observed in all 
active eluents (Figure 3.3). This band corresponds to the monomeric molecular weight of 
E. coli PK1 (Mattevi et al. 1995).  Only trace impurities were seen on SDS-PAGE gels 
after size-exclusion chromatography. In addition, the specific activities of PK1 
derivatives usually increased three-fold during purification (Table 3.1). 
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Figure 3.3       SDS-PAGE gel of the purified wild-type PK1 and its derivatives following 
size-exclusion chromatography.  Lane 1: Protein marker. Lane 2: Wild-type PK1. Lane 2-8: 
P70T, P70Q, D127N, I264F, A301T, A301S and G381A PK1 mutants. In each lane, 6 µg of protein 
was loaded. 
 
Table 3.1       Purification of the wild-type PK1 and its derivatives 
Sample Purification 
Procedure 
Total 
protein 
(mg) 
Total 
activitya 
(U)b
Specific 
activity 
(U/mg) 
% 
Yield 
Relative 
purity 
(fold) 
crude extract 122 154 1.3 - - 
Step 1 87 86 0.98 55 0.8 
Step 2 33 160 4.9 104 3.9 
P70T 
Step 3 21 66 3.2 43 2.5 
crude extract 161 156 0.97 - - 
Step 1 57 76 1.3 49 1.4 
Step 2 36 95 2.6 61 2.7 
P70Q 
Step 3 20 50 2.6 32 2.7 
crude extract 131 1.4 0.01 - - 
Step 1 100 0.9 0.009 69 0.9 
Step 2 57 1.3 0.02 97 2.2 
D127N 
Step 3 28 1.1 0.04 80 3.8 
crude extract 110 108 0.98 - - 
Step 1 91 93 1.0 86 1.0 
Step 2 47 76 1.6 70 1.7 
I264F 
Step 3 20 63 3 58 3.2 
crude extract 206 92 0.5 - - 
Step 1 200 96 0.5 104 1.1 
Step 2 73 85 1.2 93 2.6 
A301T 
Step 3 11 23 2.0 25 4.5 
crude extract 194 105 0.5 - - 
Step 1 192 106 0.6 101 1.0 
Step 2 38 68 1.8 65 3.3 
A301S 
Step 3 12 31 2.6 30 4.9 
crude extract 132 93 0.7 - - 
Step 1 109 97 0.9 105 1.1 
Step 2 37 73 2.0 79 2.8 
G381A 
Step 3 31 77 2.5 83 3.6 
a   Activity was determined using the LDH coupled assay. 
b   1 unit is defined as the oxidation of 1 µmol of NADH per second.  Assays were performed at 30 
°C at pH 7.5, with 2 mM of PEP, ADP and FBP, 0.12 mM NADH and with 22 units of LDH. 
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3.3 Steady-state kinetics of the PK1 mutants 
A kinetic study of the PK1 variants was performed using a method adapted from Valentini 
(2000), (Section 6.4.2), and was essentially the same as that used for the wild-type. 
 
PEP titrations were performed for all seven mutants in the presence and absence of FBP 
(Figures 3.4 & 3.5, Table 3.2) in order test the activity of the mutants and the allosteric 
regulation pattern in response to FBP. Without FBP present in the assay, the saturating 
concentrations of PEP for the majority of the enzymes were higher than 2 mM, except for 
the wild-type and PK1-I264F enzymes. Despite that, ADP titrations were performed with 
and without FBP, at 2 mM PEP constant. Therefore, for ADP titrations, the kcatADP values 
were dependent on both PEP and ADP concentrations. The S0.5PEP for A301T was 20 mM 
in the absence of FBP. Not surprisingly, this mutant enzyme did not show detectable 
activity with up to 10 mM ADP, at constant 2 mM PEP, when FBP was not present in the 
assay (Figure 3.5, Table 3.2). 
 
FBP titrations were also performed. The FBP titrations were dependent on two factors, 
which are, the FBP affinity to the enzyme, and the extent to which FBP influences PEP 
affinity (Fenton & Blair 2002). Therefore, kcat values relative to FBP activation were 
represented in the results (Figure 3.6, Table 3.3). 
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Figure 3.4       PEP titration curves for the wild-type PK1 and the mutants P70T, P70Q, 
D127N, I264F, A301T, A301S and G381A. Enzyme activity was assayed at 30 °C and pH 7.5, as 
described in Section 6.4.2 with ADP present at 2 mM. (a) The titration in the presence of 2 mM 
FBP and (b) in the absence of FBP: wild-type (■, black), P70T (●, red), P70Q (▲, green), D127N 
(▼, blue), I264F (◆, cyan), A301T (◄, pink), A301S (►, yellow) and G381A (★, olive). Error bars 
represent the standard error of the mean for two replicates. The insets highlight those curves 
difficult to distinguish in the main plot. 
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Figure 3.5       ADP titration curves for the wild-type PK1 and the mutants P70T, P70Q, 
D127N, I264F, A301T, A301S and G381A.  Enzyme activity was assayed at 30 °C and pH 7.5, as 
described in Section 6.4.2 with PEP present at 2 mM. (a) The titration was performed in the 
presence of 2 mM FBP; (b) the titration was performed in the absence of FBP: wild-type (■, black), 
P70T (●, red), P70Q (▲, green), D127N (▼, blue), I264F (◆, cyan), A301T (◄, pink), A301S (►, 
yellow) and G381A (★, olive). A301T was not active with the absence of FBP, when a fixed 2 mM 
PEP was present in the solution.  Error bars represent the standard error of the mean for two 
replicates. The insets highlight those curves difficult to distinguish in the main plot. Note that ADP 
titrations were performed at 2 mM PEP (constant) for both assays, at this concentration is not the 
saturating concentration for most enzymes at the situation when FBP is absent, except the wild-type 
and the PK1-I264F mutant (as adjusted by S0.5PEP, FBP(-). Therefore, only the S0.5ADP values were 
discussed here.
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Table 3.2      Kinetic parameters of the wild-type and mutant E. coli PK1 by fitting the Hill equation (Hill 1910) (Equation 2.1b). Results are mean 
values ± standard errors for duplicate measurements. 
PEP  
FBP (-) FBP (+) 
kcat S0.5PEP nH kcat/S0.5 kcat S0.5PEP nH kcat/S0.5 
s-1 mM   s-1 mM   
wt  243 ± 2 1.5 ± 0.1 3.1 ± 0.6 162 268 ± 4 0.06 ± 0.002 1.0 ± 0.04 4467 
P70T Active site mutant 116 ± 17 3.1 ± 0.9 1.2 ± 0.3 37 124 ± 3 0.12 ± 0.01 0.7 ± 0.03 1033 
P70Q Active site mutant 163 ± 6 2.5 ± 0.2 3.6 ± 0.5 65 197 ± 6 0.1 ± 0.006 1.3 ± 0.03 1970 
D127N Active site mutant 3 ± 0.1 1.8 ± 0.08 2.3 ± 0.1 2 4 ± 0.4 0.14 ± 0.04 1.3 ± 0.2 29 
I264F A/A’ interface mutant 114 ± 3 0.4 ± 0.03 3.7 ± 1 285 154 ± 7 0.03 ± 0.006 1.3 ± 0.2 5133 
A301T A/A’ interface mutant 42 ± 3 20 ± 1.8 1.9 ± 0.07 2 496 ± 46 0.9 ± 0.1 2.1 ± 0.1 551 
A301S A/A’ interface mutant 301 ± 6 3.9 ± 0.3 1.4 ± 0.1 77 292 ± 27 0.2 ± 0.06 0.7 ± 0.1 1460 
G381A FBP binding site mutant 274 ± 17 4.6 ± 0.2 3.2 ± 0.07 60 402 ± 9 0.09 ± 0.009 1.4 ± 0.1 4467 
ADP  
FBP (-) FBP (+) 
kcat S0.5ADP nH kcat/S0.5 kcat S0.5ADP nH kcat/S0.5 
s-1 mM   s-1 mM   
wt  241 ± 12 0.54 ± 0.11 0.75 ± 0.07 446 309 ± 19 0.34 ± 0.07 1.0 ± 0.08 909 
P70T Active site mutant 39 ± 1 0.15 ± 0.02 1.1 ± 0.2 260 120 ± 11 0.24 ± 0.06 1.0 ± 0.1 500 
P70Q Active site mutant 67 ± 3 1.4 ± 0.2 1.6 ± 0.08 48 223 ± 7 0.6 ± 0.04 1.0 ± 0.02 372 
D127N Active site mutant 1 ± 0.04 0.9 ± 0.08 1.8 ± 0.2 1 7 ± 0.7 1.2 ± 0.2 1.3 ± 0.1 6 
I264F A/A’ interface mutant 69 ± 1 0.7 ± 0.03 1.3 ± 0.06 99 183 ± 4 1.6 ± 0.7 0.9 ± 0.1 114 
A301Ta A/A’ interface mutant --a --a --a --a 494 ± 47 0.5 ± 0.1 1.2 ± 0.1 988 
A301S A/A’ interface mutant 68 ± 3 1.0 ± 0.06 1.4 ± 0.1 68 292 ± 6 0.4 ± 0.02 1.0 ± 0.04 730 
G381A FBP binding site mutant 18 ± 1 2.8 ± 0.4 1.2 ± 0.05 6 430 ± 9 0.3 ± 0.02 1.6 ± 0.1 1433 
a A301T is essentially inactive with 2 mM PEP up to 10 mM ADP, in the absence of FBP (refer to Section 3.3.1 text).
 
 
Figure 3.6       Enzyme activity relative to FBP for the wild-type PK1 and the enzymes with 
P70Q, D127N, I264F, A301T, A301S and G381A mutations.  Enzyme activity was assayed at 30 
°C and pH 7.5, with the absence of FBP as background (V0[FBP]). The assay was then performed at 
various FBP concentrations, as described in Section 6.4.2. Relative enzymatic activities in the 
presence of FBP are shown here by subtracting the background activity (V0[FBP]). PEP and ADP 
were present at 2 mM respectively: wild-type (■, black), P70Q (▲, green), D127N (▼, blue), I264F 
(◆, cyan), A301T (◄, pink), A301S (►, yellow) and G381A (★, olive). Titration for P70T was not 
performed. Error bars represent the standard error of the mean of the kcat between two replicates. 
The insets highlight those curves difficult to distinguish in the main plot. 
 
Table3.3        The relative kcat with respect to FBP (i.e. kcat[FBP]-kcat0[FBP]). Parameters were 
determined in the presence of 2 mM PEP and 2 mM ADP using Michaelis-Menten model (Equation 
2.1a). A301T was fitted using Hill cooperative model (Hill 1910) (Equation 2.1b).  P70T was not 
examined. Results are mean values ± standard errors for duplicate measurements unless stated. 
 kcat[FBP]-kcat0[FBP]
s-1
KM
mM 
nH
Wild-type  57 ± 4 0.08 ± 0.01 1 
P70Ta Active site mutant n/aa n/aa n/aa
P70Q Active site mutant 130 ± 11 0.06 ± 0.01 1 
D127N Active site mutant 2.5 ± 0.08 0.01 ± 0.001 1 
I264F A/A’ interface mutant 67 ± 6 0.5 ± 0.1 1 
A301T A/A’ interface mutant 150 ± 6 0.2 ± 0.03 2.7 ± 0.5 
A301S A/A’ interface mutant 172 ± 3 0.01 ± 0.001 1 
G381A FBP binding site mutant 250 ± 11 0.1 ± 0.01 1 
a FBP titration for PK1-P70Q was not performed.
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3.4 Kinetic properties of the mutants 
Generally, the mutated enzymes showed altered kinetic properties compared to the 
wild-type. When FBP was present in the reaction, some of the mutated enzymes were 
more active than the wild-type when titrated against PEP (PK1-A301T, PK1-A301S and 
PK1-G381A) and ADP (PK1-A301T and PK1-G381A), while others were less active 
(PK1-P70T, PK1-P70Q, PK1-D127N and PK1-I264F) (Figures 3.4 & 3.5). In addition, 
some mutants showed altered substrate affinity in response to FBP in terms of allosteric 
cooperativity, as judged by the nH values (Table 3.2). The degree of the FBP activation 
was also examined (Figure 3.6, Table 3.3). 
 
All mutants except PK1-D127N showed activities much higher than the residual PK1 
activity, which was estimated using the LDH coupled assay early on in the E. coli BL21 
(DE3) whole cell lysate (0.2% of wild-type activity) (Section 2.3). PK1-D127N is highly 
inactive (1.5% of wild-type activity) with a distinct ADP titration pattern from the 
wild-type. Given the low activity, the possibility of wild-type contamination cannot be 
excluded; however, we note that S0.5ADP in the presence of FBP (Table 3.2) is quite 
different to that of the wild-type, which would not be the case if the measured activity was 
due to residual wild-type enzyme alone. That the activity is still affected by FBP, 
precludes the possibility that the residual activity is from E. coli PK type 2, which is 
regulated AMP and monophosphorylated sugars (Mattevi et al. 1995). 
 
As mentioned in Section 1.4, the seven mutations fall loosely into three groups with 
respect to the PK structure (Figures 1.11 & 3.7), those are, P70T, P70Q and D127N 
belonging to the active site mutation group; I264F, A301T and A301S belonging to A/A’ 
subunit interface mutation group; and G381A at the FBP binding site. The mutations at 
the active site were predicted to have an effect on catalysis, while those at the FBP binding 
site was possible to affect FBP binding. 
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Figure 3.7       Mutations in evolved PK1 enzymes.  Mutated residues are represented as 
spheres.  The active site residue P70 is in red, and D127 in orange; the A/A’ subunit interface 
residue I264 is in blue, and A301 in yellow; the FBP binding site residue G381 is in green. Figure 
was generated by Pymol (DeLano 2002) using PDB file 1pky (E. coli PK1) (Mattevi et al. 1995). 
3.4.1 The active site 
The residues P70 and D127 are situated within or close to the active site, which lies in a 
pocket between domains A and B (Figure 3.7) (Muirhead et al. 1986). Thus, it was 
predicted that mutations at these positions would affect the catalytic activity of the mutant 
enzymes compared to the wild-type enzyme. However, because the regulatory 
mechanism of PK1 is unclear, we could not predict whether the regulation would also be 
affected. 
 
Both mutations at position 70 exchanged the nonpolar side-chain of proline for more polar 
side-chains. Kinetic data showed that the P70T and P70Q mutants were less active than 
the wild-type (Table 3.2, Figure 3.8). Interestingly, P70Q showed similar cooperative 
activation with respect to PEP titration (nH = 3.6 ± 0.5) compared to nH = 3.1 ± 0.6 for the 
wild-type, while P70T showed little PEP cooperativity (nH = 1.2 ± 0.3). P70 is positioned 
on an extended loop connecting the A and B domains. The proline produces a kink in the 
loop and a number of residues about this position are thought to be responsible for binding 
the K+ ion (Figure 3.9). In addition, P70 is close to S192, which is thought to interact 
with both PEP and ADP (Munoz & Ponce 2003). 
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Figure 3.8       Kinetic properties of wild-type, PK1-P70T and PK1-P70Q enzymes. a-c: 
The relative kcat of wild-type, PK1-P70T and PK1-P70Q enzymes with respect to the wild-type 
enzyme measured at varying concentrations of PEP (Section 6.4.2). d-e: The relative kcat of 
wild-type, PK1-P70T and PK1-P70Q enzymes with respect to the wild-type enzyme measured at 
varying concentrations of ADP. Titrations are in the absence (○) or presence (■) of 2 mM FBP. 
Curves represent the best fit to the Hill cooperative model (presented in Table 3.2). Error bars 
represent the standard error of the mean between two replicates. 
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Figure 3.9     The residues involved in K+ and substrate binding in E. coli PK1. Residues in 
blue are involved in binding K+, while those in green bind ADP, PEP and Mg2+. P70 and S192 are 
indicated in the figure from a view down to the barrel of the active site. Figure is generated by 
Pymol (DeLano 2002) using PDB file 1pky (Mattevi et al. 1995). 
 
For rabbit muscle PKM1, the binding of ADP appears to facilitate a large movement of 
domain B, closing the active site, as demonstrated by the Bis(Mg2+)-ATP-oxalate complex 
(Figure 3.10). This complex represents the enzyme:product complex of the reaction 
between oxalylphosphate (the slow substrate of PK, (Kofron & Reed 1990)) and ADP. 
P116 (P70 in E. coli PK1 numbering) sits at one of the hinge points for this movement 
(Larsen et al. 1998). A structure overlay of the E. coli PK1 and rabbit muscle PKM1 
(unbound form, free of Mg2+-ATP) revealed high similarity between the two structures at 
domains A and B (Figure 3.11). Therefore, it is possible that a similar role for P70 exists 
in E. coli PK1 during the substrate binding transition. 
 
 
Figure 3.10     ATP and oxalate defined the PK active site (orange yellow stick) for rabbit 
muscle PKM1.  a: an overall view and b: a close up view.  P116 overlay is shown in stick form 
(pink and yellow).  Pink, ATP unbound subunit; yellow, ATP bound subunit.  This plot illustrates the 
40° rotation of the B domain relative to the A domain.  P116 is situated at the hinge of this rotation.  
Mg2+ cations are shown as green balls and K+ as purple balls.  Figure is generated by Pymol 
(DeLano 2002) using PDB file 1a49 (Larsen et al. 1998). 
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Figure 3.11      Overlay of E. coli PK1 (blue) and rabbit muscle PKM1 (pink), unbound.  It 
shows that the A and B domains have excellent structural conservation, although this is not true for 
the allosteric FBP binding domain (C).  The 2 proteins share 46% sequence identity (Mattevi, 1995).  
Figure was generated by Pymol (DeLano 2002) using PDB files 1pky (E. coli PK1) (Mattevi et al. 
1995) and 1a49 (rabbit muscle PKM1) (Larsen et al. 1998), with r.m.s.d. of Cα overlay 1.7. 
 
The lower activity observed for both enzymes with P70T and P70Q mutations compared to 
the wild-type (as judged by the specificity constant, kcat/S0.5) is perhaps because of altered 
K+ (via adjacent residues) or substrate binding (via S192).  Mutations at P70 may also 
affect the domain movement upon substrate binding. Presumably, the nature of the 
extended loop connecting domains A and B (to which P70 belongs) is to attenuate activity 
by modulating the domain movement upon ADP binding. Thus, mutations at P70 would 
have the effect of not positioning within the active site those residues at domain B 
important for catalysis, such as R119, K156, and D127. The lack of PEP cooperativity 
for PK1-P70T compared to the wild-type and PK1-P70Q is interesting, but more difficult 
to explain, given that a detailed and rational mechanism for such cooperativity has not 
been proposed.  Future structural studies may be required to explain this behavior. 
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The residue D127 is situated on a loop of the B domain (Larsen et al. 1998; Mattevi et al. 
1995). Like P70, D127 is also highly conserved across species (Munoz & Ponce 2003). 
It is proposed to have a critical role in forming a salt-bridge with the side chain of R292 
from the adjacent subunit across the A/A’ interface in the T- to R-state transition upon FBP 
binding (Mattevi et al. 1995).  Moreover, a structural study of the rabbit PKM1 found that 
D177, which corresponds to D127 in E. coli PK1, moved substantially (6.8 Å) from the 
open conformation to the closed conformation in the Mg2+-ATP binding state (Larsen et al. 
1998), interacting with the hydration shell of Mg2+. Thus, this residue appears to be 
involved in both allosteric and catalytic functions and this mutation tests both of these 
proposals. 
 
The mutation D127N involved the change of aspartic acid to asparagine at position 127, 
exchanging the carboxylic acid moiety with a carbamoyl group and loss of the associated 
-ve charge.  Consistent with it proposed role in catalysis, PK1-D127N shows severely 
attenuated catalytic activity (kcat/S0.5 ranging from 2-29) compared to the wild-type enzyme.  
Given this mutation is isosteric, it is reasonable to conclude that the carbamoyl group of 
N127 is not able to interact with the hydration shell of Mg2+ in the same way as the 
carboxyl may.  Thus, D127 appears to have a critical role in catalysis which has not been 
reported for the E. coli enzyme. 
 
In addition, the overall S0.5 for the substrates is similar to the wild-type enzyme except for 
the S0.5 for ADP, which is increased three-fold (Table 3.2, Figure 3.12), suggesting that the 
mutant binds substrates with similar affinity.  The possibility of large structural changes 
cannot be excluded (which will be tested by CD in Chapter 4) and a crystal structure will 
be sought in the future. 
 
It is interesting to note that in a human erythrocyte PK study, when D211, which occupies 
the same position as D127 in E. coli PK1 (Figure 1.5), is mutated to an asparagine and 
causes severe PK function deficiency (Fermo et al. 2005; Pendergrass et al. 2006; Zanella 
et al. 2005). This mutational study at this position begins to explain why this might be 
the case from a protein structure/function viewpoint. 
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Figure 3.12      Kinetic properties of the wild-type and PK1-D127N enzymes. a & b: The 
relative kcat of purified wild-type and PK1-D127N enzymes to the kcat of the wild-type enzyme was 
measured at varying concentrations of PEP as described (Section 6.4.2). c & d: The relative kcat of 
purified wild-type and PK1-D127N enzymes to the kcat of the wild-type enzyme was measured at 
varying concentrations of ADP as described (Section 6.4.2). Varying concentrations of PEP and 
ADP are in the absence (○) or presence (■) of 2 mM FBP. Curves represent the best fit to the Hill 
equation. Kinetic parameters determined by fitting the results to the Hill equation are presented in 
Table 3.2. Error bars represent the standard error of the kcat relevant to the wild-type kcat between 
two replications. Note that the scales for the wild-type enzyme and for the PK1-D127N are not the 
same. 
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3.4.2 The A/A’ interface 
The residues I264 and A301 are near the A/A’ interface (Figure 3.7).  Both residues are 
very close to one another in space, being situated on adjacent α-helices, which make up the 
A/A’ interface (Figure 3.13).  A sequence alignment among PK1 enzymes from a variety 
of organisms showed that I264 and A301 are well conserved across species (Figure 1.5).   
 
Mutations at both positions were of particular interest, since allosteric binding is thought to 
promote domain movements, interface rearrangements, or change in oligomeric states 
(Fenton & Blair 2002) and thus the PK mutants in this category may inform a new 
allosteric mechanism.  In addition, four separate populations from Lenski’s evolution 
experiment developed mutations at A301, suggesting a hitherto unknown function. 
 
 
Figure 3.13      Positions of I264 and A301 at A/A’ interface of E. coli PK1.  The adjacent 
subunit is illustrated in purple. Ile264 and Ala301 are shown in red sticks.  Figure was generated 
by Pymol (DeLano 2002) using PDB file 1pky (E. coli PK1) (Mattevi et al. 1995). 
 
The mutation I264F replaces a nonpolar side group with a similarly hydrophobic, but 
sterically larger aromatic group. I264 is part of the Aα6 helix and the side chain sits in a 
largely hydrophic pocket with hydrophobic interactions with V274, I268, T306 and V242 
(Figure 3.14).  The A/A’ interface is largely formed by contacts between helices Aα6 and 
Aα7.  Given the juxtaposition of the helices, a bulkier mutation may interfere with the 
helical packing about the (β/α)8-barrel, and also the A/A’ interface that these helices 
contribute to.  This distortion may in turn affect a number of conserved contacts between 
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the helices, but specifically the conserved salt bridge between R244 of Aα6’ and D297 of 
Aα7 (Fenton & Blair 2002; Jurica et al. 1998; Valentini et al. 2000).  The short helix Aα6’ 
sits in the loop (loop6) between Aβ6 and Aα6 and is highly conserved (Figure 1.5). It is 
proposed to play a role in both PEP binding and the FBP allosteric response (Mattevi et al. 
1995).  In addition, the E. coli structure in the T-state shows that D297 of Aα7 also 
contacts R292 of the adjacent monomer.  Mutation of either D297 or R292 renders the 
enzyme completely inactive (Valentini et al. 2000). 
 
 
Figure 3.14      Overlay of E. coli PK1 (blue), rabbit PKM1 (pink) and yeast PK (yellow) A/A’ 
interface structures and the important residues.  (a) an overall view; (b) An expanded view with 
the overly of residues at the interfaces. 
 
Kinetic analysis (Table 3.2, Figure 3.15) showed that PK1-I264F was less active than the 
wild-type PK1. PK1-I264F had similar substrate binding properties to the wild-type 
enzyme, although it showed greater affinity for PEP in the absence of FBP.  Interestingly, 
the specificity constant (kcat/S0.5) for PEP increased compared to the wild-type (285 
s-1mM-1 vs. 162 s-1mM-1 in the absence of FBP; 5133 s-1mM-1 vs. 4462 s-1mM-1 in the 
presence of FBP), suggesting that the enzyme had a more specific response to increasing 
PEP concentrations. 
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Figure 3.15     Kinetic properties of the wild-type and PK1-I264F enzymes. a & b: The 
relative kcat of wild-type and PK1-I264F enzymes to the kcat of the wild-type enzyme was measured 
at varying concentrations of PEP as described (Section 6.4.2). c & d: The relative kcat of wild-type 
and PK1-I264F enzymes to the kcat of the wild-type enzyme was measured at varying 
concentrations of ADP as described (Section 6.4.2). Varying concentrations of PEP and ADP are 
in the absence (○) or presence (■) of 2 mM FBP. Curves represent the best fit to the Hill equation. 
Kinetic parameters determined by fitting the results to the Hill equation are presented in Table 3.2. 
Error bars represent the standard error of the kcat relevant to the wild-type kcat between two 
replications. 
 
With respect to allostery, I264F showed remarkably diminished binding of FBP (Figure 3.6, 
Table 3.3). This result suggests that the A/A’ interface is critical for communicating the 
allosteric signal from domain C to the active site, via the Aα6 helix. Fenton and Blair 
(2002) have previously communicated this proposal when considering the results of a 
mutagenic study with the yeast PK enzyme (in their work helix Aα6 is called H10). This 
result is consistent with the proposal that FBP binding alters the activity via a signal 
through the Aα6 helix. 
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For the mutations A301T and A301S, a similar analysis was carried out. These mutations 
were interesting because of their high incidence in the evolutionary study (Section 1.1).   
 
Residue A301 belongs to helix Aα7 (Figures 1.12 & 3.13), which holds a number of highly 
conserved residues (Figure 1.5).  A301 sits at the top of the same hydrophobic pocket for 
which I264F is a part and is also close to R292 (4.8 Å) and D297 (5.4 Å) (Figure 3.14), 
both of which are involved in the A/A’ interfacial transition and affect enzyme catalysis 
and, as discussed above, may be the link that connects the FBP binding site with the active 
site (Mattevi et al. 1996; Mattevi et al. 1995; Valentini et al. 2000). Both the A301S and 
A301T mutations introduce a hydroxyl moiety and moderate steric bulk to the side chain. 
 
Given the similarity of the mutations (i.e. serine and threonine), the most surprising feature 
was how different they behaved kinetically. In the absence of FBP, both mutations were 
attenuated, but where PK1-A301S was still active, PK1-A301T showed essentially no 
activity at all (Figure 3.16). Although both were very active in the presence of FBP, 
PK1-A301T showed a greater kcat than the wild-type. 
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Figure 3.16      Kinetic properties of the wild-type, PK1-A301T and PK1-A301S enzymes. 
a - c: The relative kcat of wild-type, PK1-A301T and PK1-A301S enzymes with respect to the 
wild-type enzyme measured at varying concentrations of PEP as described (Section 6.4.2). d - f: 
The relative kcat of wild-type, PK1-A301T and PK1-A301S enzymes with respect to the wild-type 
enzyme measured at varying concentrations of ADP as described (Section 6.4.2). Titrations were 
in the absence (○) or presence (■) of 2 mM FBP. A301T is inactive at 2 mM PEP with ADP up to 10 
mM. Curves represent the best fit to the Hill equation and are presented in Table 3.2. Error bars 
represent the standard error of the kcat relevant to the wild-type kcat between two replications. Note 
that the scales for the wild-type enzyme and for the PK1-A301T are not the same. 
 
Perhaps the most intriguing result was that PK1-A301T showed activation by PEP even in 
the presence of FBP. It would seem that this mutation has disentangled the affect of 
allosteric FBP activation and PEP activation. The structure of these mutated enzymes 
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would be very helpful in understanding the processes of both FBP activation and PEP 
activation. Both enzymes showed decreased cooperativity to PEP when FBP was absent 
in the solution, as judged by the decreased nH value (Table 3.2). Clearly, mutations at the 
A/A’ interface have a profound affect on enzyme regulation.  The results in this thesis are 
entirely consistent with the hypothesis put forward by Fenton and Blair (2002). However, 
structural studies of the mutated enzymes will be required to more fully explain the altered 
kinetic behaviour. 
3.4.3 The FBP binding site 
Residue G381 is the only residue situated at the FBP binding site that was found to have a 
mutation in the evolution study.  G381 belongs to a stretch of conserved residues involved 
in the formation of FBP binding site (Munoz & Ponce 2003) and is adjacent to residues 
found to be crucial for the FBP binding to PK1 (Section 1.4.3, Figure 1.16).  Figure 3.17 
shows that G381 is within a loop joining Cβ1 and Cα3 of the C domain, and this loop 
region contributes to FBP binding (assuming the same FBP binding pocket for E. coli PK1). 
The mutation of a glycine to an alanine residue is a subtle change, although glycine 
residues are more conformationally tolerant and thus often found in loop regions.  It was 
hypothesised that this mutation may affect FBP binding caused by a reorientation of the 
Cβ1 and Cα3 loop. 
 
 
Figure 3.17     Overlay of FBP binding site of E. coli PK1 (green), rabbit PKM1 (purple), 
yeast PK (blue) and B. stearothermophilus PK (yellow). G381 (E. coli PK numbering) is 
labelled. FBP is shown in orange sticks, which shows the orientation as in yeast PK crystal. 
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The PK1-G381A enzyme showed similar kinetic profiles to the wild-type in the presence 
of FBP for both PEP and ADP titration experiments, with comparable S0.5 and kcat/S0.5 
ratios, but had a greater kcat (Figure 3.18). When FBP is absent, however, the S0.5PEP 
increased in comparison to the wild-type, which indicated some impairment in PEP 
binding (Figure 3.18b). G381 belongs to the pocket which binds to 6’-phosphate of FBP 
in the yeast PK (Fenton & Blair 2002; Jurica et al. 1998). Although the residues making 
the pocket are not completely conserved, G381 itself is absolutely conserved among the 
sequences (Figure 1.5) (Munoz & Ponce 2003). Mutation G381A probably distorts this 
pocket. 
 
Figure 3.18      Kinetic properties of the wild-type and PK1-G381A enzymes.  a & b: The 
relative kcat of purified wild-type and PK1-G381A enzymes to the kcat of the wild-type enzyme was 
measured at varying concentrations of PEP as described (Section 6.4.2).  c & d: The relative kcat of 
purified wild-type and PK1-G381A enzymes to the kcat of the wild-type enzyme was measured at 
varying concentrations of ADP as described (Section 6.4.2). Varying concentrations of PEP and 
ADP are in the absence (○) or presence (■) of 2 mM FBP. Curves represent the best fit to the Hill 
equation.  Kinetic parameters determined by fitting the results to the Hill equation are presented in 
Table 3.2. Error bars represent the standard error of the kcat relevant to the wild-type kcat between 
two replications. 
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3.5 Summary 
In this chapter, the kinetic properties of the mutated PK1 enzymes were discussed in detail, 
along with the comparison with the wild-type enzyme. Mutations found in the previous 
evolutionary study (Woods et al. 2006), which were discussed in this thesis, were not 
random in that they all (apart from D127N) appeared to play a part in allosteric 
mechanisms. When mapped to the structure, P70T/Q and D127N are seen to be active 
site mutations, which affect substrate affinity and the catalysis (Larsen et al. 1998; Larsen 
et al. 1997); the mutations I264F and A301T/S belonged to the A/A’ subunit interface, 
which was proposed to involve allosteric signal transition in previous studies (Fenton & 
Blair 2002; Friesen et al. 1998a); and G381A was a mutation that caused a subtle change at 
the FBP binding site, which affected FBP binding (Fenton & Blair 2002; Jurica et al. 1998). 
G381 was also close to the A/C domain interface, which may therefore be involved in the 
allosteric signal transition (Mattevi et al. 1996; Mattevi et al. 1995). 
 
PK1 with mutations at different positions showed distinct kinetics to the wild-type enzyme. 
Some of the mutations led to activation of the enzyme, as judged by S0.5 and kcat values, 
such as A301T and G381A mutations. Others caused the enzyme to be less active, such 
as P70 mutations, D127N and I264F. A301S had similar activity when FBP was present 
in the assay, however, became less active in response to ADP, partly due to a non-saturating 
PEP level. The most surprising finding was that although A301T and A301S differed by 
only one methyl group, their kinetic profiles were significantly different with respect to 
both the catalysis and allosteric regulation pattern. PK1-A301T was the only mutated 
enzyme exhibiting sigmoidal type kinetics to PEP, even with FBP present in the assay. 
Clearly, the populations have not evolved parallel PK1 function. 
 
These results generally support the study carried out by Fenton and colleagues (2002) on 
yeast PK. Some of the results (e.g. kinetic results for PK1-A301T) highlighted the 
important role of A/A’ subunit interface in the allosteric regulation in E. coli PK1 (Fenton 
& Blair 2002), and the role of Aα6 loop involved in the allosteric signal transition under 
the “network mechanism” (Friesen et al. 1998a). 
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Chapter 4 
Biophysical characterisation of the PK1 
mutants 
 
4.1 Introduction 
The biophysical properties of an enzyme are reflected in its structure, hydrodynamic and 
thermodynamic properties. The altered kinetic properties of the mutants seen in Chapter 
3 may have resulted from altered structure, reflecting the protein structure-function 
relationship of this enzyme. Secondary structure, quaternary structure and the 
hydrodynamic properties of the mutant PK1 enzymes were compared to the wild-type 
enzyme. In addition, X-ray crystallography was attempted, however, crystals of several 
mutated PK1 enzymes diffracted only weakly and data has not been collected. 
4.2 Circular Dichroism 
The secondary structure of the seven PK1 mutants was examined by circular dichroism 
(CD) using the same conditions as for the wild-type (Section 2.5.1). Similar to the 
wild-type enzyme, the results were processed using software on DICHROWEB (Whitmore 
& Wallace 2004) using the analysis algorithms SELCON3, CONTIN-LL and CDSSTR 
(Section 6.5.2) (Compton & Johnson 1986; Sreerama et al. 1999; van Stokkum et al. 1990) 
and dataset 7, with the quality of the fit judged by the n.r.m.s.d. value. CD plots have 
been drawn according to the CDSSTR fit (with lowest n.r.m.s.d. value) (Table 4.1, Figure 
4.1), and the parameters had been listed (Table 4.1). 
 
In the analysis, data with a HT voltage above 600 mV, observed in some samples to 190 
nm, were not included. Parameters for the mutant enzymes were compared with those of 
the wild-type, which showed that the α and β contents of the wild-type and mutated 
enzymes were not identical. This indicated changed secondary structures of mutants. 
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Figure 4.1      Comparison of the mutated PK1 enzymes with the wild-type. (Enzymes of 
wild-type 0.15 mg/ml, ▲; A301T 0.15 mg/ml, ▲; G381A 0.2 mg/ml, ▲; P70T 0.2 mg/ml, ●; D127N 
0.25 mg/ml, ▲; A301S 0.2 mg/ml, ▲; and I264F 0.22 mg/ml, ■); CD was performed in a Jasco-815 
CD spectropolarimeter at 20 ºC. Wavelength scans were recorded from 240 to 195 nm in 0.5 nm 
pitch using step scan method. The HT voltage was below 600 mV. 
 
The mutated enzymes have similar CD plots compared to the wild-type, except enzymes 
with mutations I264F and G381A. PK1-I264F has lower α-helical content than the 
wild-type enzyme. Residue I264, which belonged to helix Aα6, was mutated to a 
phenylalanine with a bulker side chain. This may have affected the helical structure at 
Aα6, as suggested by the CD result. PK1-G381A, on the other hand, had higher α-helical 
content compared to the wild-type. G381 is part of a loop at the FBP binding site. 
Given that alanine is less flexible than glycine, it may have affected the protein structure in 
a way that the helices are packed differently around the FBP binding site. 
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Table 4.1      Fitted parameters of the PK1 enzymes using CDSSTR software on DICHROWEB.  a CD for PK1-P70Q was not performed. 
 Wild-type P70T P70Qa D127N I264F A301T A301S G381A 
n.r.m.s.d. 0.017 0.034 n/a a 0.042 0.046 0.028 0.026 0.044 
α-helix(1) 0.14 0.08 n/a a 0.06 0.05 0.09 0.07 0.15 
α-helix(2) 0.10 0.09 n/a a 0.09 0.07 0.1 0.08 0.13 
β-strand(1) 0.16 0.19 n/a a 0.21 0.23 0.18 0.21 0.14 
β-strand(2) 0.1 0.11 n/a a 0.11 0.12 0.11 0.11 0.08 
Turn 0.2 0.22 n/a a 0.24 0.21 0.24 0.23 0.21 
uncoiled 0.30 0.3 n/a a 0.3 0.33 0.28 0.29 0.29 
Total 1 0.99 n/a a 1.01 1.01 1 0.99 1 
Helix segments per 100 residues    2.6 2.3 n/a a 2.2 1.6 2.4 2.0 3.3 
Ave helix length per segment 9.3 7.7 n/a a 6.5 7.1 7.7 7.5 8.6 
Strand segments per 100 residues 4.7 5.3 n/a a 5.5 5.8 5.5 5.7 4.1 
Ave strand length per segment 5.2 5.7 n/a a 5.8 6.1 5.3 5.7 5.4 
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4.3 Mass spectrometry 
Electrospray mass spectrometry (ES-MS) was performed for all the seven mutants, as for 
the wild-type (Section 6.5.1). Molecular weights of the mutants obtained by mass 
spectrometry were compared with the previously predicted isotopically averaged molecular 
weights by protein calculator v 3.3 (from the Scripps research institute, La Jolla, CA). 
The results are shown in Figure 4.2 and Table 4.2. 
 
 
Figure 4.2      Counts vs. Deconvoluted mass (amu) of the wild-type PK1 and the mutants. 
(a) Wild-type PK1 with the main peaks labelled. (b) PK1-P70T mutant. (c) PK1-P70Q mutant. (d) 
PK1-D127N mutant. (e) PK1-I264F mutant. (f) PK1-A301T mutant. (g) PK1-A301S mutant. (h) 
PK1-G381A mutant.
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Table 4.2      Comparison of the molecular weights of the wild-type PK1 and the mutated 
enzymes obtained from mass spectrometry and the isotopically averaged molecular weights. 
 Isotopically Averaged MW 
(Da) 
MW obtained by MS 
(Da) 
Wild-type 50729.28 50729.34 
P70T 50733.27 50732.98 
P70Q 50760.29 50760.24 
D127N 50728.29 50728.20 
I264F 50763.29 50766.63 
A301T 50759.30 50759.24 
A301S 50745.28 50745.01 
G381A 50743.30 50742.93 
 
MS data were consistent with the isotopically averaged molecular weights, which further 
confirmed the identities of the mutated enzymes obtained by mutagenesis. In all the 
mutants, several adducts similar to those found in wild-type were observed (Figure 4.2).  
One adduct with a molecular weight of ~76 Da was found in the MS data of the wild-type 
(i.e. 50805.18 Da - 50729.34Da = 75.84 Da) and all the mutants. The molecular weight is 
consistent with β-mercaptoethanol molecule (76 Da) (estimated using ABRF DeltaMass 
mass finder from http://www.abrf.org/index.cfm/dm.home).  β-Mercaptoethanol (2 mM) 
was added into all buffer solutions during the protein purification procedure, which made it 
likely that the ethoxythiol group was attached to the protein covalently, however, the 
mechanism is unknown. Two adducts associated with the main peak were also observed, 
with molecular weights ~18 Da (i.e. 50746.47 Da - 50729.34 Da = 17.13 Da for the 
wild-type PK1) and ~37 Da (i.e. 50766.04 Da- 50729.34 Da = 36.7 Da for the wild-type 
PK1), respectively, which are consistent with the molecular weights of sodium (22 Da) and 
potassium (37 Da) (http://www.abrf.org/index.cfm/dm.home), which are present in the 
buffer (Section 6.3.3). 
4.4 Analytical ultracentrifugation (AUC) 
The quaternary structure and the hydrodynamic properties of the mutants were studied by 
analytical ultracentrifugation (AUC), as for the wild-type (Section 6.5.3). At 1.0 mg/ml 
(19.7 μM) (graphs not shown) and 0.1 mg/ml (1.97 μM) (Figures 4.3-4.9), respectively, all 
the mutants had sedimentation coefficients around 8.5 S, which corresponded to a single 
tetrameric species. There were subtle differences with the friction ratios; however, these 
do not indicate an altered quaternary structure. The results were generally consistent with 
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the wild-type PK1, thus indicating that the quaternary structure in solution was the same 
for the wild-type PK1 and the mutants.  
 
Figure 4.3       Sedimentation velocity analysis of PK1-P70T at 0.1 mg/ml (1.97 μM). (a) 
Absorbance at 227 nm as a function of radius (cm) from the axis of rotation is plotted. The raw 
data are presented as open circles and are overlaid with the nonlinear least squares best-fit to a 
continuous-size distribution model (Lamm equation) by SEDFIT.  Residuals for the nonlinear least 
squares best-fit are also shown. (b) The continuous sedimentation coefficient [c(s)] distribution as 
a function of sedimentation coefficient (Svedberg, S). The fit had a resolution of 150 species 
between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 
p, and ƒ/ƒ0 = 1.38. The r.m.s.d. and runs test-Z score for the fit were 0.0052 and 1.71, respectively. 
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Figure 4.4       Sedimentation velocity analysis of PK1-P70Q at 0.1 mg/ml (1.97 μM).  (a) 
Absorbance at 227 nm as a function of radius (cm) from the axis of rotation is plotted. The raw 
data are presented as open circles and are overlaid with the nonlinear least squares best-fit to a 
continuous-size distribution model (Lamm equation) by SEDFIT.  Residuals for the nonlinear least 
squares best-fit are also shown. (b) The continuous sedimentation coefficient [c(s)] distribution as 
a function of sedimentation coefficient (Svedberg, S). The fit had a resolution of 150 species 
between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 
p, and ƒ/ƒ0 = 1.45. The r.m.s.d. and runs test-Z score for the fit were 0.0051 and 1.07, respectively. 
 97
 
Figure 4.5       Sedimentation velocity analysis of PK1-D127N at 0.1 mg/ml (1.97 μM).  (a) 
Absorbance at 227 nm as a function of radius (cm) from the axis of rotation is plotted. The raw 
data are presented as open circles and are overlaid with the nonlinear least squares best-fit to a 
continuous-size distribution model (Lamm equation) by SEDFIT.  Residuals for the nonlinear least 
squares best-fit are also shown. (b) The continuous sedimentation coefficient [c(s)] distribution as 
a function of sedimentation coefficient (Svedberg, S). The fit had a resolution of 150 species 
between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 
p, and ƒ/ƒ0 = 1.34. The r.m.s.d. and runs test-Z score for the fit were 0.0062 and 6.27, respectively. 
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Figure 4.6       Sedimentation velocity analysis of PK1-I264F at 0.1 mg/ml (1.97 μM).  (a) 
Absorbance at 227 nm as a function of radius (cm) from the axis of rotation is plotted. The raw 
data are presented as open circles and are overlaid with the nonlinear least squares best-fit to a 
continuous-size distribution model (Lamm equation) by SEDFIT.  Residuals for the nonlinear least 
squares best-fit are also shown. (b) The continuous sedimentation coefficient [c(s)] distribution as 
a function of sedimentation coefficient (Svedberg, S). The fit had a resolution of 150 species 
between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 
p, and ƒ/ƒ0 = 1.45. The r.m.s.d. and runs test-Z score for the fit were 0.0053 and 0.01, respectively. 
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Figure 4.7       Sedimentation velocity analysis of PK1-A301T at 0.1 mg/ml (1.97 μM).  (a) 
Absorbance at 227 nm as a function of radius (cm) from the axis of rotation is plotted. The raw 
data are presented as open circles and are overlaid with the nonlinear least squares best-fit to a 
continuous-size distribution model (Lamm equation) by SEDFIT.  Residuals for the nonlinear least 
squares best-fit are also shown. (b) The continuous sedimentation coefficient [c(s)] distribution as 
a function of sedimentation coefficient (Svedberg, S). The fit had a resolution of 150 species 
between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 
p, and ƒ/ƒ0 = 1.44. The r.m.s.d. and runs test-Z score for the fit were 0.0054 and 1.51, respectively. 
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Figure 4.8       Sedimentation velocity analysis of PK1-A301S at 0.1 mg/ml (1.97 μM).  (a) 
Absorbance at 227 nm as a function of radius (cm) from the axis of rotation is plotted. The raw 
data are presented as open circles and are overlaid with the nonlinear least squares best-fit to a 
continuous-size distribution model (Lamm equation) by SEDFIT.  Residuals for the nonlinear least 
squares best-fit are also shown. (b) The continuous sedimentation coefficient [c(s)] distribution as 
a function of sedimentation coefficient (Svedberg, S). The fit had a resolution of 150 species 
between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 
p, and ƒ/ƒ0 = 1.57. The r.m.s.d. and runs test-Z score for the fit were 0.0053 and 5.66, respectively. 
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Figure 4.9       Sedimentation velocity analysis of PK1-G381A at 0.1 mg/ml (1.97 μM).  (a) 
Absorbance at 227 nm as a function of radius (cm) from the axis of rotation is plotted. The raw 
data are presented as open circles and are overlaid with the nonlinear least squares best-fit to a 
continuous-size distribution model (Lamm equation) by SEDFIT.  Residuals for the nonlinear least 
squares best-fit are also shown. (b) The continuous sedimentation coefficient [c(s)] distribution as 
a function of sedimentation coefficient (Svedberg, S). The fit had a resolution of 150 species 
between smin of 0.1 S and smax of 14 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 
p, and ƒ/ƒ0 = 1.36. The r.m.s.d. and runs test-Z score for the fit were 0.0045 and 1.85, respectively. 
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4.5 Analytical ultracentrifugation coupled with 
fluorescence detection system (AUC-FDS) 
To further examine the association/dissociation limit of PK1, AUC-FDS experiments were 
performed. This technology utilises traditional AUC principles and integrates a novel 
fluorescence detection unit onto the ultracentrifuge equipment (Schmidt et al. 1990). By 
labelling the protein using a fluorescent dye, the fluorescence emission intensity is 
monitored by a photomultiplier (Schmidt et al. 1990).  For detecting trace amount of 
materials, this technology is advantageous over absorbance and interference detections 
where the detection limit is within picomolar (pM) range (MacGregor et al. 2004).  
 
Three mutants were selected for AUC-FDS analysis. Of the seven mutated PK1 found in 
the previous evolutionary study (Lenski 1991), two were mutated at position 301 along the 
amino acid chain, namely PK1-A301T and PK1-A301S (Cooper et al. 2003). A301 
belongs to Aα7, which is an important loop at the A/A’ interface (Figures 1.12 & 3.12) 
crucial for the enzyme catalysis and is involved in the allosteric regulation (Section 3.4.2). 
Moreover, PK1-A301T showed distinct kinetic behaviour to the wild-type.  These make it 
a good candidate for AUC-FDS analysis for the investigation of the possible quaternary 
structural changes or an altered dissociation strength caused by these mutations at low 
concentration. The PK1-A301S enzyme was found in three independently evolved 
populations, which further emphasised the importance of this mutation (Cooper et al. 
2003). PK1-G381A was also examined by AUC-FDS, as it belongs to the FBP binding 
site (Mattevi et al. 1996). It was suspected that the quaternary structure of G381A might 
be sensitive to the presence of FBP.  
 
Pure protein samples of PK1-A301T, PK1-A301S and PK1-G381A were labelled as for the 
wild-type enzyme (Section 2.5.4) and the degree of labelling (DOL) was determined 
(Section 6.5.4). The DOL of the three protein samples is shown in Table 4.3. 
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Table 4.3        Protein concentrations and DOL for Alexa Fluor® 488 dye labelled proteins. 
 A280 Amax Aprotein [protein] 
(mg/ml) 
DOL 
PK1-A301T 0.33 0.46 0.28 1.9 0.17 
PK1-A301S 0.63 1.3 0.48 3.3 0.29 
PK1-G381A 0.080 0.041 0.076 0.51 0.057 
 
Figure 4.10      AUC-FDS analysis of PK1-A301T at 0.01 mg/ml (197 nM), with gains set at 2 
× 84%. (a) Fluorescence counts at 488 nm as a function of radius (cm) from the axis of rotation 
plotted. The raw data are presented as open circles and are overlaid with the nonlinear least 
squares best-fit to a continuous-size distribution model (Lamm equation) by SEDFIT. Residuals for 
the nonlinear least squares best-fit are also shown. (b) The continuous sedimentation coefficient 
[c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). The fit had a resolution 
of 100 species between smin of 0.1 S and smax of 15 S, with P = 0.95, v-bar = 0.7413, ρ = 1.00117 
g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.42. The r.m.s.d. and runs test-Z score for the fit were 15 and 
17.3, respectively. 
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Figure 4.11      AUC-FDS analysis of PK1-A301T at 0.001 mg/ml (19.7 nM), with gains set at 
8 × 95%. (a) Fluorescence counts at 488 nm as a function of radius (cm) from the axis of rotation 
plotted. The raw data are presented as open circles and are overlaid with the nonlinear least 
squares best-fit to a continuous-size distribution model (Lamm equation) by SEDFIT. Residuals for 
the nonlinear least squares best-fit are also shown. (b) The continuous sedimentation coefficient 
[c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). The fit had a resolution 
of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, 
ŋ = 0.010066 p, and ƒ/ƒ0 = 1.43. The r.m.s.d. and runs test-Z score for the fit were 25 and 26.0, 
respectively. 
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Figure 4.12      AUC-FDS analysis of PK1-A301T at 0.001 mg/ml (19.7 nM) with 1.8 mM PEP 
added, with gains set at 1 × 63%. (a) Fluorescence counts at 488 nm as a function of radius (cm) 
from the axis of rotation plotted. The raw data are presented as open circles and are overlaid with 
the nonlinear least squares best-fit to a continuous-size distribution model (Lamm equation) by 
SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The continuous 
sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). 
The fit had a resolution of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 
0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.46. The r.m.s.d. and runs test-Z score for 
the fit were 20 and 25.5, respectively. 
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Figure 4.13      AUC-FDS analysis of PK1-A301T at 0.001 mg/ml (19.7 nM) with 1.8 mM ADP 
added, with gains set at 8 × 95%. (a) Fluorescence counts at 488 nm as a function of radius (cm) 
from the axis of rotation plotted. The raw data are presented as open circles and are overlaid with 
the nonlinear least squares best-fit to a continuous-size distribution model (Lamm equation) by 
SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The continuous 
sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). 
The fit had a resolution of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 
0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.40. The r.m.s.d. and runs test-Z score for 
the fit were 23 and 26.8, respectively. 
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Figure 4.14      AUC-FDS analysis of PK1-A301T at 0.001 mg/ml (19.7 nM) with 1.8 mM FBP 
added, with gains set at 8 × 95%. (a) Fluorescence counts at 488 nm as a function of radius (cm) 
from the axis of rotation plotted. The raw data are presented as open circles and are overlaid with 
the nonlinear least squares best-fit to a continuous-size distribution model (Lamm equation) by 
SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The continuous 
sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). 
The fit had a resolution of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 
0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.43. The r.m.s.d. and runs test-Z score for 
the fit were 27 and 31.0, respectively. 
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Figure 4.15      AUC-FDS analysis of PK1-A301T at 0.0005 mg/ml (9.9 nM) with 0.1 mg/ml 
ovalbumin added, with gains set at 2 × 84% (a) Fluorescence counts at 488 nm as a function of 
radius (cm) from the axis of rotation plotted. The raw data are presented as open circles and are 
overlaid with the nonlinear least squares best-fit to a continuous-size distribution model (Lamm 
equation) by SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The 
continuous sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient 
(Svedberg, S). The fit had a resolution of 100 species between smin of 0.1 S and smax of 15 S with P 
= 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.40. The r.m.s.d. and runs 
test-Z score for the fit were 23 and 28.4, respectively. 
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Figure 4.16      AUC-FDS analysis of PK1-A301S at 0.01 mg/ml (197 nM), with gains set at 2 
× 84%. (a) Fluorescence counts at 488 nm as a function of radius (cm) from the axis of rotation 
plotted. The raw data are presented as open circles and are overlaid with the nonlinear least 
squares best-fit to a continuous-size distribution model (Lamm equation) by SEDFIT. Residuals for 
the nonlinear least squares best-fit are also shown. (b) The continuous sedimentation coefficient 
[c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). The fit had a resolution 
of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, 
ŋ = 0.010066 p, and ƒ/ƒ0 = 1.46. The r.m.s.d. and runs test-Z score for the fit were 21 and 20.4, 
respectively. 
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Figure 4.17      AUC-FDS analysis of PK1-A301S at 0.001 mg/ml (19.7 nM), with gains set at 
8 × 95%. (a) Fluorescence counts at 488 nm as a function of radius (cm) from the axis of rotation 
plotted. The raw data are presented as open circles and are overlaid with the nonlinear least 
squares best-fit to a continuous-size distribution model (Lamm equation) by SEDFIT. Residuals for 
the nonlinear least squares best-fit are also shown. (b) The continuous sedimentation coefficient 
[c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). The fit had a resolution 
of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, 
ŋ = 0.010066 p, and ƒ/ƒ0 = 1.47. The r.m.s.d. and runs test-Z score for the fit were 30 and 33.0, 
respectively. 
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Figure 4.18      AUC-FDS analysis of PK1-A301S at 0.001 mg/ml (19.7 nM) with 1.8 mM PEP 
added, with gains set at 2 × 84%. (a) Fluorescence counts at 488 nm as a function of radius (cm) 
from the axis of rotation plotted. The raw data are presented as open circles and are overlaid with 
the nonlinear least squares best-fit to a continuous-size distribution model (Lamm equation) by 
SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The continuous 
sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). 
The fit had a resolution of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 
0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.73. The r.m.s.d. and runs test-Z score for 
the fit were 24 and 27.9, respectively. 
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Figure 4.19      AUC-FDS analysis of PK1-A301S at 0.001 mg/ml (19.7 nM) with 1.8 mM ADP 
added, with gains set at 1 × 63%. (a) Fluorescence counts at 488 nm as a function of radius (cm) 
from the axis of rotation plotted. The raw data are presented as open circles and are overlaid with 
the nonlinear least squares best-fit to a continuous-size distribution model (Lamm equation) by 
SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The continuous 
sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). 
The fit had a resolution of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 
0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.52. The r.m.s.d. and runs test-Z score for 
the fit were 26 and 28.3, respectively. 
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Figure 4.20      AUC-FDS analysis of PK1-A301S at 0.001 mg/ml (19.7 nM) with 1.8 mM FBP 
added, with gains set at 8 × 95%. (a) Fluorescence counts at 488 nm as a function of radius (cm) 
from the axis of rotation plotted. The raw data are presented as open circles and are overlaid with 
the nonlinear least squares best-fit to a continuous-size distribution model (Lamm equation) by 
SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The continuous 
sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). 
The fit had a resolution of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 
0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.45. The r.m.s.d. and runs test-Z score for 
the fit were 37 and 36.8, respectively. 
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Figure 4.21      AUC-FDS analysis of PK1-A301S at 0.0005 mg/ml (9.9 nM) with 0.1 mg/ml 
ovalbumin added, with gains set at 2 × 84%. (a) Fluorescence counts at 488 nm as a function of 
radius (cm) from the axis of rotation plotted. The raw data are presented as open circles and are 
overlaid with the nonlinear least squares best-fit to a continuous-size distribution model (Lamm 
equation) by SEDFIT. Residuals for the nonlinear least squares best-fit are also shown. (b) The 
continuous sedimentation coefficient [c(s)] distribution as a function of sedimentation coefficient 
(Svedberg, S). The fit had a resolution of 100 species between smin of 0.1 S and smax of 15 S with P 
= 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, ŋ = 0.010066 p, and ƒ/ƒ0 = 1.48. The r.m.s.d. and runs 
test-Z score for the fit were 31 and 24.9, respectively. 
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Figure 4.22      AUC-FDS analysis of PK1-G381A at 0.01 mg/ml (197 nM), with gains set at 2 
× 84%. (a) Fluorescence counts at 488 nm as a function of radius (cm) from the axis of rotation 
plotted. The raw data are presented as open circles and are overlaid with the nonlinear least 
squares best-fit to a continuous-size distribution model (Lamm equation) by SEDFIT. Residuals for 
the nonlinear least squares best-fit are also shown. (b) The continuous sedimentation coefficient 
[c(s)] distribution as a function of sedimentation coefficient (Svedberg, S). The fit had a resolution 
of 100 species between smin of 0.1 S and smax of 15 S with P = 0.95, v-bar = 0.7413, ρ = 1.00117 g/ml, 
ŋ = 0.010066 p, and ƒ/ƒ0 = 1.43. The r.m.s.d. and runs test-Z score for the fit were 18 and 25.6, 
respectively. 
 
The DOL for PK1-A301T and PK1-A301S was 17.1% and 28.9%, respectively (Table 4.3). 
It was sufficient to perform AUC-FDS, even at a very low concentration (0.0005 mg/ml or 
9.9 nM), and high fluorescent signals were observed (Figures 4.15 & 4.21). The 
recommended protein concentration for amine labelling was above 2 mg/ml; however, the 
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concentration of the PK1-G381A protein before labelling was much lower than the 
recommended level. This affected the yield of labelling, with a low DOL of 0.06 
achieved for the PK1-G381A sample, which led to a low yield of FDS signal. 
 
At 0.01 and 0.001 mg/ml (197 nM and 19.7 nM), both PK1-A301T and PK1-A301S had a 
single maximum of sedimentation coefficient around 8.5 S, which indicated the single 
protein species of the tetrameric form (Figures 4.10 & 4.11; Figures 4.16 & 4.17). 
PK1-G381A had a similar sedimentation coefficient maximum at around 8.5 S at 0.01 
mg/ml (197 nM) (Figure 4.22); however, the signal was not reliable for 0.001 mg/ml (19.7 
nM) or lower concentrations for AUC-FDS detection due to the low DOL.  
 
At a much lower concentration, 0.0005 mg/ml (9.9 nM), a single maximum at 8.5 S were 
observed for PK1-A301T and PK1-A301S with a spread of the peak, which might indicate 
the merge between the symmetric tetramer and a highly asymmetric species in solution 
(Cole et al. 2008). To prevent the loss of sample material to the cell surfaces, 0.1 mg/ml 
ovalbumin was added to the solution as the carrier protein at 0.0005 mg/ml (9.9 nM) 
sedimentation velocity runs (Cole et al. 2008; MacGregor et al. 2004) (Figures 4.15 & 
4.21). 
 
PEP, ADP and FBP were added to the buffer with 0.001 mg/ml (19.7 nM) protein 
concentration for both PK1-A301T and PK1-A301S, to test the effects of the substrate and 
allosteric effector binding to the quaternary structure of the protein (Figures 4.12-4.15; 
Figures 4.18-4.20). When 1.8 mM PEP was added into the PK1-A301S protein, a high 
f/f0 ratio of 1.73 was again observed. This is comparable to the wild-type enzyme 
centrifuged with FDS at the same condition (f/f0 = 1.71, Figure 2.14), and is higher than the 
f/f0 ratio obtained by normal AUC at 0.1 mg/ml (1.97 μM) or higher. The increment in 
the f/f0 ratio at 19.7 nM for the wild-type enzyme and PK1-A301S may indicate that the 
quaternary structures of these enzymes have changed, as compared to the structure at a 
higher concentration, or that an asymmetric species is present in the solution (Figure 4.18).  
However, no smaller peaks were observed on the c(s) distribution besides the mean peak 
with maximal s around 8.5 S. This indicates that the mutant enzymes were all tetrameric 
under the conditions. As the concentration of the proteins lowered, signal-to-noise ratio 
decrease dramatically, the result became unreliable (Cole et al. 2008), therefore, analysis at 
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lower concentrations was not performed. 
 
These results, combined with circular dichroism, suggest that the mutated enzymes have 
the same quaternary structure as the wild-type enzyme and that the impact of the ligands 
(PEP, ADP and FBP) on the quaternary structure of the PK1 wild-type and the mutant 
enzymes was minimal. A structural characterisation of the PK1 mutants may provide 
more information. 
4.6 Attempted X-ray crystallography 
Protein crystallisation was performed using both handing-drop method for the wild-type 
enzyme (Mattevi et al. 1995) and robotic crystallisation screening for the mutants 
(Newman et al. 2005) (Section 6.6). Three mutants formed crystals, each in different 
conditions to the wild-type enzyme and to each other. Crystallisation trials were 
performed using the pH-, anion- and cation-testing (PACT) screen and the diffraction 
experiments were conducted at the Australian Synchrotron, beamline 3BM1, to no better 
than 3.5 Å. 
 
 
Figure 5.1       Crystals obtained at the Bio21 Collaborative Crystallisation Centre.  The 
crystals were grown from the PACT screen and diffracted to < 3.5 Å at beamline 3BM1 at the 
Australian synchrotron. 
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4.7 Summary 
In this chapter, the structural properties of the mutated enzymes were tested, and compared 
to those of the wild-type enzyme (discussed in Chapter 2). In addition, the effect of the 
substrates (PEP and ADP) and the allosteric effector FBP to subunit assembly and 
disassembly of PK at very low concentrations were investigated. 
 
The mutated PK1 enzymes were examined by circular dichroism, which revealed some 
changes in the secondary structure, whereby different α-helix and β-sheet contents among 
themselves and compared to the wild-type enzyme were found. The increased α-helix 
content of PK1-G381A may be consistent with the mutation allowing an extension to an 
α-helix in the FBP binding domain, perhaps explaining the altered affect of FBP on this 
mutant enzyme (Chapter 3).  In addition, PK1-I264F showed decreased α-helix content, 
suggesting that this mutation had affected the structure of Aα6. 
 
The molecular masses of the mutated PK1 enzymes were confirmed by electrospray mass 
spectrometry. Results indicated that a molecule, probably β-mercaptoethanol with or 
without K+ salt, which was used as a reducing agent during protein purification, was 
attached to the enzyme. 
 
AUC experiments showed that all mutated enzymes had similar friction ratios around 1.34, 
and a sedimentation coefficient about 8.5 S, which indicated a tight tetrameric form in very 
dilute solution (nanomolar range). To further investigate the dissociation thresholds of 
the enzymes, AUC coupled with FDS was performed on three selected mutated enzymes. 
This was the first time that this novel technology has been performed on pyruvate kinase. 
In this experiment, although an increase in the friction ratio has been observed in some 
experiments, no clear sign of dissociation was evident, even at low concentrations (low 
nanomolar range). These results indicated the tight association of the tetramer of the 
mutated enzymes and the overall similarity with the wild-type, and the dissociation 
constant (KD) of the wild-type and mutant enzyme are at picomolar range, below the 
concentrations tested. 
 
Protein crystals of the wild-type enzyme and some of the mutants were obtained. The 
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wild-type enzyme crystallised using conditions described by Mattevi and colleagues (1995). 
The mutants crystallised at conditions different to the wild-type. Unfortunately, these 
crystals did not diffract to better than 3.5 Å resolution. 
 
The changed kinetics of the mutated enzymes is not due to altered quaternary structure, but 
may be the consequences of the secondary structure change or some subtle changes 
affecting substrate/effector binding or the allosteric signal transition. This awaits further 
investigation by protein crystallography. 
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Chapter 5 
Summary and Conclusions 
 
This chapter summarises the research findings of this thesis, which builds on a previous 
study that found mutations in PK1 in the evolved E. coli populations (Woods et al. 2006). 
This is the first study to examine these mutations at a biochemical level, in an effort to 
relate the molecular changes to the phenotype that emerged during adaptive evolution. 
Given pyruvate kinase has a crucial role in carbohydrate metabolism, it was of interest to 
explore how mutations in this enzyme may account for the improved fitness observed in 
the descendent populations compared to the ancestor. The findings firstly address the 
degree of parallel adaptation at a molecular level for the first time (previously observed at 
the cell physiology, gene expression and genetic levels among the evolved populations) 
and secondly contribute to the understanding of the allosteric regulation of pyruvate 
kinase. 
 
In this study, seven mutated PK1 enzymes were obtained by site-directed mutagenesis.  
Steady-state kinetic experiments were performed to examine the function of the mutated 
enzymes. This was followed by structural studies involving circular dichroism to study 
the secondary structure and AUC (including AUC-FDS) to study the quaternary structure 
of the enzymes as well as the effects of PEP, ADP and FBP on subunit association. 
Crystallisation trials were also performed in an attempt to explain the structural basis of the 
mutation effect on enzyme function. 
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5.1 Insights into the enzymology of PK1 
5.1.1 Catalysis 
The mutated PK1 enzymes exhibited quite different catalytic competencies (kcat) and 
altered affinity to the substrates (S0.5). The patterns of change for each enzyme were 
distinct, making interpretation of the data complex. The mutated enzymes all adopted a 
similar quaternary structure to the wild-type, with a very tight association between subunits 
(KD < 1 × 10-8 M). However, some mutant enzymes showed differences in the secondary 
structure, as judged by circular dichroism. 
 
Mutations at residue P70 resulted in enzymes with lower turnover numbers compared to 
the wild-type enzyme. While a similar cooperative binding pattern to PEP between 
PK1-P70Q and the PK1 wild-type was observed, a hyperbolic pattern was shown for 
PK1-P70T. These results implied that P70 was a critical residue involved in interactions 
at the active site and PEP binding during catalysis. This is consistent with a previous 
observation that P70 serves as a “kink” at the loop connecting domains A and B, thus 
undergoing a large movement during catalysis.   
 
Another mutation at the active site (D127N) resulted in an enzyme with less than 2% 
activity compared to the wild-type enzyme. That the affinity of the substrates did not 
change, suggests that D127 is essential in a catalytic step, likely via interactions with the 
solvent shell of Mg2+ (Larsen et al. 1998; Larsen et al. 1997). 
 
Mutations found at the subunit interface also showed altered catalytic properties; however, 
the more striking results were their effect on the regulation patterns of PK1 (Section 5.1.2). 
The mutation G381A, at the FBP binding site, caused elevated enzymatic activity 
compared to the wild-type and a similar substrate affinity when FBP was present. 
 122
5.1.2 Regulation 
PK is usually tightly regulated due to its core role in glycolysis. The regulation in E. coli 
is mainly achieved via the allosteric effector FBP. Although several mechanisms have 
been put forward regarding the mechanism of FBP allostery (Christofk et al. 2008; Friesen 
et al. 1998b; Mattevi et al. 1996; Mattevi et al. 1995; Rigden et al. 1999), a definite 
conclusion is elusive. This is mainly due to the lack of protein crystals from the same 
source in both the low affinity T-state and the high affinity R-state (Mattevi et al. 1995). 
Therefore, PK crystals at each state from different sources were compared to gain insight 
into the conformational changes during catalysis, and hence the allosteric regulation 
pattern (Jurica et al. 1998; Mattevi et al. 1996; Valentini et al. 2000). 
 
For E. coli PK1, the “domain rotation” model has been proposed (Mattevi et al. 1996; 
Mattevi et al. 1995). This model depicts PK1 as a modular enzyme, undergoing 
conformational changes by a combination of domain rotations and movements among 
subunits within the tetramer, upon FBP binding, whereas the movements within domains 
are minimal (Mattevi et al. 1995). The key prediction of this model is that residues at the 
interfaces are involved in transfer of the allosteric signal from the allosteric binding site 
and the active site, which are over 40 Å apart (Jurica et al. 1998; Mattevi et al. 1996; 
Mattevi et al. 1995; Valentini et al. 2000). Another model, namely “the network 
mechanism”, was proposed by Friesen et al. (1998b) and further supported by Fenton et al. 
(2002) in studying the yeast PK. This mechanism hypothesised the formation of salt 
bridges across the subunit interface to transfer the allosteric signal to the active site. 
 
In this study, the wild-type E. coli PK1 showed typical allosteric regulation by FBP, with 
PEP affinity increasing in response to FBP binding (S0.5PEP changed from 1.5 mM to 0.06 
mM). The mutated enzymes showed a different response to FBP binding compared to the 
wild-type PK1.  The most striking finding was that A301T was the only mutation that 
caused the PEP binding pattern of the enzyme to change from hyperbolic to a sigmoidal 
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pattern when FBP was present. Residue A301 belongs to helix Aα7 at A/A’ subunit 
interface, next to helix Aα6, which was proposed be part of the allosteric signal 
transmitting pathway at the subunit interface (Friesen et al. 1998a; Friesen et al. 1998b). 
The kinetic data implied a crucial role of the residues at the A/A’ interface in relaying the 
allosteric signal between the active centre and the allosteric binding site. Despite the 
similarity in the structure between PK1-A301T and the wild-type PK1 (as judged by CD 
and AUC), the mutation may have distorted the interfacial communication pathway 
between the active site and the allosteric regulation site, thus altering the allosteric 
regulation pattern.  Another mutated enzyme (PK1-I264F) where the mutation was at the 
subunit interface (specifically α-helix Aα6) had an altered secondary structure (as judged 
by CD) with a lower α-helical content. The enzyme showed diminished FBP binding. 
Combining the above results, distortion of the interfacial structure and, therefore, 
transmission of the allosteric signal may be possible. However, more detailed structural 
information (such as from X-ray crystallography) is needed for further study of this 
mutation. Nevertheless, these results are in general agreement with the study carried out 
by Fenton and colleagues (2002). 
5.2 Impact on glycolysis 
Glycolysis is an essential energy producing pathway for bacterial survival. During this 
process, glucose is consumed to generate energy, in the form of ATP and NADH. 
Meanwhile, pyruvate is generated, which further feeds into various metabolic pathways. 
In the experimental environment defined in the evolutionary study (Lenski et al. 1991), 
bacteria grow in an environment with a limited amount of glucose for several hours, before 
the glucose is depleted. It is hypothesised that in the initial conditions, cells utilise 
glucose for cell growth and reproduction, which also feeds into the glycogen synthesis 
pathway, whereas at later stages, when glucose depletes, it is necessary for the cells to 
release the stored energy for a series of cellular functions. 
 
Previously, it was found that the descendent populations showed improved fitness in a 
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competition assay with the ancestor by having a shorter lag-phase in the growth period 
(Cooper & Lenski 2000; Lenski et al. 1998). It has also been demonstrated in previous 
studies that glycogen synthesis and glycolysis are co-regulated, with several enzymes 
involved in regulation (Dietzler et al. 1979a; Dietzler et al. 1979b). Glycogen 
biosynthesis was found to be regulated by the cellular level of ADP-glucose in the bacteria 
(Kumar et al. 1989). 
 
Although the mutated PK1 enzymes investigated in this study behaved differently to each 
other, and to the wild-type, in terms of substrates and allosteric regulator binding, the fact 
that all the mutants still functioned confirmed that the glycolysis pathway was not shut 
down in any of the twelve populations. 
5.3 Is the evolution of E. coli parallel at an enzyme 
structure/function level? 
The molecular basis of adaptation is a major focus in evolutionary biology (Wichman et al. 
1999). This study was born from Lenski’s evolutionary experiment (Woods et al. 2006), 
which is designed to study adaptation and evolutionary reproducibility. In previous 
studies it was found that parallel adaptation occurred at the phenotypic level (larger cells 
and improved fitness) (Cooper & Lenski 2000; Lenski et al. 1998; Lenski et al. 1991; 
Lenski & Travisano 1994) and at the genome level (gene expression) (Cooper et al. 2003; 
Elena & Lenski 2003). Woods et al. (2006), by showing mutations in pykF and nadR loci 
in all twelve populations, concluded that although there was extensive parallel adaptation 
at the genetic level (i.e. the same genes had mutations in each of the twelve populations) at 
a base pair level the mutations of the genes were only rarely parallel.  However, this work 
did not exclude the possibility that different mutations on the gene (e.g. pykF) produced the 
same biochemical phenotype. The work in this thesis directly tested this by performing 
kinetic and biophysical analyses on the mutant enzymes and comparing them with the 
wild-type enzyme. 
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The mutated enzymes investigated in this study exhibited distinct kinetic behaviour and 
response to FBP regulation, compared to the wild-type enzyme and to each other. 
Therefore, it is concluded that no parallel adaptation at the level of PK1 function had 
occurred. However, the gene expression and protein analyses performed for this 
evolutionary experimental system to date cannot alone explain the overall changes in the 
cell. Further work involving structural studies and in vivo metabolic studies will help to 
investigate this system further. 
5.4 Ongoing biological questions & future experiments 
5.4.1 Structural studies of PK1 and mutants 
Structural changes may have taken place in the mutated PK1, as suggested by the 
differences observed in CD (Section 4.2). These changes may be responsible for the 
altered kinetic properties and the regulation patterns observed in the kinetic experiments 
(Section 3.3). X-ray crystallography trials were attempted on the wild-type enzyme as 
well as the mutated enzymes. However, no diffraction patterns were found (3.5 Å). 
This work continues to look into the structural changes of the mutants. 
5.4.2 The role of mutations in other genes 
This study was not able to test whether altered function in PK1 has been coupled with 
other effects in the metabolic pathway, with the combined effect resulting in improved 
fitness to the glucose-limited environment over the ancestor. How do the mutations in 
other genes contribute to the improved fitness (e.g. nadR, which codes nadR, a negative 
protein regulates NAD biosynthesis pathway in E. coli (Raffaelli et al. 1999) and how are 
they related to one another? What changes do the mutations confer to the metabolic 
profile of the evolved bacteria? And what synergies are there between different enzymes 
in individual populations? 
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Perhaps one way to address this is to use metabolomics. Metabolomics is a 
comprehensive analysis in which all the metabolites of a biological system are identified 
and quantified (Fiehn et al. 2000). By studying the metabolic profiles of the evolved 
populations in combination with future research of PK1 and nadR and other altered genes 
in the various populations, a comprehensive view of the outcome of the parallel adaptation 
at the molecular level can be established. 
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Chapter 6 
Experimental 
 
6.1 Materials 
General chemicals were purchased from the Sigma-Aldrich Chemicals Company, unless 
otherwise stated. Bacterial culture media, SDS-PAGE gels and site-directed mutagenesis 
kit were purchased from Invitrogen. Bio-Rad protein assay kit was purchased from 
Bio-Rad Laboratories. 
6.2 Microbiology and molecular biology methods 
‘Molecular Cloning: A laboratory Manual, 3rd edition’ (Sambrook & Russell 2001) was 
used as a general reference for manipulating bacterial strains and DNA. 
6.2.1 Bacterial Strains 
Two bacterial strains were used in this study. E. coli XL-1 Blue strain (genotype: recAl 
endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB lacl Z∆M15]) was used for 
mutagenesis as part of the QuikChange site-directed mutagenesis kit from Stratagene.  E. 
coli BL21 (DE3) strain (genotype: E. coli BF- dcm ompT hsdS (rB-mB-) gal λ (DE3)) was 
used for protein expression and purification. 
6.2.2 Plasmids 
The pyruvate kinase type 1 gene (pykF) had been previously cloned into a pBluescript II 
KS+ vector. This plasmid (pGV5A) was kindly donated by Professor Mattevi (University 
of Pavia, Italy) (Mattevi et al. 1996). Point mutations were made using pGV5A as a 
template and the resulted plasmids with PK1 mutation are listed below: 
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Plasmids Relevant genotype 
pGV5A  ::pykF, Ampr
pP70T ::pykF-pro70thr, Ampr
pP70Q ::pykF-pro70gln, Ampr
pD127N ::pykF-asp127asn, Ampr
pI264F ::pykF-ile264phe, Ampr
pA301T ::pykF-ala301thr, Ampr
pA301S ::pykF-ala301ser, Ampr
pG381A ::pykF-gly381ala, Ampr
6.2.3 Bacterial cultures 
Media for bacterial cultures were sterilised by autoclaving at 121 °C for 15 minutes. 
Equipment for handling the bacterial culture was either autoclaved or purchased sterile. 
Solutions were prepared with sterilised distilled water (ddH2O) or distilled water (dH2O) 
filtrated by 0.22 µm syringe driven filter units (Millipore). Standard sterile techniques 
were used for each experiment and any possible contamination was monitored by controls. 
6.2.4 Media 
6.2.4.1 Luria-Bertani medium (LB) 
LB base was purchased from Invitrogen in ready-to-use powder form. 2% w/v of LB 
medium was prepared by mixing 20 g LB powder with every litre of dH2O and autoclaved.  
 
6.2.4.2 SOB medium  
SOB medium was prepared in ddH2O with 2% w/v tryptone, 0.5% yeast extract, 10 mM 
NaCl with pH adjusted and autoclaved. 10 ml/l of filter-sterilised 1 M MgCl2 and 10 ml/l 
of filter-sterilised 1 M MgSO4 were added prior to use.  
 
6.2.4.3 SOC medium 
SOC medium was prepared immediately before use, by adding 2 ml of filter-sterilised 20% 
(w/v) glucose into 98 ml of SOB medium. 
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6.2.5 Antibiotics 
Ampicillin was the main antibiotic marker in this study. A 1000 × concentrated stock 
solution was prepared by adding 100 mg/ml of ampicillin in dH2O, followed by filtration 
using the 0.22 µm syringe driven filter units (Millipore). Ampicillin stocks were stored in 
1.5 ml aliquots at -20 °C. 
6.2.6 Agar plate preparation 
6.2.6.1 LB agar plates 
2% w/v LB powder and 1.6% w/v bacterial grade agar were dissolved in dH2O and 
sterilised by autoclaving. Appropriate antibiotics were added into the molten media at 
about 50 °C and mixed by gentle swirling. 20 ml of media was then poured into each 
sterile Petri dish in a sterile laminar flow hood. The plates were cooled in the hood for 30 
minutes before being covered with lids and sealed in plastic bags. The plates were stored 
in the fridge up to one week. 
 
6.2.6.2 Agar plates for blue-white colour screening 
For the blue-white colour screening, 8 µl of 100 mg/ml isopropyl-1-thio-β-D- 
galactopyranoside (IPTG) in ddH2O and 40 µl of 20 mg/ml 5-bromo-4-chloro- 
3-inolyl-β-D-galactopyranoside (X-gal) in dimethylformamide (DMF) were spread onto a 
LB plate with ampicillin and dried 30 minutes prior to plating.  
6.2.7 Inoculating bacterial culture 
Bacteria from a glycerol freeze stock solution were streaked on LB plates with ampicillin 
using flame-sterilised nichrome wire and incubated at 37 °C overnight.  Each colony was 
used to inoculate a 10 ml LB medium with antibiotics. This starter culture was then 
incubated in a 37 °C water bath with moderate shaking (175-200 rpm) for at least 4 hours 
(until cloudy). It was then used to inoculate 1 l of LB medium containing appropriate 
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antibiotics and incubated at 37 °C with shaking overnight.  
6.2.8 Strain storage using glycerol freeze stocks 
1.5 ml of overnight bacterial culture was centrifuged at 4,000 g for 2 minutes in Eppendorf 
tubes and most of the supernatant removed.  The pellet was resuspended in fresh LB 
medium and transferred into a 1.5 ml screw-top cryo-storage tube.  A 1:1 volume of 50% 
glycerol was added and mixed gently.  The tubes were snap frozen in liquid nitrogen and 
stored at -80 °C freezer. 
6.2.9 QuikChange Site-directed mutagenesis 
Site-directed mutagenesis was carried out as described in the Stratagene QuikChange 
site-directed mutagenesis manual.  
 
6.2.9.1 Primer Design 
Site-directed mutagenesis introduces specific alterations (changed nucleotides) into the 
template DNA by incorporating mutated primers into the plasmid during the PCR reaction. 
Primers were designed based on the QuikChange site-directed mutagenesis manual 
(Stratagene). 
 
Both primers contained the required mutation and annealed to opposite strands of the 
plasmid at the same point in the sequence. The primers were between 25 and 45 bases in 
length and had a melting temperature (Tm) > 78 °C. The equation for calculating the 
melting temperature was as follows: 
Tm = 81.5 + 0.41 (% GC) – 675/N - % mismatch 
where % GC is the GC content, N is the number of base pairs and % mismatch is the 
unpaired base content, as compared to all the primer bases. The above equation is 
specifically used to calculate melting temperature in 1 M Na+, as the melting temperature 
is highly affected by salt concentration. The substituted bases were placed in the middle 
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of the primer with 10 to15 bases at each end. Ideally, the % GC should be over 40% with 
one or more GC pair at each terminus of the primer for stronger hydrogen bonding. In 
addition, self-complementary for each primer should be avoided.  
 
6.2.9.2 PCR Reaction 
PCR reactions were performed with 20 ng and 50 ng template DNA per tube. The 
pWhitescript plasmid and the mutagenic primers were used as a control. pWhitescript has 
a point mutation at the lacZ gene (which codes for β-galactosidase) to generate a stop 
codon that is exchanged to a glutamine by the mutagenic primers and β-galactosidase 
activity is restored when the mutagenesis reaction is successful. Bacteria expressing 
β-galactosidase activity form blue colonies on IPTG/X-gal plate. In this way, the 
mutation efficiency can be determined by the ratio of blue/white colonies on an 
IPTG/X-gal plate.  
 
In this study, site-directed mutagenesis was performed on pGV5A. Template DNA was 
quantified using a Nano-Drop spectrophotometer by measuring absorbance at 260 nm and 
280 nm. PCR reactions were carried out in a DNA Engine PTC-200 Peltier thermal 
cycler (MJ research). All PCR reaction used thin-wall PCR tubes from Eppendorf. 
 
Reagents for the PCR reaction mixture of pykF-P70T site-directed mutagenesis are listed 
below: 
 
 Initial conc. Volume (µl) Amount (ng) 
Reaction buffer (10 ×)  5  
pGV5A plasmid (3.0 kb) 10 ng/µl 2 and 5 20 and 50 
P70T #1 (forward) 100 ng/µl 1.25 125 
P70T #2 (backward) 100 ng/µl 1.25 125 
dNTP mix  1  
PCR water (ddH2O)  8.5 and 35.5  
Pfu Turbo DNA polymerase 2.5 units/µl 1  
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Reagents for the reaction mixture of pWhitescript mutagenesis control are shown below: 
 
 Initial conc. Volume (µl) Amount (ng) 
Reaction buffer (10x)  5  
pWhitescript plasmid (4.5kb) 5 ng/µl 2 10 
Oligonucleotide control primer #1 100 ng/µl 1.25 125 
Oligonucleotide control primer #2 100 ng/µl 1.25 125 
dNTP mix  1  
PCR water (ddH2O)  38.5  
Pfu Turbo DNA polymerase 2.5 units/µl 1  
 
PCR cycling condition is listed as follow: 
 
Step Temperature (°C) Time (min) 
1. Initiation 95 0.5 
2. Denaturing 95 0.5 
3. Annealing 55 1 
4. Final annealing 68 12 
5. Cycles Steps 2-4 were repeated 15 times 
 
Agarose gel electrophoresis was performed to confirm the amplification of the DNA, with 
10 µl of reaction product loaded into each well. 
 
6.2.9.3 Enzymatic digestion of the old templates 
After PCR amplification, 1 µl of DpnI at 10 units/µl was added into each tube and mixed 
gently. The tubes were incubated at 37 °C for 1 hour to fully digest the template DNA. 
DpnI specifically targets methylated and hemi-methylated parental template DNA and does 
not affect the new mutated cDNA.  
 
6.2.9.4 Transformation of XL1-Blue sub-cloning grade competent cells 
Transformation was performed by adding 1 µl of each mutated plasmid DNA into 50 µl of 
competent XL1-Blue cells. 100 pg of pUC18 plasmid was transformed into 50 µl of 
XL1-Blue cells as a control. The solutions were mixed gently and incubated on ice for 30 
minutes followed by a 45-second heat shock at 42 °C and cooled on ice for 2 minutes. 1 
 134
ml of SOC medium pre-heated at 42 °C was added into each tube and the tubes were 
incubated at 37 °C with vigorous shaking (225-250 rpm) for 1 hour. The transformation 
mixtures were then centrifuged to remove excess medium and less than 200 µl of each 
mixture was plated on LB agar plates with appropriate antibiotics. For the pUC18 control 
reaction, 100 µl of transformation mixture was plated on LB-ampicillin agar plates. 
6.2.10 Plasmid preparation by alkaline lysis 
Solutions required for performing the plasmid preparation by the alkaline lysis are listed as 
follow: 
 
Solution 1 50 mM glucose 
 10 mM EDTA 
 25 mM Tris-HCl, pH 8.0 
  
Solution 2 0.2 M sodium hydroxide 
 1% SDS 
  
Solution 3 3 M sodium acetate, pH 4.8 
 11.5% v/v glacial acetic acid 
 
An agar plate streaked with XL1-Blue cells containing a plasmid with desired mutation 
was grown at 37 °C overnight. A single colony was transferred into 10 ml LB medium 
with ampicillin in 37 °C water bath shaker (175-200 rpm) for approximately 4 hours. 
Cells were then harvested by centrifugation at 12,000 g at 4 °C for 30 seconds. The 
supernatant was aspirated and the pellet was resuspended in 100 µl of ice-cold solution 1 
with gentle vortex. 200 µl of freshly made solution 2 was added into the tube and mixed 
by inverting the tube 5 times and stored on ice. 150 µl of solution 3 was added, the tube 
vortexed for 10 seconds and stored on ice for 3 to 5 minutes. The tube was then 
centrifuged at 12,000 g at 4 °C for 5 minutes, and the supernatant was transferred to a new 
Eppendorf tube. dsDNA was precipitated out with two volume equivalents of pure 
ethanol (analytical grade) at room temperature, vortexed and allowed to stand for 2 
minutes. It was then centrifuged at 12,000 g at 4 °C for 5 minutes. After the 
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supernatant was discarded, the pellet was rinsed with 1 ml of ice-cold 70% ethanol and the 
pellet was dried for 10 minutes in a sterile laminar hood. The dsDNA pellet was 
rehydrated in 30 µl of sterile water at 4 °C overnight and stored at -20 °C. Alternatively, 
the plasmid was further purified (Section 6.2.11). 
6.2.11 Plasmid purification by RNA removal and 
phenol/chloroform protein extraction 
A 10 mg/ml RNAse solution was made by dissolving pancreatic RNAse in a buffer 
containing 10 mM Tris-HCl buffer at pH 7.5 and 15 mM NaCl. The solution was then 
incubated at 100 °C for 15 minutes and allowed to cool to room temperature slowly. 1 µl 
of this RNAse solution was added into 30 µl of the DNA solution obtained by the alkaline 
lysis method (Section 6.2.10) and incubated at 37 °C for 1 hour. 70 µl of ddH2O was then 
added, together with 1/8 volume of 2 M potassium acetate. 100 µl of phenol and 100 µl 
chloroform:isopropanol solution were added and the mixture was centrifuged at 12,000 g 
for 5 minutes. The aqueous layer was then transferred into a new tube with 100 µl 
chloroform:isopropanol and 100 µl phenol and centrifuged again. The aqueous layer was 
transferred into a tube containing 2 volumes of cold ethanol, incubated on ice for 10 
minutes and centrifuged at 12,000 g at 4 °C for 10 minutes. The DNA was precipitated 
out to form a pellet. The pellet was rinsed with 70% ice-cold ethanol and dried in a 
sterile laminar hood. Finally, the purified DNA pellet was rehydrated in 10 µl sterile 
water and stored at -20 °C. 
6.2.12 Plasmid preparation by Purelink™ Quick Plasmid 
Miniprep Kit 
Alternatively, plasmids were prepared using Purelink quick plasmid miniprep kit 
(Invitrogen). According to the protocol, 5 ml of overnight culture of E. coli BL21 (DE3) 
were pelleted by centrifugation. The pellet was then resuspended in 250 µl resuspension 
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buffer (R3) with RNase. 250 µl of the lysis buffer (L7) was added and mixed well by 
inverting 5 times. The tube was incubated at room temperature for 5 minutes before 350 
µl of the precipitation buffer (N4) was added. The solution was mixed thoroughly to 
homogeneity, and the lysis debris was removed by centrifugation at 12,000 g for 10 
minutes at room temperature. The supernatant was loaded onto a spin column. 
 
For plasmid clean up, the spin column containing the supernatant was placed into a wash 
tube and centrifuged at 12,000 g for 1 minute. The flow through was discarded, and 500 
µl of the wash buffer (W10) with ethanol was added to the column to wash the remaining 
lysis solution. The plasmid was washed again with 700 µl wash buffer (W9) with ethanol 
and then centrifuged to remove any residual wash buffer (W9). 
 
The plasmid DNA was then eluted with TE buffer. The spin column was placed into a 
recovery tube and 75 µl of preheated TE buffer (65-70 °C) was added to the centre of the 
column. The column was incubated for 1 minute at room temperature, followed by 
centrifugation at 12,000 g for 2 minutes. The recovering tube contained the purified 
plasmid, which was stored at -20 °C for downstream applications. The plasmid 
concentration was quantified using a Nano-Drop spectrophotometer (Section 6.3.1.2). 
The purity of the pGV5A plasmid and its derivatives was tested by electrophoresis (Section 
6.2.13). 
6.2.13 Agarose gel electrophoresis 
Reagents required for agarose gel electrophoresis is listed below: 
 
Loading dye 30% v/v glycerol 
 0.25% w/v bromophenol blue 
 0.25% w/v xylene cyanol 
  
TAE buffer 40 mM Tris-acetate, pH 8.0 
 1 mM EDTA 
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An agarose gel was made by melting 1.5% w/v agarose in 30 ml of TAE buffer, cooled 
down to about 50 °C and poured into a gel casting tray with the comb inserted. The gel was 
left to set for at least 30 minutes. When set, the comb was removed and the tray was 
transferred into a gel tank containing ice-cold TAE buffer. DNA fragments were mapped 
on a 1.5% w/v agarose gel against a 1 kb+ ladder, by adding 8 µl DNA solution with 2µl 
loading dye into each well. The gel was run at 80 V for approximately one hour, until the 
loading dye nearly reached the bottom of the gel. The gel was then stained with 0.5 mg/ml 
ethidium bromide for 30 minutes and DNA fragments were visualised under UV radiation 
in a CHEMI GENIUS bio-imaging system (Syngene). 
6.2.14 DNA sequencing 
DNA sequencing was carried out at the Genomics Unit in University of Auckland. 
Plasmids obtained by mutagenesis which contained the mutated pykF gene were quantified 
using a Nano-Drop spectrophotometer with the purity checked. Approximately 200 ng/µl 
of purified plasmid in sterile water was prepared for sequencing. Each reaction required 
5 µl of such plasmid as the DNA template. The sequencing reactions were carried out 
using BigDye dye terminator version 3.1 on a 9700 thermal cycler (Applied Biosystems) 
with T7 and T3 primers. Fragments were separated by a 3130XL capillary sequencer 
(Applied Biosystems) by capillary electrophoresis. 
6.2.15 Transforming BL21 (DE3) cells by the calcium chloride 
method 
6.2.15.1 CaCl2 solution 
A 1 M CaCl2 solution was sterilised by filtering through a 0.22 µm syringe driven filter 
unit and stored in 10 ml aliquots at -20 °C. Upon usage, the calcium chloride stock 
solution was diluted 10 fold using distilled water and filtered. The solution was then 
stored on ice. 
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6.2.15.2 MgCl2-CaCl2 solution 
8 ml of a 1 M MgCl2 stock solution and 2 ml of a 1 M CaCl2 solution were mixed and 
diluted 10 times. The solution was then filtered and chilled on ice. 
 
6.2.15.3 Preparation of competent cells 
BL21 (DE3) cells were streaked onto an LB plate and incubated at 37 °C overnight.  A 
colony (2-3 mm) was transferred into a 1 litre flask containing 100 ml sterilised LB 
medium. The flask was then incubated in a 37 °C water bath with vigorous shaking 
(200-225 rpm) until the OD600 reached 0.4. The cells were then transferred into sterile 50 
ml Falcon tubes and incubated on ice for 10 minutes. Cells were centrifuged at 2,700 g at 
4 °C for 10 minutes and the supernatant was discarded.  The pellets were drained and 
resuspended in 30 ml ice-cold MgCl2-CaCl2 solution by gentle vortexing and then 
centrifuged. Finally, the pellets were resuspended in 2 ml of ice-cold calcium chloride 
solution for each 50 ml of bacterial culture (cells are now competent) and stored in 200 µl 
aliquots at -80 °C.  
 
6.2.15.4 Transformation 
200 µl of competent BL21 (DE3) cells were thawed on ice. 50 ng of plasmid DNA in a 
volume of 10 µl or less was added, mixed by swirling and kept on ice for 30 minutes. 
Subsequently, cells were heat-shocked at 42 °C for 90 seconds and cooled on ice for 2 
minutes. 800 µl SOC medium was then added into each tube and incubated at 37 °C for 
45 minutes with slow shaking (150 rpm). The cell culture was centrifuged to remove 
excess medium, and less than 200 µl of cell culture was plated onto a LB plate with 
ampicillin. 
6.3 Biochemistry general methods 
Enzymes were stored at -20 °C in 100 µl aliquots. All enzymes were manipulated at 4 °C 
or kept on ice, unless otherwise stated. Centrifugation was carried out in an Eppendorf 
centrifuge 5810 R (maximum speed 12,000 rpm) using an EL082 rotor for small scale 
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(≤1.5 ml), or a DL091 rotor (maximum speed 6,000 rpm) for larger scale (<50 ml) 
centrifugations. Alternatively, swing rotor A-4-81 (maximum speed 4,000 rpm) was used 
for cell harvesting (<400 ml). All centrifugations for protein purification were performed 
at 4 °C. Protein purification was carried out in several chromatography columns using an 
AKTA purifier system (Amersham Biosciences) at 4 °C. Frac-950 fraction collector 
(Amersham) with 96-well plates was used for fraction collection. SDS-PAGE was carried 
out with a Bio-Rad gel electrophoresis unit using Bio-Rad 300 power pack. pH of all 
solution was measured using a standard pH meter equipped with an UltraBasic electrode 
(type number 300729.1). 
6.3.1 Determination of protein concentration 
6.3.1.1 Bio-Rad protein assay 
Bio-Rad protein assay, which was based on the method of Bradford (Bradford 1976), was 
used to determine the protein concentrations in each purification step. The microassay 
procedure was performed. Firstly, 5 dilutions of a BSA protein standard were prepared 
within the linear range of the assay (1.2-10.0 µg/ml).  800 µl of each the diluted BSA 
solution and the protein sample solution were added into 200 µl of the protein assay dye 
reagent concentrate (Bio-Rad) in a cuvette and mixed thoroughly. The solutions were 
then incubated at room temperature for exactly 10 minutes for the time-dependent colour 
development of the dye. Absorbance at 595 nm was measured in a Hewlett Packard 
diode array spectrophotometer (model 8452A), and compared to the calibration curve. 
800 µl of distilled water was added into the cuvette instead of the protein sample to serve 
as a blank. Protein samples were assayed in duplicate. 
 
6.3.1.2 Spectrophotometry 
Pure protein solutions in 20 mM Tris buffer were quantified by measuring absorbance at 
280 nm using a Nano-Drop ND-1000 UV-Vis spectrophotometer. Fluorescently labelled 
protein (Section 6.5.4) was quantified by performing a wavelength scan from 800 nm to 
200 nm in a UV-Vis spectrophotometer. 
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6.3.2 NuPAGE® SDS-PAGE (Poly-Acrylamide Gel Electro- 
phoresis) 
The reagents used in the sample preparation are listed: 
 
Reagent Reduced Sample 
Sample x µl 
Sample Buffer (4x) 2.5 µl 
Reducing Agent (10x) 1 µl 
Deionised water  up to 6.5 µl 
Total Volume 10 µl 
 
The NuPAGE® MOPS SDS running buffer contains reagents listed as follow: 
 
Reagent Concentration 
MOPS 50 mM 
Tris Base, pH 7.7 50 mM 
SDS 0.1% 
EDTA 1 mM 
 
The reagents for Stain and destain solutions are listed: 
 
Coomassie blue stain 1% w/v Coomassie blue 
 50% v/v methanol 
 10% v/v glacial acetic acid 
  
Destain 5% v/v methanol 
 10% v/v glacial acetic acid 
 
Samples were heated in a 70 °C water bath for 10 minutes and cooled on ice. An 
SDS-PAGE gel chamber was set with a NuPAGE® 10-well 4-12% Bis-Tris gel (Invitrogen) 
and filled with MOPS SDS running buffer. 10 µl of each sample was loaded into the well, 
with 5 µl of Novex® sharp pre-stained protein standard (3.5-260 kDa) loaded in the first 
well. Electrophoresis was run at 200 V (constant) for 50 minutes. The gel was then 
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stained with Coomassie blue stain for 30 minutes and destained in the destain solution 
overnight. Finally, the gel was visualized in the CHEMI GENIUS bio-imaging system 
(Syngene). 
6.3.3 Over-expression and purification of the wild-type 
and mutant PK1 enzymes 
6.3.3.1 Growth of E. coli BL21 Star™ (DE3) with pGV5A and its derivatives 
 
Crude extract buffer 1 mM EDTA 
 2 mM Mercaptoethanol 
 10 mM Tris, pH 8.5 at 4 °C 
 100 mM KCl 
 10 mM MgCl2
 
Glycerol freeze cultures of E. coli BL21 (DE3) containing pGV5A and its derivatives were 
streaked onto LB plates with appropriate antibiotics and incubated at 37 °C overnight. 
For each strain, a single colony was used to inoculate 10 ml LB broth with antibiotics and 
incubated in a 37 °C water bath shaker with moderate shaking (175-200 rpm) for at least 4 
hours. This culture was used to inoculate 1 litre of LB medium, which was then 
incubated at 37 °C for 20 hours (with shaking). 0.16 mM of 
isopropylthio-β-D-galactoside (IPTG) was added into the culture 3 hours prior to harvest to 
induce protein expression. Cells were harvested by centrifugation at 4,000 g at 4 °C for 
15 minutes. The supernatant was discarded and the cell pellet was resuspended in the 
crude extract buffer and centrifuged again to wash off the residual LB. Finally, the cell 
pellet was suspended in 40 ml of ice-cold crude extract buffer.  
 
6.3.3.2 Purification of PK1 from E. coli BL21 (DE3) 
The protocol for the purification of PK1 from BL21 (DE3) was adapted from the procedure 
used by Mattevi and colleagues (Mattevi et al. 1996) and involved ion-exchange, 
hydrophobic interaction and size-exclusion chromatography to obtain pure and functional 
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enzymes. 
 
6.3.3.3 Preparation of cell free crude extract by ultrasonication 
Cells suspended in crude extract buffer were sonicated for 5 minutes using the Sonics cell 
vibrates amplifier in cycles of 1 second bursts and 2 seconds pauses. Sonication was 
performed on ice. The solution was then centrifuged at 6,000 g for 15 minutes to 
precipitate cell debris. The supernatant containing soluble protein was collected.  
 
6.3.3.4 Ion exchange chromatography 
 
Ion-exchange buffer A 1 mM EDTA 
 2mM Mercaptoethanol 
 10 mM Tris, pH 8.5 at 4 °C 
 100 mM KCl 
  
Ion-exchange buffer B 1 mM EDTA 
 2mM Mercaptoethanol 
 10 mM Tris, pH 8.5 at 4 °C 
 500 mM KCl 
 
The supernatant collected from the ultrasonication was loaded on to a Q-sepharose ion 
exchange column (bed volume 106 ml, 2.6 × 20 cm) that had been pre-equilibrated with 
200 ml of ion-exchange buffer A. The column was then washed with 100 ml of buffer A 
and the enzyme was eluted with ion-exchange buffers A and B in an increasing salt 
gradient (100-500 mM KCl). Eluted fractions were collected and the UV peaks were 
tested for PK1 activity using a LDH-coupled assay (Section 6.4.1). All the active fractions 
were pooled and tested by SDS-PAGE (Section 6.3.2). 
 
6.3.4.5 Phenyl-Sepharose chromatography 
Pooled fractions of protein sample from the ion-exchange column were pre-equilibrated 
with 1.17 M ammonium sulphate before the hydrophobic-interaction chromatography was 
performed. 
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Phenyl-Sepharose buffer A 1 mM EDTA 
 2 mM Mercaptoethanol 
 50 mM Tris, pH 7.5 at 4 °C 
 100 mM KCl 
 1.17 M (NH4)2SO4
  
Phenyl-Sepharose buffer B 1 mM EDTA 
 2 mM Mercaptoethanol 
 50 mM Tris, pH 7.5 at 4 °C 
 100 mM KCl 
 
The phenyl-Sepharose column (bed volume 80 ml, 2.6 × 15 cm) was pre-equilibrated with 
160 ml of phenyl-Sepharose buffer A. After the solution had been loaded on to the 
column, 80 ml of buffer A was used to wash the column and then the enzyme was eluted 
with increasing phenyl-Sepharose buffer B in a decreasing concentration of ammonium 
sulphate 1.17-0 M. Again, the fractions with high UV absorbance were tested for activity 
(Section 6.3.1) and the SDS-PAGE (Section 6.3.2). 
 
6.3.4.6 Gel filtration chromatography  
Buffer containing 10 mM Tris (pH 7.5) and 1 mM EDTA and 2 mM β-mercaptoethanol at 
4 °C was used as the gel filtration buffer. 
 
A Hi-Load Superdex 200 column (bed volume 120 ml, 60 × 1.6 cm) pre-equilibrated with 
the gel filtration buffer was used as the size-exclusion column. Up to 2 ml (maximum 
amount of protein 50 mg) of pre-concentrated pooled sample from the previous 
purification step (Section 6.3.3) was loaded onto the column and eluted. Finally, the 
activity assay and SDS-PAGE were performed on the eluted fractions.  
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6.4 Kinetic study 
6.4.1 LDH coupled activity assay 
A LDH-coupled activity assay (Malcovati & Valentini 1982) was used to test the activity of 
fractions collected in the protein purification procedure. The LDH catalysed reaction is 
illustrated: 
 
The reaction was initiated by the addition of 10 µl from the eluted fractions into the assay 
mixture, which had been pre-incubated at 30 °C for 10 minutes. Activity was measured 
by monitoring the decrease of NADH absorbance at 340 nm, which was caused by the 
reaction between NADH and pyruvate, catalysed by LDH, producing NAD+ and lactate. 
The decrease of NADH corresponded to PK1 activity. 1 unit of PK1 enzymatic activity 
(U) was determined to be 1 μmole NADH per second per mg of enzyme. 
 
The reagents for carrying out the LDH-coupled activity assay are listed as follow: 
 
 [Initial] (mM) Volume (µl) [Final] (mM) 
Hepes (pH 7.5) 100 100 10 
KCl 500 100 50 
MgCl2 100 100 10 
PEP 200 10 2 
ADP 200 10 2 
FBP 200 10 2 
NADH 12 10 0.12 
LDH  10 22 (unit/cell) 
ddH2O  640  
Total volume  990  
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6.4.2 Steady state kinetic study of PK1 wild-type and the 
mutants 
Steady state kinetics of the enzyme was performed by the same LDH coupling assay 
method as did for activity test (Section 6.4.1). The reaction mixture contained 10 mM 
Hepes at pH 7.5, 50 mM KCl, 10 mM MgCl2, 22 unit/ml LDH, 0.12 mM NADH and 
varying amount of PEP, ADP and FBP. Five sets of conditions were examined, so as to 
determine the mutation effects on PEP binding, ADP binding and FBP regulation. Firstly, 
enzymatic activity was measured in the presence of 2 mM FBP, 2 mM ADP and varying 
concentrations of PEP. Secondly, the assay was performed with 2 mM FBP, 2 mM PEP 
and varied amount of ADP. The above two assays were then performed with the absence 
of FBP. Finally, FBP titration experiments were performed at fixed 2 mM PEP and ADP. 
Each reaction mixture was incubated in 30 °C water bath for 10 minutes. The reaction 
was initiated by addition of enzyme. The total volume of reaction solution (including the 
enzyme) was 1 ml. 
6.5 Biophysical methods 
6.5.1 Mass spectrometry 
Mass spectrometry was performed in the Bio21 Molecular Science and Biotechnology 
Institute, University of Melbourne, Australia, using an Agilent 6510 LC/Q-TOF mass 
spectrometer with an electrospray ionising (ESI) source coupled to an Agilent 1100 LC 
system (Agilent, Palo Alto, CA). Data were collected and processed with the program 
Mass Hunter (Agilent). 
 
The enzyme was directly injected (5 μl) into the mass spectrometer at various time points 
with 25% v/v acetonitrile in water with 0.1% v/v formic acid at 0.25 ml/min. Mass 
spectrometric data were collected using the Agilent 6510 LC/Q-TOF mass spectrometer 
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with an electrospray ionising (ESI) source coupled to an Agilent 1100 LC system (Agilent, 
Palo Alto, CA). All data were acquired and reference mass corrected via a dual-spray ESI 
source. Each scan or data point on the total ion chromatogram was an average of 10,000 
transients, producing a scan every second. Spectra were created by averaging the scans 
across each peak. Data for the enzyme without inhibitor were also collected. The 
conditions for the mass spectrometer were: positive mode; drying gas flow was 7 l/min; 
nébuliser was 30 psi; drying gas temp was 300 °C; Vcap was set to 3000 V; the fragmentor 
was set to 225 V; the skimmer was set to 60 V; the OCT RFV was 750 V; and the scan 
range acquired was 100-2500 m/z. 
6.5.2 Circular dichroism spectroscopy (CD) 
Circular dichroism (CD) spectra of the wild-type and the mutant PK1 enzymes were 
recorded on a Jasco-815 CD spectropolarimeter in a rectangular quartz cuvette with 0.2 cm 
path length. Protein samples with appropriate ligands were dissolved in 10 mM sodium 
phosphate buffer at pH 8.0 (CD buffer). 
 
6.5.2.1 Sample preparation 
Wild-type PK1 and its mutants kept in Tris buffer were run through a HiTrap™ 5 ml 
desalting column (GE Healthcare Life Science) for buffer exchange to phosphate buffer. 
CD buffer was degassed for one hour in prior, as oxygen was an UV light quencher 
(Greenfield 2006). Protein samples were concentrated to approximately 1.0 mg/ml, with 
concentration accurately determined by a Nano-Drop spectrophotometer with published 
molar extinction coefficient of pyruvate kinase. This stock solution was then diluted for 
CD measurement. 
 
6.5.2.2 CD Experiment 
Before starting theinstrument, the optics compartment was flushed with nitrogen for 15-20 
minutes as to remove the oxygen. Subsequently, CD spectra were done by UV scanning 
from 250 nm to 185 nm, with 0.5 nm bandwidth and 1 second intervals, and accumulated 
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for 131 seconds. Data were stored every second in wavelength (nm) versus millidegree (θ, 
mdeg). Simultaneously, a wavelength scan was performed in order to monitor the 
absorbance. Cells were rinsed thoroughly with ethanol and distilled water between 
experiments. Data were processed using SELCON3, CONTIN-LL and CDSSTR 
programs from DICHROWEB online analysis using reference data 7 (Whitmore & 
Wallace 2004). 
6.5.3 Analytical ultracentrifugation (AUC) 
Sedimentation velocity experiments of the wild-type and mutated PK1 enzymes were 
performed using an Optima™ XL-I analytical ultracentrifuge (Beckman-Coulter) equipped 
with absorption optical scanner (ABS). 20 mM Tris (pH 8.0) with 50 mM KCl was used 
as the AUC buffer. Addition of KCl to the buffer increased ionic strength thus prevented 
the primary charge effect, which is caused by long range electrostatic interactions (Schuck 
et al. 2002). Protein samples at 1.0 mg/ml and 0.1 mg/ml were examined. Centrifuge 
cells with Epon double-sector centrepieces and quartz windows were assembled before 
each experiment. 380 µl of sample and 400 µl of the reference solution (buffer) were 
loaded into the cells pre-tightened to 120 psi. 
 
To optimise wavelength selection for the high speed centrifugation, an initial wavelength 
scan was performed at 3,000 rpm and 20 °C between 200-300 nm. Sedimentation velocity 
experiments were then performed at 35,000 rpm for 120 scans, and the data was recorded 
at step size 0.001 cm. Data were processed by SEDFIT software (which can be 
downloaded from www.analyticalultracentrifugation.com) using c(s) distribution analysis 
(Schuck 2000). SEDNTERP software was used for calculating the protein partial-specific 
volumes and extinction properties, as well as buffer density and viscosity. Graphs were 
drawn using Origin software (OriginLab, version 8E). 
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6.5.4 AUC-FDS: Analytical ultracentrifugation coupled with 
fluorescence detection system 
Confocal fluorescence optics (Aviv Biochemical) was integrated into a Beckham Coulter 
Optima™ XL-1 analytical ultracentrifuge (Beckham-Coulter) the for fluorescence 
detection experiments. Centrifuge cells were assembled before each experiment from 
aluminium cell housing, a sapphire window, and an Epon two-sector centrepiece. 
 
6.5.4.1 Protein labelling 
Pure protein samples stored in Tris buffer were buffer exchanged with 0.1 M sodium 
bicarbonate (pH 8.3) and concentrated to about 2.0 mg/ml, as recommended in 
amine-reactive probe (Invitrogen). 
 
Approximately 10 ml of acetonitrile (CH3CN) was dehydrated using molecular sieves (3 Å 
beads, 4-8 mesh, Sigma-Aldrich) by pouring acetonitrile over the beads and left in the dark 
for 20 minutes. 1 mg of Alexa Fluor® 488 succinimidyl ester dye (Invitrogen) was 
centrifuged briefly to move all the dye to the bottom of the vial and added with 1 ml 
dehydrated acetonitrile. Various volumes of this dye suspension in acetonitrile were 
aliquotted into Eppendorf tubes, so that a 1:1 molar ratio of protein to dye was made. 
Specific volumes of the dye suspension solution required by each protein sample for the 
labelling are listed as follow: 
 
 MW 
(Da) 
[protein] 
[mg/ml] 
Volume 
(ml) 
M 
(mole/ml) 
Volume dye 
(µl) 
Wild-type 50729.3 2.36 0.8 4.652 x 10-5 26 
A301T 50759.3 1.42 0.8 2.798 x 10-5 16 
A301S 50745.3 2.65 1.0 5.222 x 10-5 36 
G381A 50743.3 0.30 1.0 5.912 x 10-6 4.2 
 
Acetonitrile in the tubes with the required amount of dye suspension for each protein was 
evaporated. Protein samples in 100 mM Na2CO3 buffer (pH 8.3) were then added and 
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mixed gently. The protein-dye solution was incubated on ice in the dark for 2 hours to 
allow the labelling reaction to proceed. The resulting solution had a fluorescent bright 
green colour. 
 
A Sephadex G-25 column (bed volume 24 ml, 30 × 1.0 cm) was used for separating the 
labelled protein from the dye. The column was pre-equilibrated with 20 mM Tris, pH 8 
and 50 mM KCl. The protein conjugated to the dye was separated from unreacted protein 
by monitoring the eluted fractions with UV at 280 nm (for unlabelled protein) and 495 nm 
(for labelled protein and the dye). Fractions with the labelled protein were collected in 
1.5 ml Eppendorf tubes and pooled. The protein concentration was checked by 
measuring the absorbance of the protein-dye conjugate at 280 nm (A280) and at the 
absorbance maximal wavelength (λmax) for the dye (Amax). The λmax for Alexa Fluor 488 
dye is 495 nm (amine-reactive probes, Invitrogen). Corrected protein absorbance for the 
contribution of the dye to the absorbance at A280 was calculated as follows: 
Aprotein = A280 – Amax × (CF), 
where CF is (A280 free dye/Amax free dye). CF for the Alexa Fluor® 488 dye is 0.11, as listed in 
the appendix of the amine-reactive probes (Invitrogen).  
 
The protein concentration ([protein]) was then calculated: 
[Protein] = Aprotein ×Єprotein, 
where Єprotein is the extinction coefficient of E. coli PK1 at 280 nm and protein 
concentration is in mg/ml. Єprotein is 0.147 (without disulfides). 
 
Degree of labelling (D.O.L) was calculated: 
DOL = Amax × MW/ [protein] × Єdye, 
where MW is the molecular weight of the protein, Єdye is the extinction coefficient of the 
dye at its absorbance maximum and protein concentration is in mg/ml. Єdye for Alexa 
Fluor® 488 dye is 71,000 as listed in the appendix of the Invitrogen amine-reactive probes. 
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Protein concentrations and degrees of labelling of Alexa Fluor® 488 dye labelled proteins 
are listed as follow: 
 
 A280 Amax Aprotein [protein] 
(mg/ml) 
DOL 
Wild-type 0.3374 0.5621 0.276 1.875 0.214 
A301T 0.3340 0.4599 0.283 1.928 0.171 
A301S 0.6305 1.3303 0.484 3.294 0.289 
G381A 0.0801 0.0412 0.076 0.514 0.057 
 
6.5.4.2 AUC-FDS performance 
350 μl of each sample comprising Alexa Fluor® 488 dye-labelled PK1 was initially 
centrifuged at 3,000 rpm and then 40,000 rpm at 20 °C. 50 µl heavy mineral oil and 2 µl 
light mineral oil, which included 0.1% bodipy fluorescent dye, were added into the cells in 
order to define the boundaries (meniscus of the solvent and bottom of the cell). 200 
radial scans were collected continuously. Data were collected between 5.8 and 7.2 cm at 
0.002 cm increments and represented the average of five scans. The excitation beam (488 
nm output from a frequency-doubled 13 mW CW solid-state laser) was positioned directly 
above the sample and directed confocally to a small spot beneath the sapphire window. 
The sample emission was also recorded from directly above, reaching the photomultiplier 
tube (PMT) after passing through a dichronic mirror (to eliminate reflected excitation) and 
505 nm cut-off filter (MacGregor et al. 2004). Sedimentation velocity data were analysed 
according to a continuous size distribution model using the program SEDFIT. 
 
 
 
 
 
 
 
 
 151
The AUC-FDS logsheet with protein name and location in the rotor, cell content and FGA 
gains specified is shown below: 
 
Cell Sample 
(mg/ml) 
Volume 
(µl) 
Light oil 
(µl) 
Heavy oil (µl) FGA 
Gains 
1 Counter balance     
2A G381A, 0.103 350 2 50 
2B A301T, 0.096 350 2 50 
1× 
63% 
3A G381A, 0.0103  350 2 50 
3B A301T, 0.0096  350 2 50 
2× 
84% 
4A G381A, 0.00103  350 2 50 
4B A301T, 0.00096 350 2 50 
8× 
90% 
5 Counter balance     
6A A301S, 0.103 350 2 50 
6B Wild-typ, 0.1042 350 2 50 
1× 
63% 
7A A301S, 0.0103 350 2 50 
7B Wild-type, 0.01042 350 2 50 
2× 
84% 
8A A301S, 0.00103 350 2 50 
8B Wild-type, 1.00042 350 2 50 
8× 
90% 
 
AUC-FDS was performed at a lower concentration at 0.0005 mg/ml for the wild-type 
enzyme and enzymes with A301T and A301S mutations. Ovalbumin at 0.1 mg/ml was 
added into the AUC-FDS buffer to stabilise the enzymes. The sample volume and the 
amount of light oil (with 0.1% bodipy fluorescent dye) and heavy oil added was identical 
to those in the logsheet shown below, with the FGA gains set at 8 × 95%. 
6.6 X-ray crystallography 
Hanging drop vapour-diffusion method with conditions specified in the work done by 
Mattevi and colleagues (1995) was used in this study. 5 μl protein solution and 5 μl 
reservoir solution was pipetted onto the cover slide, without mixing. 500 μl of reservoir 
solution was used in each well. 
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Reservoir solution: 
 
MES/NaOH, pH 6.2 100 mM 
MgSO4 100 mM 
KCl 10 mM 
NaN3 0.02% (w/v) 
PEG 8000 16% (w/v) 
 
Protein solution: 
 
Purified enzyme 10 mg/ml 
Tris-HCl, pH 7.5 10 mM 
β-mercaptoethanol 2 mM 
 
For the mutated enzymes, robotic crystallisation screening was performed at Bio21 
collaborative crystallisation centre, Melbourne, Australia, using sitting-drop method. A 
pH-, anion- and cation-testing (PACT) screen was performed, and diffraction trials were 
performed using beamline 3BM1 at the Australian synchrotron.
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